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Total Synthesis and Structural Revision of (+)-Muironolide A  






In the Zakarian group, we are interested in the synthesis and application of marine 
natural products. Elucidating the biological properties of marine natural products is often 
hampered by a lack of its availability from natural sources in meaningful quantities. 
Therefore, chemical synthesis remains the most viable option for the production of these 
molecules. The syntheses of marine natural products frequently open opportunities to 
develop new synthetic methods, which push the boundaries of current state-of-the-art 
bond constructions.  
Herein, we report the total synthesis and structural revision of (+)-muironolide A. 
Asymmetric intramolecular Diels-Alder reaction and late stage macrolactonization were 
the key transformations used for the synthesis of muironolide A, which led us to the 
reassignment of its structure as (−)-C21-epi-muironolide A.   
The second portion describes the late stage derivatization of pinnatoxin compounds. 
The ultimate goal for pinnatoxin derivatives is introducing 18F, 13C and 3H isotope 
labeling to probe cellular metabolism and biodistribution in biological systems. This 
 ix 
work builds upon a growing body of information that will provide an understanding of 
the full biological profile of the structurally complex pinnatoxin compounds.  
 The last portion of this thesis will focus on synthetic studies towards the synthesis of 
pteriatoxin A. A regioselective catalytic asymmetric dihydroxylation of pinnatoxin G is 
the featured method for the installment of the 1,2-diol moiety. Establishing this key step 
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In 2009, the Molinski group at the University of California, San Diego (UCSD) 
published a report of the isolation and characterization of muironolide A.1 Muironolide 
A, a secondary metabolite, was isolated from the marine sponge Phorbus sp. Muironolide 
A most likely arose from heterogeneous microbial interactions with the marine sponge. 
These types of associations provide a diverse array of natural products. For example, this 
same sponge also produced known metabolites such as phorboxazoles A and B and 
phorbaside A. 2  State-of-the-art microcryobe NMR spectroscopy and degradation 
techniques were employed to elucidate the structure of muironolide A with only 90 µg of 
the material isolated from the natural source. From these structural studies, it was 
discovered that muironolide A possessed two unprecedented features: a hexahydro-1H-
isoindolone ring and a trichlorocarbinol ester. Other notable features include a 16-
membered macrocyclic diester and a chlorocyclopropane ketide (CCK). With 
exceedingly small amounts of sample available, some preliminary biological screening 
was performed, and muironolide A was shown to exhibit moderate activity towards 
HCT116 colon tumor cell line with IC50 = 96.5 µg/mL and antifungal activity against 
Cryptococcus neoformans MIC = 16 µg/mL. In order to unveil the full biological profile 
of 1 (Figure 1), more material was required. Extraction from natural sources was not 
feasible. Since 2009, the authors of the original isolation have not encountered the marine 
sponge Phorbus. The only option to access additional supply of muironolide A was 
through total synthesis. 
 
 3 
1.2: Isolation and Characterization of Muironolide A 
Marine sponge Phorbus was encountered off the western coast of Australia near the 
Muiron islands. Extraction and HPLC purification afforded 90 µg of muironolide A. 
Microcryobe NMR spectroscopy, Fourier Transform Mass Spectrometry (FTMS), 
circular dichroism (CD) and synthesis/chemical degradation techniques were employed 
to elucidate its structure. FTMS result showed a molecular formula of 1 as C27H33Cl4NO5 
and m/z = 5.92.11869 [M+H]+ to reveal 10 double bonds. Carbon-13 NMR showed three 
ester or amide groups. Circular dichroism (CD) spectrum established the absolute 
configuration of muironolide A based on Harada−Nakanishi nonempirical rule.  
Figure 1. HMBC and NOESY Determination of Stereochemistry at C4, C5,    
                      C11, C14 and C17. 
 
The relative stereochemistry of the northern portion of the diester was established 
through key NOE signals shown in Figure 1. Strong NOE correlation was observed 
between H11 and H6 (AB system JHH = 8.8 Hz) positions of the γ-lactam. Also, H14 and 
H17 NOE signals indicated a gauche-turn conformation of the macrocycle. The 
stereochemistry at C21 adjacent to the chlorocyclopropyl ketide (CCK) fragment could 
not be resolved through NMR spectroscopic methods. NOESY or J-based methods could 
not relay the stereochemical information of the C4 stereocenter through the α,β-

















































corresponding CCK fragment for HPLC trace analysis were performed to establish C23, 
C22 and C21 stereocenters.   
Figure 2. Chlorocyclopropanes in Natural Products 
 
Chlorocyclopropanes are present in other natural products such as phorbaside A3 and 
callipeltosides A-C. 4  Molinski proposed that the stereochemistry at C22 and C23 
positions of muironolide A have the same absolute configuration found in callipeltosides 
A-C but opposite to phorbaside A. Interestingly, phorbaside A was extracted from the 
same marine sponge Phorbus as muironolide A.  





























































































Efforts to confirm the stereochemistry of CCK 5 by HPLC traces prompted the 
synthesis of four synthetic CCK diastereomers shown in Scheme 1A. Sonication of 
chloroform solutions containing (−)-menthyl acrylate 2, potassium hydroxide and 
tetramethylammonium bromide afforded dichlorocyclopropane 3 in 88% ee. 
Diastereoselective reduction of 3 was achieved with lithium aluminum hydride that 
provided trans-alcohol 4. The configuration of the chlorocyclopropyl alcohol 4 matched 
the same compound that was reported by Olivo and coworkers.5 Oxidation and treatment 
of the resulting aldehyde with zinc powder and methyl 2-bromoacetate completed the 
synthesis of the CCK fragment.  A total of four isomers at C23, C22 and C21-positions 
were made from this synthesis. Further modifications to install a chromophore to aid in 
the HPLC analysis were necessary. Hydrolysis of the methyl ester and esterification with 
2-bromo-1-(naphthalen-2-yl)ethanone were performed. Similarly, muironolide A was 
subjected to the same hydrolysis and esterification procedures. Then, the natural product 
derived CCK fragment 5 was spiked with samples 5-B and 5-D. The natural CCK 5 
showed matching retention times with sample 5-B. Therefore, they concluded that the 
natural CCK unit was the C23-(R), C22-(S) and C21-(S) isomer.  
1.3: Synthetic Studies Towards Hexahydro-1H-Isoindolone Unit of Muironolide A 
1.3.1: Molinski’s Study Towards Hexahydro-1H-Isoindolone Unit 










The hexahydro-1H-isoindolinone (referred to here as isoindolinone) bears three 
contiguous stereocenters on the C4, C5, and C11-positions and unsaturation at the α,β-
positions of the amide. Asymmetric intramolecular Diels-Alder (IMDA) cycloaddition 
with MacMillan-type organocatalyst was used to construct the isoindolinone subunit from 
precursor 6 (Scheme 2).6  
Scheme 2. Asymmetric Intramolecular Diels-Alder using Organocatalyst 
 
Under optimized conditions, the treatment of amide 6 with 20 mol % of (S)-5-benzyl-
3-(2-hydroxyethyl)-2,2-dimethylimidazolidin-4-one perchlorate (7) in a 2% water-
acetonitrile solution at 0 °C for 84 h provided a 6:1 (8:9) mixture of diastereomers in 
73% yield and 88% ee. Diastereomer 8 was converted to the desired isomer 9 with DBU. 
Attempts to isomerize the C9 and C10 double bond into conjugation were unsuccessful 
with a variety of different bases (NaOMe-MeOH, DBU-benzene, NaH-DMF). 
Conformational analysis provided some insight into the reluctance of this isomerization.  
Figure 4. Conformational Analysis of Double Bond Isomers 
 
The double bond at the α,β-positions of 10 confers a strained half-chair conformation 


































G = 0.6 kcal/mol
9 10
 7 
the β,γ-position (9) was more stable than the α,β-positions (10) by 0.6 kcal/mol (PM3).  
The authors suggested that one possible method to place the double into conjugation was 
through hydrogenation, α-selenation and oxidation/elimination.  
1.3.3: Mitchell’s Study Towards Hexahydro-1H-Isoindolone Unit 
In 2013 and 2015, Mitchell reported a unique intermolecular Diels-Alder approach to 
the isoindolinone core of muironolide A.7 In their study, an electronically deficient diene 
11 underwent [4+2] cyclization with dienophile 12 to afford endo product 13 in 76% 
yield and > 19:1 dr.  
Scheme 3. Mitchell’s Intermolecular Diels-Alder Approach 
 
Unfortunately, the stereocenter at the C11 position was epimeric from the desired 
configuration due to the cyclic restraint of the dienophile. Attempts with acyclic 
dienophile to correct the stereochemical configuration were unsuccessful. The treatment 
of α,β-unsaturated aldehyde 14 and diene 11 with Macmillan’s organocatalyst provided 
no cycloaddition adduct.  






































1.3.4: Zakarian’s Study Towards Hexahydro-1H-Isoindolone Unit 
In 2013, we reported a study utilizing an intramolecular Diels-Alder (IMDA) reaction 
to access the isoindolinone subunit in an efficient manner.8 We identified that compound 
35 was structurally similar to the natural product and would serve as a suitable model to 
study the IMDA reaction.  
Scheme 5. IMDA Strategy 
 
We envisioned that β-ketoamide Z-33, in the enol form, would undergo a 
cycloaddition or a double Michael addition to access 34. The strategic placement of β-
keto amide served two purposes in our synthetic design. First, the placement of the 
double bond between C9 and C10 after cycloaddition was inconsequential as this existed 
as the enol-tautomer. Also, the dicarbonyl functional group could chelate with a chiral 
Lewis acid to promote an asymmetric IMDA reaction. At the onset of our plan, we were 
aimed to test the influence of double bond geometry on the stereochemical outcome of 
the IMDA reaction with Z-33 and E-24 as substrates. This investigation started with 
substrate E-24. 
The synthesis of E-24 was completed in a four-step sequence. Swern oxidation of 

























direct exposure with PMB-amine (K2CO3, DMF) provided 19 in 34% overall yield. 
Dioxinone 23 was completed in three-steps by treatment of (E)-ethyl 2,4-dimethylpent-2-
enoate 20 with i-Bu2AlH, Swern oxidation to 21, followed by olefination with Horner-
Wadsworth-Emmons (HWE) reagent 22 provided 23 in 44% overall yield.10,11 Direct 
coupling of amine 19 and dioxinone 23 in the presence of pyridinium p-toluenesulfonate 
in refluxing toluene afforded amide E-24 in 62% yield.12  
Scheme 6. Synthesis of E-24 IMDA Precursor 
 
Upon heating of substrate E-24 in toluene, a highly endo-selective IMDA product 25 
was isolated in 61% yield and dr >30:1. The addition of any base additives (e.g., triethyl 
amine, Cs2CO3, LiN(SiMe3)2, n-Bu4NF)13 did not accelerate the reaction rate but rather 
poor yields or decomposition products were isolated. Therefore this suggested a 
concerted cycloaddition was occurring rather than a double Michael addition.   
After the Luche reduction (NaBH4, CeCl3) of the ketone, the relative stereochemistry 
of 26 was confirmed by NOE studies. The stereochemistry consistent with muironolide A 
could be obtained by epimerizing C4-position. Treatment of ester 26 with i-Bu2AlH and 
MnO2 provided unsaturated aldehyde 27 in 79% yield. Epimerization was performed in 
1. Swern Ox.
2. Ph3PCHCO2Et
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the presence of piperidinium trifluoroacetate (toluene, 75 °C) to afford 28 in 80% yield 
and dr >20:1.14  
Scheme 7. Highly Endo-Selective IMDA Reaction with E-24 
 
The stereochemical outcome of this key IMDA transformation deserves a comment. 
At the onset, the reactive enol form of E-24 was hydrogen bond stabilized (TS1). This 
underwent an endo-selective cycloaddition reaction, followed by rapid C8 epimerization 
(Figure 5). We hypothesized that the origin of this highly diastereoselective 
transformation was based on hydrogen bond stabilization in the transition state (TS1) 
rather than stabilization gained from secondary orbital overlap (TS2). There was notable 
erosion in diastereoselectivity (~5:1 favoring endo) when E-24 was trapped as a silyl 
ketene acetal, suggesting minor influences of secondary orbital overlap to the 
stereoselective outcome of this transformation. The IMDA reaction of Z-33 was 
investigated next.  
The synthesis of IMDA precursor Z-33 began with Kumada coupling of iodide 29 
with vinylmagnesium-bromide and Pd(PPh)4,  followed by a one-pot substitution of the 
hydroxyl group to  PMB-amine 32 in 32% overall yield (Scheme 8).15 Amide bond 









































toluene for 3 h to provide rotamer 34 in 95% yield. Cross metathesis of methyl acrylate 
with diene 34 in the presence of Hoyveda-Grubbs II (HGII) catalyst (10 mol%) 
completed IMDA precursor Z-33 in 81% yield.16 
Figure 5. Rational for Endo-selective IMDA Reaction for E-Isomer 
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Scheme 9. Highly Exo-Selective IMDA Reaction with Z-33 
 
Heating β-keto amide Z-33 in toluene at 100 °C for 24 h, provided IMDA product 34 
in 60% yield and dr > 30:1. NOE studies confirmed the relative stereochemistry at C4, 
C5 and C11 were consistent with the natural product.  
Figure 6. Rational for Exo-selective IMDA Reaction for Z-Isomer 
 
Three additional steps were required to complete the isoindolinone subunit. Luche 



















1. NaBH4, CeCl3, MeOH
2. CH3SO2Cl, Et3N, CH2Cl2
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alcohol and mesylate elimination (DBU at 85 °C) provided isoindolinone 35 in 64% yield 
over three steps. The significance of this transformation was the ability to access the 
correct stereoconfiguration of the isoindolinone in one-step. This study represents the 
most concise entry to the isoindolinone core to-date.  
1.3.5: Heteroleptic Lanthanide–Terpyridine Complexes with 2-Oxo Amides 
 
The ultimate goal of the IMDA approach to access the isoindolinone core of 
muironolide A was to render this transformation stereoselective. Asymmetric catalysis 
with lanthanide complexes has increasing utility in organic synthesis. 17  Unique 
characteristics of lanthanides include high coordination numbers, stability and dynamic 
binding towards ligands that impart catalytic efficiency.18  
Table 1. Lewis Acid Screening for IMDA Reaction 












15	 Dy(NO3)3	 EtOAc	 45	 24	 73	 10:1	
 
Initial screening of the IMDA reaction in the presence of catalytic amounts of metal 
salts revealed that La(III) salts were superior. Under optimized conditions, entries 13 and 
15 (see Table 1), β-keto amide Z-33 was converted to isoindolone 34 in the presence of 
either La(OTf)3 or Dy(NO3)3 in ethyl acetate at 45 °C for 24 h with dr >20:1 and 10:1, 
respectively. Screening different D-block transition metals such as copper, iron and 
zirconium salts led to poor conversions (16-43%) and long reaction times (40-70 h) 
(entries 2-4).  
Figure 7. Screening of Ligands for IMDA Reaction 
 
With optimized conditions at hand, we next turned our focus towards chiral ligands 



























L5, R1=H, R2=Ph; 
L6, R1=H, R2=i-Pr; 







L 11 mol% 
Et3N (2.0 equiv) 










were individually optimized and L1 provided the most satisfactory enantioselectivity at 
40% ee.  
At this point, we were inspired to explore unconventional ligands for the IMDA 
reaction. Our goal was to rationally design chiral ligands that were suitable for β-
ketoamides. Inspiration first came from a report by Fukuda and co-workers, who reported 
crystal structures of heteroleptic lanthanum-terpyridine complexes with acetoacetate 
(Ln(terpy)(acac)(NO3)2).19 Surprisingly, there was little literature precedence for chiral 
terpyridine (terpy) ligands with rare earth metals used in asymmetric synthesis. The only 
relevant application was modestly enantioselective cyclopropanation of styrene using 
chiral terpy ligand with Cu(II) or Rh(III) catalysts reported by Kwong et. al.20 Other 
applications of non-chiral Ln(III)-terpy complexes range from the study of fluorescent 
emissions properties and application as photochemotherapeutic agents.21 
At the onset, we chose to replace acac with unsymmetrical ligands such as 
pyrolidineamide 38 or N,N-dibenzyl-2-oxobutanamide 39 (Scheme 10). Known 
complexes of [Ln(terpy)(NO3)2(H2O)n]NO3 were obtained by the treatment of 
Ln(NO3)3•xH2O with one equivalent of terpyridine in ethanol for one hour at room 
temperature followed by filtration. This bench-top stable complex was treated with three 
equivalents of β-keto amide, two equivalence of triethylamine in a 1:1 mixture of 
acetonitrile and ethanol. Slow evaporation at room temperature (~36 h) provided 
colorless crystals ranging from 10-50 µm. Crystal structures of this type were obtained 




Scheme 10. Synthesis and X-Ray Structures of Ln-Terpyridine Complexes with β- 
                    Keto Amide Ligands.  
 
 
 The ORTEP drawing of Dy(terpy)(NO3)2(pyacac) is shown in Scheme 10. As 
expected, the two nitrate groups occupy the axial positions above and below the plane 
occupied by terpy and pyacac ligands. Of note, while the majority of reported acac 
complexes with lanthanides contain more than two units of the ligand, in our case only 
one pyacac unit was present in the Dy complex.22 This property was highly desirable for 
catalyst development because it was indicative of a more defined, unambiguous substrate 
binding. Both the terpyridine and pyacac ligands are nearly planar; the angle between the 
planes was approximately 33°. XRD structures with closely related complexes were also 
obtained for Sm(terpy)(NO3)2(pyacac) and Eu(terpy)(NO3)2(pyacac), with the angles 
between the planar terpyridine and pyacac ligands at 29° and 30°, respectively. With 
these compounds on-hand, we continued with a more complex, conformationally labile 
dibenzyl amide 39. We were delighted that when [Dy(terpy)(NO3)2(H2O)2]NO3 was 
treated with amide 39 in the presence of triethylamine, the resulting complex 
[Ln(terpy)(NO3)2(H2O)n]NO3




38, R = -(CH2)4-
39, R = Bn
+
Et3N, MeCN-EtOH (1:1)

























Dy(terpy)(NO3)2(dbacac) 40 Dy(terpy)(NO3)2(pyacac) 41
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Dy(terpy)(NO3)2(dbacac)  afforded crystals suitable for crystallographic analysis (Scheme 
10).  
From these structures, we concluded that Ln(III)-terpy complexes could be excellent 
catalysts for the IMDA application, not only for its ability to generate the reactive enolate 
form of β-ketoamides but also for its well-defined and predictable metal-ligand geometry. 
In the future, these crystal structures could aid in the strategic placement of chiral groups 
on the terpyridine ligand to impart a chiral environment necessary for asymmetric 
catalysis  
1.4: Total Synthesis and Structural Revision of (+)-Muironolide A 
We reported the first enantioselective total synthesis of (+)-muironolide A (44).23 
Based on chemical synthesis and NMR studies, synthetic 1 did not match the 
characterization data of the natural substance. The synthesis of two C21, C22, C23-
diastereomers (43 and 44) led to the discovery of the correct structure of muironolide A 
to be the C21-epimer (44) shown in Figure 8. The full characterization of 44 was in full 
agreement with that of natural muironolide A. However, the CD spectrum of 44 was 
found to be antipodal; therefore, we established the absolute configuration of the natural 
product to be (-)-muironolide A.  
In this synthetic strategy, we envisioned a challenging late stage 16-membered 
macro-lactonization shown in Scheme 11. Concise reduction and dehydration steps 
completed the isoindolinone subunit. An asymmetric lanthanum catalyzed intramolecular 




Figure 8. Muironolide A and C21, C22 and C23-Diastereomers 
 
Scheme 11. Synthesis Plan for (+)-Muironolide A 
 
Strategically, the natural product was divided into three segments (Figure 9). The 
synthesis of the eastern fragment started with (+)-β-citronellene 52. The southern 


















































































hydroxy pentenoate 51. Finally, the synthesis of the western portion began from known 
iodo-alcohol 50.  
Figure 9. Three Key Starting Material Fragments 
 
The preparation of the western fragment began by converting (+)-β-citronellene24 to 
trichloromethyl carbinol 53 (Scheme 12). Selective ozonolysis and treatment of the 
resulting aldehyde with TMSCCl3 and sodium formate afforded alcohol 53 in 79% yield 
in a 1:1 dr.25  

















1. O3, CH2Cl2, -78 oC; Me2S
2. Me3SiCCl3, HCO2Na, DMF
79% yield
1. DMSO, (CF3CO)2O, i-Pr2NEt
    -78 oC, CH2Cl2
2. 2.5 mol% [Ru(cymene)Cl]2, DMF
    5 mol% (R,R)-TsDPEN, HCO2H
    Et3N,t-BuOMe
78% yield
dr 10:1
HO CCl3 HO CCl3
1. BOMCl, i-Pr2NEt, n-Bu4NI, 
    CH2Cl2, 45 oC
2. CH2   C(Me)CHO





























No literature precedence existed for asymmetric trichloromethyl addition to aldehydes 
and our attempts were met without success. Therefore, the synthesis of 54 required 
oxidation (DMSO, (CF3CO)2O, i-Pr2NEt) followed by an asymmetric Noyori reduction 
of the corresponding ketone with [Ru(cymene)Cl]2 and (R,R)-TsDPEN to afforded 54 in 
78% yield with a 10:1 dr.26  Benzyloxymethyl (BOM) protection of 54 and cross 
metathesis with methacrolein in the presence of Hoveyda-Grubbs II catalyst (HGII) gave 
aldehyde 55 in 62% yield and an E:Z ratio of 10:1. Installment of dioxinone 56 through 
Horner-Wadsworth-Emmons (HWE) olefination with aldehyde 55 provided intermediate 
57. Thermolysis of the resulting dioxinone (PPTS, toluene, 110 °C) with amine 58 
afforded amide 59 in 93% yield.27  
Figure 10. Macrolactonization Strategy: Pathway A and Pathway B 
 
At this juncture, our synthetic plan for late stage macrolactonization was left flexible 
for ring closure through pathway A (positions 19, 18, Figure 10) or pathway B (positions 
1, 21). Ultimately, both routes have been explored. Our investigation began with pathway 
A, which required early installment of the CCK fragment.  
The chlorocyclopropyl ketide was prepared in three steps from tert-butyl 3-
hydroxypent-4-enoate 51.28 Allylic acetate 52 was obtained through a robust and scalable 

























yield (50% theoretical yield) and 98% ee. Treatment of acetate 52 with potassium 
carbonate in methanol afforded allylic alcohol 54 in 83% yield. 
Scheme 13. Synthesis of Chlorocyclopropyl Ketide (CCK) 
 
Treatment of allylic alcohol 54 with CHI2Cl and diethyl zinc at -40 °C for 24 h 
afforded CCK fragment 47 in 56% yield in a dr of 5:1 (Scheme 13).29 Acylation of 
intermediate 47 with acryloyl chloride and its cross metathesis with diene 59 (5 mol% 
HG(II), CH2Cl2, 45 °C, 12 h) provided IMDA precursor 61 in 64% yield with an E:Z of 
>20:1.  
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Optimized cycloaddition conditions required 12 mol% PYBOX ligand L1, 10 mol% 
La(OTf)3 and Et3N in ethyl acetate at 45 °C for 24 h, furnishing isoindoledione 62 in 61% 
yield as an inseparable 3:1 mixture of diastereomers (Scheme 14). The exo IMDA 
reaction pathway was preferred due to stabilization of the metal enolate in the transition 
state (as mentioned previously). The lanthanum enolate was expected to raise the HOMO 
energy of the diene system by increasing its electron density, which was favorable for the 
cycloaddition reaction.  
Scheme 15. Separation of Diastereomers by Preparative HPLC 
 
The reduction of ketone 62 with sodium borohydride made the separation of the 
diastereomeric mixtures possible by preparative HPLC. The major diastereomer 63 was 
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isolated in 70% yield, and the minor diastereomer was isolated in 25% yield. A single 
crystal of 63 suitable for X-Ray analysis was obtained. This crystal structure 
unequivocally established all stereogenic centers present in muironolide A (Scheme 15). 
Dehydration with DCC and CuCl in refluxing toluene completed the isoindolinone 
subunit in 80-90% yield.30 Other dehydration methods (MsCl/DBU, Burgess or Martin 
reagents) solely provided the C9-C10 double bond isomer (versus C8-C9 double bond). 
In preparation for macrolactonization, a one-pot deprotection of the tert-butyl ester and 
benzyloxymethyl (BOM) ether was achieved with trifluoroacetic acid in CH2Cl2 to reveal 
hydroxyl acid 60 in 95% yield (Scheme 16).  
Scheme 16. Macrolactonization via Pathway A 
 
Conditions for macrolactonization using Yamaguchi reagent appeared to be the most 
promising.31 However, hydroxyl acid 65 was isolated in 30-50% yield as a major product 
apparently arising from β-elimination of the CCK fragment. Therefore, our attention 
shifted towards macrolactonization through pathway B.  
From a common diene intermediate  (59), cross metathesis with methyl acrylate 
afforded IMDA precursor 66 in 89% yield and an E:Z of >20:1 (Scheme 17). The same 
CF3CO2H
CH2Cl2




























four-step sequence shown previously for the construction of the isoindolinone core and 
BOM-deprotection afforded alcohol 67 in 38% yield over 4 steps.  
Scheme 17. Synthesis of Alcohol 67 
 
Scheme 18. Pathway B: Yamaguchi Protocol for Macrolactonization 
 
Esterification of 67 with acid 23 was achieved through Yamaguchi’s protocol to provide 
ester 69 in excellent yield. Simultaneous cleavage of methyl ester and silyl ether in the 
presence of LiCl in DMF with microwaved-assisted heating (170 °C for 1 h) afforded 61 
in 81% yield. We were delighted when, under Yamaguchi conditions, hydroxyl acid 61 
5 mol% HG(II)
CH2Cl2





































































underwent macrolactonization at 50 °C to afford macrocycle 70 in 55% yield. The final 
steps of this synthesis consisted of oxidative deprotection of the p-methoxybenzyl (PMB) 
group with DDQ and controlled amounts of water (5 equiv.) in dioxanes at 100 °C. These 
conditions afforded 1 in 90% yield.32 
Scheme 19. Completion of the Synthesis of C21-epi-Muironolide A 
 
Unfortunately, 1H NMR, 13C NMR and HMBC data for 1 did not match the 
spectroscopic data of the natural compound. Graphical analysis of the differences in 
chemical shifts of the synthetic versus natural is shown in Scheme 19. This graph depicts 
carbon numbering of muironolide A (X-axis) versus differences in chemical shift denoted 
as Δδ (δ 13C (1) - δ 13C (natural)) on the Y-axis. Examination of this graph revealed the 
biggest discrepancies were confined to the macrocycle and the CCK units. We were 
confident in the relative stereocenters of C4, C5 and C11 through IMDA studies to form 
the isoindolinone subunit. It was hypothesized that a C21 epimer could have a drastic 
affect on the configuration of the macrocyclic diester. We could easily test this 































Scheme 20. Synthesis of C22, C23-epi-Muironolide A 
 
Following the same four-step sequence with acid ent-68 provided C22, C23-epi-
muironolide A 43 in 32% overall yield (Scheme 20). Comparing Δδ in 13C NMR spectra 
showed remarkable similarity of this synthetic product to the natural compound. The 
main differences were now confined to the C22 and C23 positions, thereby suggesting a 
cis-relationship between C21 and C22 rather than a trans configuration. Based on this 
evaluation, we conjectured that the CCK fragment would be the original C21 epimer 71. 
Again, the same four-step sequence was applied to 67 and 71, and the synthesis of 
(+)-muironolide A was completed (44) in 23% yield (Scheme 21). All spectroscopic data 
of 44 was in full agreement with the natural product. The only deviation from physical 
data arose from the circular dichroism (CD) spectrum that showed synthetic muironolide 
was antipodal to the natural. Therefore we reassigned the absolute configuration to be (-)-





1. 2,4,6-trichlorobenzoyl chloride, Py, 
    DMAP, PhMe, 23 oC, 2 h
2. LiCl, DMF, microwave, 170 oC, 1 h
3. 2,4,6-trichlorobenzoyl chloride, Py, 
    DMAP, PhMe, 50 oC, 5 h

















 Scheme 21. Completion of the Synthesis of (+)-Muironolide A  
  
Conclusion 
We reported the first enantioselective total synthesis of (+)-muironolide A. We 
reassigned the stereochemistry as the C21-epimer and determined the absolute 
configuration of the natural product. Although, synthetic (+)-muironolide A was 
enantiomeric, material was sent to NCI60 (National Cancer Institute) to assay against 60 
cell lines with data still pending. Current efforts towards the scale-up of muironolide A 










1. 2,4,6-trichlorobenzoyl chloride, Py, 
    DMAP, PhMe, 23 oC, 2 h
2. LiCl, DMF, microwave, 170 oC, 1 h
3. 2,4,6-trichlorobenzoyl chloride, Py, 
    DMAP, PhMe, 50 oC, 5 h










































2.1: Background of Pinnatoxin and Cyclic Imine Toxins 
Cyclic imine (CI) toxins are an important class of marine toxins with worldwide 
distribution. Dinoflagellates of a genus K. selliformis, A. ostenfeldii, A. peruvianum and 
V. rogsum are members of a phytoplankton specie that are attributed to the production 
and proliferation of CI toxins.33 During favorable oceanic conditions, harmful algal 
blooms (HABs) are the source of toxic dinoflagellates that spread to aquatic life.  Filter 
feeding bivalve mollusks (shellfish) that feed on toxic phytoplankton accumulate CI 
toxins in their digestive glands and edible tissues.34 In turn, this poses a health risk to 
higher order predators either marine or terrestrial. Pinnatoxins and pteriatoxins represent 
the largest subgroups of known CI toxins. These compounds pose the highest risk to 
human health due to their potent oral toxicity.35 Although there are no reports of fatal 
toxicity in humans, widespread shellfish poisoning attributed to CI toxins was reported in 
China and Japan.36  
In 1994, Uemura and coworkers reported the isolation and characterization of 
pinnatoxins (PnTXs) from Pinna muricata, a bivalve mollusk.37 Collection of 45 kg of 
this shellfish led to the isolation of pinnatoxin A (3.5 mg), pinnatoxin B and C (1.2 mg as 
a 1:1 mixture) and pinnatoxin D (2.0 mg) (Figure 11).38 Bioassays via intraperitoneal 
(i.p.) injection in mice showed lethal toxicity of pinnatoxin A with LD99 = 180 µg/kg and 
pinnatoxin B and C with LD99 = 22 µg/kg.39 Pinnatoxin D showed the lowest potency 
with LD99 = 400 µg/kg, however it showed strong toxicity against murine leukemia cell 
line P388 at IC50 = 2.5 µg/mL.40 Pteriatoxins are the least studied members of the 
pinnatoxin family. Pteriatoxins A−C were isolated from bivalve Pteria penguin in 2001, 
 30 
were found to be more potent by i.p. injection in mice (pteriatoxin A with LD99 = 100 
µg/kg and pteriatoxins B and C (1:1 mixture) with LD99 = 8 µg/kg).41  
Figure 11. Pinnatoxins and Pteriatoxins 
 
Currently, there are no regulations that mandate acceptable levels of CI toxins in 
seafood that are bound for human consumption.42 One barrier to monitoring these marine 
toxins was the lack of access to highly pure standards.43 Chemical purity of CI standards 
used in bioassays is a growing concern, as they are persistently not reported.44  Methods 
employed for the extraction from natural sources heavily influence the purity of CI 
compounds that are used for testing. To address this problem, a reliable method to access 
these compounds is needed and one option is the direct and reliable chemical synthesis of 
these marine natural products. Additionally, very little was known about the biological 
mode of action (MOA), biodistribution, cellular metabolism and short/long-term effects 
of CI toxin exposure. Our goal was to build upon a growing body of knowledge to help 























34S: pinnatoxin B  (73)
























34R: pteriatoxin B  (77)























Pinnatoxins and related pteriatoxins are intriguing macrocycles containing a 
spiroimine AG-ring, BCD-dispiroketal and EF-bicycloketal rings. Varying the 
substituents at C34-position provided the different pinnatoxins A-D and related 
pteriatoxins A-C (Figure 11). Uemura proposed a biomimetic intramolecular Diels-Alder 
cycloaddition pathway for the construction of the 6,7-azaspiro-linked imine fragment 
(AG-ring) and the macrocycle. Feeding studies of Alexandrium ostenfeldii demonstrated 
that the polycyclic ether units of PnTX was made from linear polyketide synthesis and a 
glycine unit was incorporated intact to form the imine portion.45 The first pioneering total 
synthesis of (-)-pinnatoxin A and related pteriatoxins A, B and C was reported by Kishi 
et. al. in 1998 and 2006, respectively. 46  Murai (2002), 47  Inoue-Hirama (2004), 48 
Nakamura-Hashimoto (2008)49 and Zakarian group (2008, 2011)50 have also reported the 
total synthesis of PnTX A. A review of Kishi’s synthesis, which established the 
stereochemistry of (-)-pinnatoxin A and pteriatoxins A-C, will be briefly summarized. 
Also, the Zakarian synthesis (2011) of pinnatoxin A and biological MOA, which is the 
prelude to this work, will be presented.  
2.2: Kishi’s Total Synthesis of (-)-Pinnatoxin A (1998)51 
The synthesis of the unnatural enantiomer of pinnatoxin A was reported through a 
potentially biomimetic intramolecular Diels-Alder (IMDA) reaction pathway. Kishi and 
coworkers established the absolute stereochemistry of synthetic pinnatoxin A to be the 
antipode of the natural and confirmed the assignment of the relative stereochemistry of 
this stereo-rich natural product through their total synthesis. This synthesis, which 
remained the shortest sequence of 38 steps to-date, produced 1.0 mg of (-)-pinnatoxin A.  
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Figure 12. Kishi’s Synthetic Strategy for (-)-Pinnatoxin A 
 
In this retrosynthetic analysis, the putative biomimetic intramolecular Diels-Alder 
reaction forged the quaternary stereogenic center of the spiroimine unit. Cyclic 
ketalization formed the EF-rings and dispiroketalization reaction assembled the BCD-
bisketal rings under thermodynamic control. The synthesis of complex fragment 82 was 
achieved from four smaller fragments employing two dithiane umpolung strategies to 
form C24, C25 and C26 bonds and Nozaki-Hiyama-Kishi (NHK) reactions to form C5, 
C6 and C32, C33 bonds shown in Figure 12.  
The synthesis of BCD-rings began with diketone 83, which was prepared in 12 steps 
from 1-pentynol. The formation of the bis-spiroketal portion was made possible by 
treating diketone 83 with camphorsulfonic acid (CSA) in methanol to provide a 2:3 
mixture favoring the desired isomer. The formation of undesired compound 88 was 
assisted by hydrogen bonding of the tertiary alcohol and the oxygen of the D-ring (see 









































































fully converted the undesired tricyclic ketal 88 to more conformationally stable isomer 90 
(Scheme 22). 
Scheme 22. Bis-Ketalization to Form B,C,D-Rings 
 
 In preparation for dithiane coupling partner, tert-butyldimethylsilyl ether (TBS) was 
cleaved (TBAF) to produce the corresponding primary alcohol and subsequently 
converted to iodide 92 under standard Mitsanobu conditions. Iodide 92 was added to a 
solution of lithiated 1,3-dithiane (t-BuLi, 10% HMPA/THF) to form C24 and C25 bonds. 
After exposure with tetrabutylammonium fluoride (TBAF), this alkylation sequence was 
repeated with iodide 86 followed by oxidative deprotection of 1,3-dithiane 
(PhI(CF3CO2)2, CaCO3) delivering ketone 93 in 57% yield over four steps.  
The first NiCl2/CrCl2 (NHK) mediated coupling to install alkyl amine 84, began with 
p-methoxybenzyl (PMB) group removal, followed by Dess-Martin Periodinane (DMP) 
oxidation in 63% yield. The resulting aldehyde was treated with 1 mol% NiCl2/CrCl2 in 
DMF and vinyl iodide 84 that provided the corresponding allylic alcohol in 55% yield as 











































butyldimethylsilyl (TBS) group deprotection (HF pyridine) and DMP oxidation was 
performed. Increased amounts of catalyst loading at 33 mol% NiCl2/CrCl2 and 
bispyridinyl ligand were required to forge C32-C33 bond.   
Scheme 23. Preparation of IMDA Precursor 
 
Acetonide solvolysis mediated by trifluoroacetic acid (TFA) in aqueous 
dichloromethane allowed for formation of EF-ketal in 71% yield. IMDA precursor 81 
was completed in three additional steps through mesylation, hydroxyl protection with 
triethylsilane (TES) followed mesylate elimination with DABCO (52% yield in three 
steps). It was noteworthy that during the EF-ring formation, C19 completely epimerized 
under acidic conditions (TFA, H2O-CH2Cl2). However upon silylation (TES) of the 
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Scheme 24. Completion of Synthesis of (-)-Pinnatoxin A 
 
The exo/endo selectivity of the intramolecular Diels-Alder reaction was found to 
depend on the choice of solvent and amine substituent. For example, heating IMDA 
precursor 81 in toluene at 100 °C gave a 1:1:1 mixture of exo:endo product distribution. 
The formation of endo (undesired) product could be minimized using 2 mM dilution in 
dodecane at 70 °C that afforded 1.0:0.9:0.4 with ca. 5:1 exo:endo in 78% combined yield. 
After N-allylchloroformate cleavage (Pd(PPh3)4, AcOH), imine formation occurred under 
high temperature and pressure (200 °C, 1-2 Torr). Forcing conditions for imine 
cyclization was indicative of a high energy barrier between the imine and the amino 
ketone. The synthesis was completed by the cleavage of the tert-butyl ester to afford (-)-
pinnatoxin A in 55% yield over three steps. Synthetic pinnatoxin A was found to be 
antipodal to the natural through the optical rotation measurement.  
2.3: Zakarian’s Total Synthesis of Pinnatoxin A (2011)53 
Zakarian group first published the total synthesis of pinnatoxin A in 2008, however 
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will be the focus of this segment. The impetus for the second-generation synthesis was to 
address two issues: the scalability of PnTX synthesis and confirming the hypothesis that 
toxicity of PnTXs is solely due to their potent action on nicotinic acetylcholine receptors.  
Figure 13. Zakarian’s Retrosynthesis of Pinnatoxin A 
 
PnTX A was accessed from azido triol 98 by oxidation of the allyl alcohol to the 
carboxylate at C34, followed spiroimine formation. Tandem deprotection and ketalization 
of substrate 99 formed the EF-rings. Direct alkyllithium addition, from lithium-iodide 
exchange of 100, to aldehyde 101 united the two advanced fragments. Finally, central to 
this strategy was the use of the Ireland-Claisen rearrangement of ester 102 to form the C5 
quaternary center in a diastereospecific fashion. The significance of this design was the 
recognition that further elaboration of azido triol 98 would allow one to access all of the 
pinnatoxins A-F and related pteriatoxins A-C. 
Synthesis of aldehyde 101 began with dithioacetal formation of D-ribose followed by 
a three-step protocol for selective protection of the resulting tetraol. Cleavage of 
dithioacetal revealed the corresponding aldehyde and its olefination with Horner-

































































Scheme 25. Synthesis of Allylic Alcohol 110 
 
After reduction and oxidation to α,β-unsaturated aldehyde 108, asymmetric ethylation 
with 6 mol% ligand L109 and diethyl zinc afforded allylic alcohol 110 in 79% yield. 
Esterification, under Yamaguchi conditions, of alcohol 110 with carboxylic acid 116 
(made in 11 steps from (S)-citronellic acid) provided ester 102 in 85% yield.  
The key transformation in the synthesis was performed by a diastereospecific Ireland-
Claisen rearrangement with lithium amide 114. Traditional methods for this 
transformation gave an unwanted mixture of diastereomers at C5, which opened an 
opportunity to explore new methodology. It was well established that obtaining exclusive 
E and Z geometry during enolate formation was critical to high diastereocontrol. In model 
studies, using chiral α-branched esters, enolization with lithium diisopropyl amine (LDA) 
gave a mixture of E (65%) and Z (35%) isomers as shown in Scheme 26. However, in the 
presence of chiral lithium amide 115, the chirality match between the ester and lithium 
reagent enabled exclusive formation of Z-enolate 113. The chirality of lithium amide 
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Scheme 26. Stereoselective Enolization with Chiral Lithium Amines 
 
To demonstrate the utility of this transformation, a highly stereoselective Z-enolate 
formation was enabled by the chiral base 114 of α,α-branched ester 102, where 
rearrangement to acid 117 was possible as a single diastereomer in 81% yield.  
Scheme 27. Diastereoselective Ireland-Claisen Rearrangement 
 
Formation of the G-ring required converting rearrangement product 117 to dialdehyde 
118 in 6 steps. Treatment of the dialdehyde with dibenzylammonium trifluoroacetate 
rapidly formed aldol product 119, followed by a slow dehydration step (~20 h) to 

















































































followed by protection of the resultant hydroxy group with methoxymethyl ether (MOM) 
was performed. Selective triisopropylsilyl (TIPS) deprotection, oxidation and Wittig 
olefination with the corresponding aldehyde afforded 121 in 87% yield over five steps. In 
two steps, aldehyde 101 was completed by LiAlH4 reduction followed by Swern 
oxidation in 87% yield. 
Scheme 28. Assembly of G-Ring and Completion of Aldehyde 101 
 
The synthesis of BCD-bisketal fragment started with an efficient enzymatic resolution 
of tert-butyl hydroxy-pentenoate 51 catalyzed by amano lipase PS, using vinyl acetate in 
pentanes. The produced free allylic alcohol was advanced to borane 122 in two steps, 
while the vinyl acetate was transformed to Weinreb amide 123 in six steps in 65% yield.  

































































































Carbon extension with organolithium reagent, generated from lithium-iodide 
exchange of iodide 124, coupled with Weinreb amide 123 afforded the resulting ketone. 
Stereoselective iodo-de-silylation, from silane 125, allowed for its coupling with borane 
122 under Suzuki-Miyaura conditions in the presence of Pd(dppf)Cl2 and Ph3As.  
Scheme 30. Completion of Spiroketal Fragment 100 
 
Installation of tertiary alcohol by Sharpless asymmetric dihydroxylation with AD-mix 
β, followed by silyl group removal and oxidation to diketone completed ketal precursor 
127 in 61% yield over five steps. The treatment of precursor 127 with camphorsulfonic 
acid in methanol revealed free tetraol intermediate 128. The solvent displacement to 
cyclohexane was essential to trigger spiroketalization that was complete within 48 h 
producing the desired product under thermodynamic control. The completion of the 
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alcohol, reduction of the ester with iBu2AlH to aldehyde 131. Alkylation, Dess-Martin 
Periodinane (DMP) oxidation, Peterson olefination, para-methoxybenzyl deprotection 
and iodo-de-hydroxylation concluded the bisketal fragment 100 in 67% yield. The two 
fragments could now be united by the addition of complex organolithium reagent derived 
from iodide 100, through lithium-iodide exchange, to aldehyde 101 resulted in an 
inconsequential 1:1 mixture of diastereomers 133 in 75% yield.   
Scheme 31. Fragment Coupling and Ring Closing Metathesis 
 
The ring closing metathesis (RCM) precursor 134 was prepared in three steps with a 
76% overall yield. The treatment of 134 with 20 mol% HGII catalyst provided a 3:1 
mixture of isomers in 68% combined yield. Isolation of the minor isomer revealed an 
RCM product that formed between the allylic alcohol and the methylene group at C10. 
Ratios greater than 3:1 could not be obtained after screening different catalysts, 
temperatures and solvents. Oxidation to α,β-unsaturated ketone, stereoselective cuprate 





































































Scheme 32. Completion of Total Synthesis of Pinnatoxin A 
 
The synthesis of PnTX A was completed in six steps, where the allylic alcohol at C34 
was converted to the methyl ester. Azide reduction to the primary amine and was 
followed by imine formation, which was accomplished with triethylammonium 2,4,6-
trimethylbenzoate  in toluene at 85 °C for 60 h. Hydrolysis of the methyl ester provided 
pinnatoxin A in 37-43% yield over six steps.  
2.4: Binding Studies of Pinnatoxin A with Nicotinic Receptors (nAChRs) 
With reproducible synthetic method to access high quality PnTX A, the mode of 
action (MOA) of this toxin could now be investigated. One clue was provided from the 
observation of mice after i.p. injection of PnTX A, which led to hyperactivity, spasms, 
respiratory distress and death (3-50 min) indicating CNS related mortality. Previous 
reports revealed that gymnodimine A and 13-desmethylspirolide C (related CI toxins) 
were potent antagonists towards nicotinic receptors (nAChRs). Together with these 
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The nAChRs are homo- or heteropentamers consisting of different subunits. There 
have been 17 identified nAChRs, and the stoichiometry of the subunits uniquely defines 
its function.54 These ionotropic receptors are divided in two types based on protein 
sequences: neuronal-type and muscle-type.55 Neuronal-types only contain α,β-subunits, 
while muscle-types contain α,β,δ,γ,ε-subunits.56 Pinnatoxins A, G and pinnatoxin amino 
ketone derivative (PnTX AK) were used in binding studies with nAChRs.  
Figure 14. Pinnatoxins Tested for nAChRs Binding Studies 
 
The dual-microelectrode voltage-clamp electrophysiology study on Xenopus oocytes 
expressing human neuronal α4β2 or α7 nAChRs subtypes was performed. Control 
experiments established EC50 values with 350 µM acetylcholine (ACh), a known agonist, 
which elicited currents from 1 – 3 µA at −60 mV holding membrane potential (n = 54 
oocytes from five donors).  
The perfusion of PnTX A at varying concentrations showed partial decrease in 
desensitization (competitive binding against ACh) shown in Figure 15A-C. Dramatic 
suppression of ACh-evoked currents were observed in a concentration-inhibition curve 
(Figure 15D) at pM and nM concentrations of PnTX A. Oocytes expressing human α7 
nAChRs showed high degree of potency for PnTX A with IC50 = 0.107 nM, however 


































Figure 15. Electrophysiology Experiment of Xenopus Oocytes with PnTX A 
  
Ach and PnTX A current effect on nAChRs at holding potential −60 mV. (a) 
human α7, (b) Torpedo α12βγδ, and (c) human α4β2 nAChRs before (black line) 
and after (red line) of addition of PnTX A. (d) Inhibition of ACh-evoked 
currents by PnTX A or PnTX AK of Xenopus oocytes in human α7 (solid 
circles, black curve) and α4β2 (solid triangles, red curve), or Torpedo α12βγδ 
(solid diamonds, blue curve).  
After attempting to washout PnTX A from the medium (10-15 min), PnTX A 
remained bound to nAChRs suggesting irreversible blocking action with nAChRs. Final 
evaluation of the potency of PnTX A was dependent on the receptor type and established 
an order of inhibition on nAChRs as α7 (human) > α12βγδ (Torpedo) > α4β2 (human) 
ranging from 0.1 – 30.4 nM. The performance of PnTX AK analogue (opened form of the 
imine ring) showed no action on nAChRs subtypes in a range of concentrations. This 
indicated that the spiroimine component was the pharmacophore necessary for binding in 
nAChRs. Competitive binding studies were performed with radiotracers [125I]α-
bungarotoxin (α-BTX) and (±)-[3H]epibatidine with PnTX A  and showed high affinities 
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in Torpedo α12βγδ and α7-5HT3 (chimeric chicken neuronal nAChRs type) at 2.8 nM and 
0.35 nM, respectively. Affinities for hetereopentameric neuronal nAChRs (α3β2 and 
α4β2) were less potent, and the order of potency was α7-5HT3 > Torpedo α12βγδ > α3β2 
= α4β2.  
2.5: Studies Towards 18F, 13C and 3H Isotope Labeled PnTX Derivatives 
We proposed 18F, 13C and 3H isotope labeled pinnatoxin derivatives (Figure 16) to 
probe biodistribution, cellular metabolomics and toxicological profile in biological 
systems.57 Ultimately, information gained from these studies can be part of an effort to 
aid in the regulation of CI toxin levels in seafood, to understand short and long-term 
effects of CI exposure, and to utilize PnTX radiotracers as standards for drug discovery in 
nAChR related neurodegenerative diseases such as schizophrenia, Parkinson’s and 
Alzheimer’s.58  
In 1935, Shoenheimer and Rittenberg first used isotopic labeling in their study of fat 
metabolism in mice with deuterium.59 Since its inception, isotopically labeled bioactive 
molecules have been used heavily in areas such as drug discovery and oncology.60 For 
more than two decades, radiotracers in animal models have accelerated drug discovery by 
gathering toxicological, metabolomics, fluxomics and excretion profiles in a rapid 
manner.61 For example, drug metabolism and pharmacokinetic (DMPK) studies now 
utilize quantitative whole-body autoradiography (QWBA) for drug distribution of 
radiolabeled bioactive molecules in medicinal chemistry.62 
18F-labeled bioactive molecules are valuable tools for in vivo images that are detected 
by positron emissions tomography (PET).63 Clear 3-D images are obtained that show the 
biodistribution of the radiotracer. For example, 18F-nifene radiotracers were used to 
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obtain PET images of α4β2 nAChRs (thalamic and extrathalamic brain regions) in rhesus 
monkeys and exhibited potent binding properties at Ki=0.50 nM for this subtype.64 
Similarly, we wish to incorporate 18F-radiolabeled pinnatoxin (derivative 149 and 150) to 
acquire PET images in mice.  
Figure 16. Targets of Derivatives Accessed from Azido triol 
 
Additionally, 3H and 13C-labeling are also routinely used in metabolomics. With the 
advent of ultra-high resolution Fourier transform mass spectrometry (FT-MS); 
metabolites can be characterized accurately by mass to offer clues in cellular metabolic 
pathways.65 We carefully selected different derivative candidates for isotopic labeling 
shown in Figure 16. Our initial goal was to develop a reliable synthetic method to access 
these derivatives and to fully characterization them. Additionally, we wanted to obtain 
the potency of each derivative against nAChRs to compare its binding properties against 
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Scheme 33. Proposed Synthesis of [3H]-PnTX-OH 146 
 
The proposed synthesis of [3H]-PnTX-OH 146 (Scheme 33) would advance azido 
triol 98 to [3H]-azido triol 151 by TEMPO/PhI(OAc)2 oxidation and reduction with 
sodium borotritide.66 Standard imine formation protocol would complete the synthesis of 
[3H]-PnTX-OH 146 in four steps. The synthesis of PnTX-OH 141 could be rapidly 
accessed from azidotriol in two steps through Staudinger reduction (PPh3, THF−H2O, 55 
°C, 36 h) of azide 98 (Scheme 34), followed by imine formation (69% yield over two 
steps). The completion of derivative 141 provided the necessary substrate to investigate 
the feasibility of synthesizing PnTX-F 144 through nucleophilic substitution of the 
corresponding tosylate. 
Selective mono-tosylation of allylic alcohol 141 was achieved in the presence of p-
toluenesulfonic anhydride (Ts2O) and 2,6-di-tert-butyl-4-methyl pyridine (DTMP) in 
dichloromethane in quantitative yield (Scheme 34). Fluorine substitution conditions were 
screened with a model tosylate 155, which was made in two steps from (S)-





















































Scheme 34. Synthesis of PnTX-OH and Selective Mono Tosylation 
 
Scheme 35. Screening Conditions for Fluoro-de-Tosylation 
 
The most promising reaction conditions are presented in entries 5-8. 
Tetrabutylammonium fluoride (TBAF) in refluxing acetonitrile provided allylic fluoride 
156A in 85% yield along with hydrolysis product 157B (allylic alcohol).67  Utilization of 





















































156 A 157 B 158 C
1                          KF, CH3CN, reflux, 3 h                     0:0:100
2                          KF, CH3CN, µλ, 85 oC, 0.5 h            0:0:100
3                          KF, 18-crown-6                               70:10:20
                            CH3CN, reflux, 3 h                                               
4                          KF, 18-crown-6                               60:10:20
                            CH3CN, µλ, 120 oC, 0.5 h
5                          TBAF,  CH3CN, reflux, 3 h               85:15:0                                                                     
6                          TBAF,  CH3CN                                 85:15:0 
                            µλ, 120 oC, 0.5 h 
7                          KF, 18-crown-6                                80:5:10
                            CH3CN, reflux, 3 h                                               
8                          KF, 18-crown-6                                80:5:10
                            CH3CN, µλ, 120 oC, 0.5 h
9                          AgF, CH3CN,  µλ, 120 oC, 0.5 h       decomposition
                    experiment          reaction conditions                           results A:B:C %
155
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yield),68 however, elimination product 158C was observed in both traditional oil bath and 
microwave assisted heating.  
With these promising conditions at-hand, mono-tosylate 154 was subjected to the 
same reaction conditions (entries 5-8). The treatment of tosylate 154 with potassium 
fluoride and 18-crown-6 in refluxing acetonitrile only produced complex mixtures. We 
were delighted to find that in the presence of tetrabutylammonium fluoride in acetonitrile 
with microwave assisted heating at 120 °C for 30 min afforded 2.27 mg of fluoride 144 in 
67% isolated yield (Scheme 36). It should be noted that yields of reactions on a 4 mg 
scale were calculated by 1H NMR titration (see Supporting Information).  
Scheme 36. Synthesis of Pinnatoxin-Fluoride 
 
Our focus shifted towards our next target, pinnatoxin 2-fluropyridine 145. The 
synthetic strategy was based on a reliable reaction pathway utilizing “click” chemistry to 
couple azide 157 with pinnatox-yne 143. Pinnatox-yne 143 was made in four steps from 
azido triol. Selective oxidation at C34 with TEMPO/PhI(OAc)2 in dichloromethane 
provided aldehyde 148 in 70% yield. Homologation of the corresponding aldehyde to 
alkyne 148 was possible with Ohira-Bestmann reagent 155 in potassium carbonate and 
methanol.69 Standard conditions for imine formation began with reduction of the azide to 





















trimethylbenzoate in toluene at 85 °C for 60 h provided pinnatox-yne 143 in 48% yield 
over two steps. 
Scheme 37. Synthesis of Pinnatoxin 2-Fluoropyridine  
 
Prior to azide-alkyne cycloaddition chemistry, 3-(2-(2-(2-azidoethoxy)ethoxy)ethoxy-
2-fluoropyridine 157 was prepared in four steps from triethylene glycol (TEG) and 2-
nitropyridin-3-ol. 70  The copper catalyzed 1,3-dipolar azide-alkyne cycloaddition 
proceeded cleanly in the presence 20 mol% CuSO4 and 40 mol% sodium ascorbate in 
aqueous tert-butanol at 23 °C for 12 h producing triazole 145 in 84% yield.71  
The last target, pinnatoxin methyl ester 142, was obtained in five steps. Oxidation to 
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oxidation to the carboxylic acid followed by methyl ester formation with trimethylsilyl 
diazomethane in 70-80% yield over three steps.  
Scheme 38. Unoptimized Synthesis of Pinnatoxin Methyl Ester 
 
Standard conditions for imine formation provided pinnatoxin methyl ester 142 in 35% 
yield as an inseparable mixture with triphenylphosphine oxide. To address the issue of 
this low yielding imine formation with the methyl ester functionality, we hypothesized 
that during the Staudinger reduction, the presence of the iminophosphorane intermediate 
was the culprit that led to unproductive reaction pathways. One way to circumvent this 
issue was shortening the lifespan of the iminophosphorane in the reaction mixture by 
expediting its hydrolysis with water. Triethylamine is known to accelerate the hydrolysis 
step in Staudinger azide reductions.72 To test this hypothesis, azide 159 was treated with 
PPh3, Et3N, THF−H2O at 55 °C. We observed full consumption of starting material in 8 h 
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mixture was submitted to cyclic imine formation that afforded pinnatoxin methyl ester 
142 in 92% yield.  
Scheme 39. Synthesis of Pinnatoxin Methyl Ester 
 
Although we were able to substantially improve the yield, triphenylphosphine oxide 
was still problematic during purification. We began screening various triarylphosphines 
for suitable reactivity and separation from its corresponding oxide. Excellent results came 
from Tris(4-(trifluoromethyl)-phenyl)-phosphine that afforded pure PnTX methyl ester 
142 in 86% yield. Due to the decreased nucleophilic nature of this phosphine, the azide 
reduction required 36 h. We postulated that the rate-determining step was the formation 
of the iminophosphorane, followed by its rapid hydrolysis.  
2.6: Kishi’s Total Synthesis of Pteriatoxin A-C 
Uemura and co-workers, in 2001, isolated PtTX A and PtTX B/C as an inseparable 
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containing a cysteine residue. In 2006, Kishi reported the total synthesis 73  and 
stereochemistry74 of pteriatoxins A, B and C (PrTX A−C). Their synthetic strategy 
heavily relied on previously published synthesis of pinnatoxin A discussed above. The 
purpose of Kishi’s synthesis of PtTXs was to secure access to all possible stereoisomers 
at C34 and C2-positions to unequivocally identify each member of the PrTX family.  
Although PtTX B and C were isolated as a 1:1 mixture, they were able to identify distinct 
1H NMR signals for each isomer. The diagnostic NMR characteristics and HPLC traces 
established the stereochemistry as (34 S,2’R) PtTX A, (34R,2’R) PtTX B and (34S,2’R) 
PtTX C (Scheme 41).  
Scheme 40. Synthesis of C33−C35 Fragments through Enzymatic Resolution 
 
Enzymatic resolution of 160 was the foundation in which all C34 isomers could be 
synthesized (Scheme 40). The other building blocks for the construction of the 
macrocyclic carbostructure are the same used for the synthesis of PnTX A. Hydrolysis 
with Amano lipase PS800 of diacetate 160 resolved two optically pure fragments (ee > 






























































162 was further elaborated to the diene functionality through NHK-coupling (Ni/Cr) with 
aldehyde 165, acylation and Pd-mediated elimination in 78% yield. 
Scheme 41. Synthesis of PtTX A−C 
 
Alkylation of lithiated dithiane 168 with iodide 167 united the two complex fragments in 
high yield. After the formation of EF-rings, oxidation to the aldehyde of the C6 hydroxy 










    HMPA
2. K2CO3















    MeOH






















1. SO3 Pr, DMSO
2. ent-84, 
























    -OCHPh2
2. Pd(PPh3)4, AcOH
3. 1,3,5-(i-Pr)3C6H2CO2H










34 S: pteriatoxin A (174)











34R: pteriatoxin B (176)













oxidation completed the IMDA precursor in 40% yield over five steps. Protecting group 
manipulation of the 1,2-diol to the p-methoxybenzoate provided the best exo:endo (ca. 
2:1) selectivity for the desired exo intramolecular Diels-Alder product (dodecane, 160 °C) 
in 51% isolated yield. Introduction of cysteine residue was possible through epoxide 173 
to provide two regioisomers, PtTX A and PtTX B, in an SN2 fashion. Forcing conditions 
(200 °C) for imine cyclization used in the PnTX A synthesis was unsuccessful in this 
approach. The implication of weakly acidic conditions with sterically congested 
carboxylic acids (2,4,6-(i-Pr)3C6H2CO2H) and triethylamine delivered the requested 
cyclic imines in acceptable yields for PtTX A-C as well as the unnatural PrTX isomer 
(see Scheme 41).  
2.7: Synthetic Studies Towards Pteriatoxin A 
The landmark synthesis by Kishi required early C34 functionalization to access 
pteriatoxins A-C in 34 steps (longest linear steps). Our ultimate goal was to develop the 
synthesis of pteriatoxins by direct functionalization of pinnatoxin G. Concise synthetic 
approach to these molecules would allow establishing their bioactivity profile, which 
remained to be conclusively investigated. 
Our first approach envisioned cysteine addition to chiral allylic epoxide 173 (Figure 
17). At the onset, no literature precedence existed to access terminal chiral allylic 
epoxides from their corresponding aldehydes. Three reports by Connon, Aggarwal and 
Goodman reported asymmetric Corey-Chaykovsky epoxidation of benzaldehyde with 
chiral sulfur ylides shown in Scheme 42. Connon provided the most promising results 
with bulky ylide 180, P2-tBu base, proton sponge to afford styrene oxide in 92% yield 
and 92% ee. 
 56 
Figure 17. Retrosynthesis of PrTX A via Cysteine Addition to Chiral Epoxide 
 
Scheme 42. Precedence for Asymmetric Corey-Chaykovsky Epoxidation  
 
Performing Connon procedure on a suitable model containing the requisite α-branched 











































































































(Scheme 43). Application of this method with aldehyde 189 and 190 provided no epoxide 
but only moderate decomposition of the starting material. We hypothesized that the steric 
clash of the bulky aryl groups of the ylide with the sterically congested cyclohexenal 
prohibited this reaction. Next, we wanted to investigate the possibility of substrate (189) 
controlled asymmetric epoxidation with trimethylsulfonium iodide could be achieved. 
However, a 1:1 mixture of diastereomers (190) was obtained from trimethylsulfonium 
iodide and potassium bis(trimethylsilyl)amide (KHMDS). Unfortunately, the addition of 
cysteine residue to racemic epoxide would lead to four diastereomers. This route greatly 
deviated from our primary objective, which was the direct synthesis of pteriatoxin A. As 
an alternative approach, we envisioned chiral diols as another attractive precursor to all 
isomers of pteriatoxins.  
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We investigated the feasibility of accessing PtTX A through a direct Sharpless 
asymmetric dihydroxylation of pinnatoxin G, followed by selective mono-tosylation and 
direct SN2 addition with cysteine (Figure 18). The starting material was prepared in four 
steps from azido triol. Oxidation and Wittig olefination of the corresponding aldehyde 
with methyltriphenylphosphonium bromide, n-BuLi in THF at -78 °C to -10 °C provided 
azido triene 194 in 40-45% yield. Standard spiroimine formation provided PnTX G in 88-
91% yield.  
A review of literature suggested that we could tune the regioselectivity to favor 
dihydroxylation of the mono-substituted olefin (C34 and C35-positions). It was well 
documented that dihydroxylation of di- or tri-substituted olefins required the use of 
methanesulfonamide additive to the AD-mix. 75  
Figure 18. Retrosynthetic Plan for the Synthesis of Pteriatoxin A 
 
In contrast, methanesulfonamide was shown to slow the reactivity with terminal 
olefins (1,1-disubstituted and mono-substituted olefins).76 Additionally, the phthalazine 










































stabilization between phthalazine and cyclohexene could provide the necessary 
preference needed for dihydroxylation of the C34-C35 double bond. 
Scheme 44. Catalytic Asymmetric Dihydroxylation of Pinnatoxin G 
 
We were delighted to see that regioselective dihydroxylation of PnTX G occurred in 
the presence of AD-mix-α, tBuOH−H2O (1:1) at 0 °C (no sulfonamide additive) for 5.5 h 
afforded tetraol 192 in 55% yield and a 10:1 dr along with recovered starting material. 
Longer reaction times (16 h) under these conditions led to complex distribution of 
products and decomposition of the tetraol. Halting this reaction at 5.5 h provided clean 
tetraol in 55% yield along with recovered PnTX G in 31% yield. Tosylation of tetraol 192 
(Ts2O, DTMP, CH2Cl2, ~70% conversion) afforded a 1:1 mixture of mono-tosylate 191 
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higher conversion to the epoxide. The future direction of the synthesis of PtTX A would 
be to investigate other possibilities of substitution of C35 hydroxyl group with cysteine.  
Conclusion 
In 2011, the Zakarian laboratory established a robust and scalable synthesis of PnTX A. 
This was demonstrated in this work by producing almost 600 mg of an advanced  azido 
triol intermediate, which can be converted to PnTX A in 6 steps, or PnTX G in 4 steps. 
The azido triol has been used as a starting material for the preparation of a variety of 
bioactive pinnatoxin derivatives. Competitive binding and electrophysiological data of 
these derivatives against nicotinic acetylcholine receptors are pending. In the future, 18F, 
13C and 3H isotope labeling of these derivatives can reveal biodistribution, cellular 
metabolism and short/long-term affect of pinnatoxin exposure. Also, a catalytic 
asymmetric dihydroxylation of pinnatoxin G secured a promising route to the synthesis of 
pteriatoxins. The culmination of this work will build upon a growing body of knowledge 












General Information.  All reactions were carried out under an inert atmosphere 
of dry argon in oven or flame-dried glassware, unless the reaction procedure states 
otherwise. Tetrahydrofuran (THF) and ether (diethyl ether) were distilled from 
sodium-benzophenone in a continuous still under an atmosphere of argon. 
Dichloromethane, di-iso-propylamine and triethylamine were distilled from calcium 
hydride in a continuous still under and atmosphere of argon. Reaction temperatures 
were controlled by IKA ETS-D4 fuzzy thermo couples. Analytical thin-layer 
chromatography (TLC) was performed using pre-coated TLC plates with Silica Gel 
60 F254 (EMD no. 5715-7) and visualized using combinations of UV, anisaldehyde, 
ceric ammonium molybdate (CAM), potassium permanganate, and iodine staining.  
Flash column chromatography was preformed using 40-63 mm silica gel (EMD, 
Geduran, no. 1.11567.9026) as the stationary phase. Proton nuclear magnetic 
resonance spectra were recorded at 400, 500, and 600 MHz on Varian Unity Inova. 
Carbon nuclear magnetic resonance spectra were recorded at 100 MHz, 125 MHz, 
and 150 MHz on Varian Unity Inova, and Varian Unity Inova spectrometers.  All 
chemical shifts were reported in δ  units relative to tetramethylsilane. Optical 
Rotations were measured on a Rudolph Autopol III polarimeter. High resolution mass 
spectral data were obtained by the Mass Spectrometry laboratory at the University of 






(E)-Ethyl 2,4-dimethylpent-2-enoate (19). Ethyl 2-(triphenylphosphoranylidene) 
propanoate (7.97 g, 22.0 mmol) in dry dichloromethane (25.0 mL) was cooled to 0 
°C. Freshly distilled isobutyraldehyde (1.8 mL, 20.0 mmol) was added dropwise via 
syringe within 5 min. This mixture was warmed to 23 °C and stirred for an additional 
4 h. The crude yellow mixture was concentrated and purified by column 
chromatography (silica, 10% diethyl ether – pentanes, then 30% diethyl ether – 
pentanes) to give the desired ester 19 (2.73 g, 17.5 mmol, 79% yield) as a clear liquid. 
1H NMR (500 MHz, CDCl3); δ(ppm): 6.54 (dd, J = 9.7, 1.4 Hz, 1H), 4.16 (q, J = 7.1 
Hz, 2H), 2.61 (dhept, J = 9.7, 6.7 Hz, 1H), 1.81 (d, J = 1.4 Hz, 3H), 1.29 – 1.26 (m, 
3H), 1.00 (d, J = 6.7 Hz, 6H); 13C NMR (500 MHz, CDCl3); δ(ppm):  168.48, 148.68, 
125.57, 60.34, 27.86, 21.91, 14.25, 12.21; HRMS-EI (m/z): [M+] calcd for C9H16O2, 
156.1150; found, 156.1156. 
 
(E)-2,4-Dimethylpent-2-en-1-ol (S1). (E)-Ethyl 2,4-dimethylpent-2-enoate 5 
(1.40 g, 8.96 mmol) in dry diethyl ether (10.0 mL) was added dropwise with a syringe 
over 5 min to a mixing solution of LiAlH4 (0.850 g, 22.40 mmol) in diethyl ether 
(35.0 mL) at 0 °C. After stirring at 23 °C for 45 min, the solution was cooled to 0 °C. 
To the cooled mixture, H2O (0.9 mL), 3 M NaOH (0.9 mL) and another portion of 






CH2Cl2, 0 oC, 













The resultant mixture was warmed to 23 °C and stirred for 3 h. The salts were filtered 
and washed with ether (3 x 10 mL), and the combined filtrate was dried with 
magnesium sulfate and evaporated. The crude clear mixture was purified by column 
chromatography (silica, 20% diethyl ether – pentanes, then 40% diethyl ether – 
pentanes) to give the desired alcohol S1 (0.844 g, 7.39 mmol, 82% yield) as a clear 
liquid. 1H NMR (500 MHz, CDCl3); δ (ppm): 5.22 (ddd, J = 9.2, 2.6, 1.3 Hz, 1H), 
3.97 (d, J = 4.3 Hz, 2H), 2.58 – 2.48 (m, 1H), 1.66 (d, J = 1.3 Hz, 3H), 1.40 (t, J = 5.3 
Hz, 1H), 0.95 (d, J = 6.7 Hz, 6H); 13C NMR (500 MHz, CDCl3) ; δ(ppm): 133.93, 
132.34, 76.75, 69.00, 26.80, 22.87, 13.57. 
 
(E)-2,4-Dimethylpent-2-enal (21). Dimethylsulfoxide (1.1 mL, 16.1 mmol) was 
added dropwise to a solution of (COCl)2 (0.7 mL, 8.04 mmol) in dry dichloromethane 
(10.0 mL) at -78 °C. After stirring for 15 min, (E)-2,4-dimethylpent-2-en-1-ol S1 
(0.612 g, 5.36 mmol) in dry dichloromethane (7.0 mL) was added via syringe at -78 
°C and stirred for 25 min. Triethylamine (3.4 mL, 24.1 mmol) was added over 5 min 
at -78 °C, and then the reaction mixture was warmed to 0 °C and stirred for an 
additional 25 min. The solution was diluted with diethyl ether (10 mL) and H2O (10 
mL) and stirred for 5 min. A 1:1 mixture of brine (10 mL) and 1 M HCl (10 mL) was 
added and the aquesous phase was extracted with diethyl ether (3 x 10 mL). The 
combined organic layers were washed with a mixture of brine (10 mL) and saturated 
aqueous sodium bicarbonate (10 mL), dried with sodium sulfate, and the crude clear 
mixture was purified by column chromatography (silica, 20% diethyl ether – 
OH
(COCl)2, (CH3)2SO, NEt3, 






pentanes, then 40% diethyl ether – pentanes) to give the desired aldehyde 21 (0.367 g, 
3.28 mmol, 61% yield) as a clear liquid. 1H NMR (500 MHz, CDCl3); δ (ppm): 9.34 
(s, 1H), 6.26 (dd, J = 9.6, 1.3 Hz, 1H), 2.81 (dhept, J = 9.7, 6.7 Hz, 1H), 1.72 (d, J = 
1.3 Hz, 3H), 1.06 (d, J = 6.7 Hz, 6H); 13C NMR (500 MHz, CDCl3) ; δ(ppm): 195.60, 
161.15, 137.05, 28.16, 21.71, 9.05. 
 
6-((1E,3E)-3,5-Dimethylhexa-1,3-dien-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one  
(23). Diethyl ((2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)phosphinate 22 (3.07 
g, 11.0 mmol) was dissolved in dry THF (23.0 mL) and added dropwise to a 
suspension of NaH (60% in mineral oil, 0.463 g, 11.0 mmol) in dry THF (23.0 mL) at 
0 °C. The resulting solution was warmed to 23 °C and stirred for an additional 30 
min. A solution of (E)-2,4-Dimethylpent-2-enal 21 (1.30 g, 11.6 mmol) in dry THF 
(23.0 mL) was added via cannula at -78 °C over 15 min. The reaction mixture was 
warmed to 23 °C and stirred for 12 h and then quenched with H2O (5 mL), diluted 
with ethyl acetate (20 mL), and washed with brine (20 mL). The organic layer was 
dried with sodium sulfate and evaporated. The crude product was purified by column 
chromatography (silica, 10% ethyl acetate – hexanes) to give a white crystalline solid 
23 (1.58 g, 6.68 mmol, 58%). 1H NMR (500 MHz, CDCl3); δ (ppm): 6.92 (d, J = 15.6 
Hz, 1H), 5.87 (d, J = 15.6 Hz, 1H), 5.68 (d, J = 9.4 Hz, 1H), 5.28 (s, 1H), 2.67 (ddt, J 
= 13.3, 9.4, 6.6 Hz, 1H), 1.78 (d, J = 1.1 Hz, 3H), 1.69 (s, 6H), 0.99 (d, J = 6.6 Hz, 








NaH, THF, 0oC, 






117.16, 106.10, 93.61, 27.96, 25.03, 22.45, 12.04; HRMS-ESI (m/z): [M+Na] calcd 
for C14H20O3Na, 259.1310; found, 259.1298. 
 
(2E,4E)-Ethyl 6-bromo-5-methylhexa-2,4-dienoate  (18). The (E)-4-bromo-3-
methyl but-2-en-1-ol was synthesized from isoprene according to a known 
procedure.77 Dimethylsulfoxide (2.8 mL, 38.9 mmol) was added to a solution of 
oxalyl chloride (1.6 mL, 19.5 mmol) in dry dichloromethane (60.0 mL) at -78 °C. 
After 15 min, a solution of the (E)-4-bromo-3-methylbut-2-en-1-ol (2.14 g, 12.9 
mmol) in dichloromethane (30.0 mL total with rinses) was added. The mixture was 
stirred for 45 min. Diisopropylethylamine (10.0 mL, 58.5 mmol) was added dropwise, 
and after 30 min the mixture was warmed to 0 °C and stirred for 25 min. The reaction 
mixture was quenched by adding 100 mL of 1 M aqueous HCl. The aqueous layer 
was extracted with dichloromethane (3 x 65 mL). The combined organic layers were 
washed with water and a saturated aqueous solution of sodium bicarbonate, dried 
with sodium sulfate, concentrated at 25 °C, and the residue was used directly in the 
next step. 
 Ethyl 2-(triphenylphosphoranylidene)acetate (4.70 g, 13.5 mmol) was added to 
the solution of aldehyde in dichloromethane (40.0 mL) at 23 °C. The resultant 
mixture was stirred at the same temperature for 14 h, after which 5 g of silica gel 
were added. The mixture was concentrated and purified by column chromatography 
(silica, 5% ethyl acetate – hexanes) to give 18 as a yellow oil  (1.48 g, 49%). 1H NMR 
1. Swern Ox.
2. Ph3PCHCO2Et










(500 MHz, CDCl3); δ (ppm): 7.48 (ddd, J = 15.2, 12.8, 11.6 Hz, 1H), 6.30 – 6.20 (m, 
1H), 5.91 (dd, J = 15.2, 2.5 Hz, 1H), 4.24 – 4.17 (q, J = 7.1, 2H), 4.07 (s, 1H), 4.01 (s, 
1H), 1.99 (dd, J = 14.1, 1.2 Hz, 3H), 1.28 (t, J = 7.1, 3H); 13C NMR (125 MHz, 
CDCl3); δ(ppm): 166.87, 166.84, 139.39, 139.24, 127.29, 126.75, 122.84, 122.79, 
60.43, 60.41, 50.79, 39.43, 14.27; HRMS-EI (m/z): [M+] calcd for C9H13BrO2, 
232.0099; found, 232.0108. 
 
(2E,4E)-Ethyl 6-((4-methoxybenzyl)amino)-5-methylhexa-2,4-dienoate  (19). 
K2CO3 (1.74 g, 12.6 mmol) was added to a mixture of 4-methoxybenzylamine (0.9 
mL, 6.60 mmol) and (2E,4E)-ethyl 6-bromo-5-methylhexa-2,4-dienoate (1.48 g, 6.30 
mmol) in dimethylformamide (20.0 mL) at 0 °C. The mixture was warmed to 23 °C 
and stirred for 2 h. The reaction mixture was diluted with H2O and extracted with 
ethyl acetate (3 x 50 mL). The organic layer was washed with H2O (3 x 20 mL) and 
brine, dried with sodium sulfate, and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel (silica, 20% to 30% 
ethyl acetate – hexanes) to afford 19 (0.960 g, 70%) as a yellow oil. 1H NMR (600 
MHz, CDCl3); δ(ppm): 7.60 (dd, J = 15.2, 11.6 Hz, 1H), 7.23 (d, J = 8.5 Hz, 2H), 
6.86 (d, J = 8.5 Hz, 2H), 6.19 (d, J = 11.6 Hz, 1H), 5.84 (d, J = 15.2 Hz, 1H), 4.20 (q, 
J = 7.1 Hz, 2H), 3.79 (s, 3H), 3.68 (s, 2H), 3.27 (s, 2H), 1.91 (s, 3H), 1.47 (s, 1H), 
1.29 (t, J = 7.1 Hz, 3H); 13C NMR (150 MHz, CDCl3); δ(ppm): 167.67, 158.85, 









16.31, 14.51; HRMS-ESI (m/z): [M+Na] calcd for C17H23NO3Na, 312.1576; found, 
312.1564. 
 
(Z)-2-Methylpenta-2,4-dien-1-ol  (30). (Z)-3-Iodo-2-methylprop-2-en-1-ol 14 
was synthesized from propargyl alcohol according to a known procedure. 78 
Tetrakis(triphenylphosphine)palladium (0.292 g, 0.250 mmol) was added to a 
solution of vinyl iodide 13 (2.00 g, 10.0 mmol) in dry, degassed toluene (135.0 mL)  
at 0 °C. After stirring for 20 min, vinyl magnesium bromide (1.25 M in THF, 24.0 
mL, 30.0 mmol) was added dropwise. The reaction mixture was stirred at 0 °C for 1 h 
and at room temperature for 30 min. The reaction was quenched by adding 20 ml of 
saturated aqueous ammonium chloride. The aqueous layer was extracted with diethyl 
ether (3 x 30 mL). The combined organic layers were washed with brine, dried with 
sodium sulfate, concentrated under reduced presuure at 10 °C, and the residue was 
purified by column chromatography on silica gel (silica, 30% diethyl ether – hexanes) 
to afford 30 (0.770 g, 75%) as a yellow oil. 1H NMR (500 MHz, CDCl3); δ (ppm): 
6.63 (dt, J = 16.7, 10.6 Hz, 1H), 5.96 (d, J = 11.1 Hz, 1H), 5.17 (d, J = 16.7 Hz, 1H), 
5.07 (d, J = 10.2 Hz, 1H), 4.27 (d, J = 5.9 Hz, 2H), 1.89 (s, 3H), 1.24 (s, 1H); 13C 
NMR (125 MHz, CDCl3); δ (ppm): 137.57, 131.96, 128.37, 116.57, 61.26, 21.34; 
HRMS-EI (m/z): [M+] calcd for C6H10O, 98.0732; found, 98.0730. 
IHO
5 mol% Pd(PPh3)4







(Z)-N-(4-Methoxybenzyl)-2-methylpenta-2,4-dien-1-amine  (32). N-Bromo-
succimide (1.82 g, 10.2 mmol) was added to a stirred solution of triphenylphosphine 
(2.67 g, 10.2 mmol) and 30 (0.770 g, 7.80 mmol) in anhydrous THF (20.0 mL) at –10 
°C over 2–3 min in small portions under argon. After 20 min, TLC showed a 
complete consumption of alcohol 14. 4-Methoxybenzylamine (2.0 mL, 15.6 mmol) 
was injected via a syringe in one portion. The temperature was raised to 23 °C and the 
mixture was stirred at 23 °C for 12 h. Hexane (10 mL) was added to the reaction 
mixture and stirred for 0.5 h. to precipitate triphenylphosphine oxide and succinimide. 
The solid was filtered and washed with 1 N HCl. Then the aqueous layer was 
neutralized by sodium bicarbonate solution and extracted with diethyl ether (3 x 20 
mL). The combined organic layers were dried with anhydrous sodium sulfate and 
concentrated. The residue was purified by column chromatography on silica gel 
(silica, 60% ethyl acetate – hexanes) to afford 32 (0.730 g, 43%) as a yellow oil. 1H 
NMR (500 MHz, CDCl3); δ (ppm): 7.24 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 
6.61 – 6.50 (m, 1H), 6.04 – 5.95 (m, 1H), 5.13 (ddd, J = 16.7, 1.3, 0.6 Hz, 1H), 5.00 
(dd, J = 10.2, 1.8 Hz, 1H), 3.80 (s, 3H), 3.67 (s, 2H), 3.35 (s, 2H), 1.87 (s, 3H), 1.54 
(bs, 1H); 13C NMR (125 MHz, CDCl3); δ (ppm): 158.61, 137.28, 132.50, 132.42, 
129.32, 128.75, 115.86, 113.74, 55.25, 52.43, 49.12, 22.56; HRMS-ESI (m/z): [M+H] 














dien amido)-5-methylhexa-2,4-dienoate  (E-24). Pyridinium tosylate (4.3 mg, 
0.0172 mmol) was added to a solution of 6-((1E,3E)-3,5-dimethylhexa-1,3-dienyl)-
2,2-dimethyl-4H-1,3-dioxin-4-one 19 (40.0 mg, 0.172 mmol) and (2E,4E)-ethyl 6-(4-
methoxybenzylamino)-5-methylhexa-2,4-dienoate (50.0 mg, 0.172 mmol) 12 in dry 
toluene (3.5 mL). The resulting solution was heated to reflux for 2 h. Toluene was 
evaporated and the crude product was purified by column chromatography (silica, 
40% ethyl acetate – hexanes) to give (E)-24 as a white crystalline solid (50.0 mg, 
0.106 mmol, 62%). 1H NMR (600 MHz, CDCl3); δ (ppm): 7.56 (ddd, J = 2.4, 11.4, 
16.8 Hz, 2H), 7.19 (dd, J = 8.4, 12.5 Hz, 1H), 7.12 – 7.04 (m, 1H), 6.87 (ddd, J = 3.3, 
8.5, 20.3 Hz, 2H), 6.18 (d, J = 16.2 Hz, 1H), 6.04 (d, J = 11.6 Hz, 1H), 5.97 (t, J = 
13.4, 13.4 Hz, 1H), 5.89 – 5.75 (m, 1H), 5.62 (d, J = 9.3, 1H), 5.30 (s, 1H), 5.04 (s, 
1H), 4.53 (d, J = 5.1 Hz, 2H), 4.45 - 4.37 (m, 2H), 4.21 (qd, J = 5.2, 7.1, 7.1, 7.1 Hz, 
3H), 4.07 (d, J = 13.3 Hz, 2H), 3.84 – 3.77 (m, 5H), 3.69 (s, 2H), 2.74 – 2.61 (m, 1H), 
1.85 (d, J = 6.3 Hz, 3H), 4.45 – 4.37 (m, 3H), 1.33 – 1.23 (m, 3H), 1.04 – 0.97 (m, 
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pent-2-en-2-yl)-1,7-dioxooctahydro-1H-isoindol-4-yl)acrylate (25). (2E,4E)-Ethyl 
6-((4E,6E)-N-(4-methoxybenzyl)-6,8-dimethyl-3-oxonona-4,6-dienamido)-5-methyl 
hexa-2,4-dienoate (E-24) (8.2 mg, 17.5 µmol) and BHT (0.4 mg, 1.70 µmol) were 
dissolved in dry toluene (0.6 mL) and heated at reflux for 18 h. Toluene was 
evaporated and the crude product was purified by column chromatography (silica, 
50% ethyl acetate – hexanes) to give 25 as a yellowish oil (7.0 mg, 15.0 µmol, 86%). 
1H NMR (500 MHz, CDCl3); δ (ppm): 7.15 (t, J = 7.9 Hz, 2H), 6.84 (d, J = 8.5 Hz, 
2H), 6.64 (dd, J = 15.3, 11.0 Hz, 1H), 5.62 (d, J = 15.3 Hz, 1H), 4.70 (t, J = 12.6 Hz, 
1H), 4.53 (d, J = 14.4 Hz, 1H), 4.28 (d, J = 14.4 Hz, 1H), 4.19 – 4.11 (m, 2H), 3.77 (s, 
3H), 3.22 (d, J = 10.2 Hz, 1H), 3.03 (s, 1H), 2.86 (d, J = 10.2 Hz, 1H), 2.55 – 2.48 (m, 
2H), 2.46 – 2.30 (m, 3H), 1.46 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H), 1.04 (s, 3H), 0.86 (d, 
J = 6.6 Hz, 3H), 0.78 (d, J = 6.6 Hz, 3H); 13C NMR (500 MHz, CDCl3) ; δ (ppm): 
204.94, 168.38, 165.44, 159.46, 143.21, 135.09, 130.30, 129.88, 127.90, 125.55, 
114.36, 62.73, 60.66, 57.39, 55.44, 48.38, 46.36, 43.34, 41.19, 39.35, 27.91, 27.28, 
22.94, 22.92, 16.65, 14.42; HRMS-ESI (m/z): [M+Na] calcd for C28H37NO5Na, 




















21.0 µmol) and CeCl3⋅7H2O (74.0 mg, 20.0 µmol) in dry MeOH (1.5 mL) at -78 °C 
for 20 min. Ammonium chloride (3 mL) and H2O (10 mL) were added and the 
mixture was extracted with ethyl acetate (3 x 15 mL). The organic layers were 
combined, dried with sodium sulfate, and concentrated. Purification with column 
chromatography (silica, 60% ethyl acetate – hexanes) gave a yellowish oil 26 (10.0 
mg, 21.0 µmol, 100%). 1H NMR (500 MHz, CDCl3); δ (ppm): 7.15 (d, J = 8.4 Hz, 
2H), 6.92 (d, J = 8.4 Hz, 2H), 6.67 (dd, J = 15.4, 11.3 Hz, 1H), 5.58 (d, J = 15.4 Hz, 
1H), 4.83 (d, J = 9.1 Hz, 1H), 4.44 (d, J = 14.4 Hz, 1H), 4.35 (d, J = 14.4 Hz, 1H), 
4.14 (q, J = 7.1 Hz, 2H), 3.80 (s, 3H), 3.59 (td, J = 11.5, 4.6 Hz, 1H), 3.23 (d, J = 9.7 
Hz, 1H), 3.04 (s, 1H), 2.68 (d, J = 9.6 Hz, 1H), 2.45 – 2.36 (m, 1H), 2.22 (dd, J = 11.2, 
3.8 Hz, 1H), 2.15 (d, J = 12.5 Hz, 1H), 2.08 – 2.00 (m, 1H), 1.85 – 1.73 (m, 1H), 1.62 
– 1.53 (m, 1H), 1.49 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H), 0.90 (s, 3H), 0.87 (d, J = 6.6 Hz, 
3H), 0.75 (d, J = 6.6 Hz, 3H); 13C NMR (500 MHz, CDCl3) ; δ (ppm): 176.07, 165.77, 
159.41, 145.38, 134.36, 131.87, 129.79, 128.25, 123.64, 114.38, 71.68, 60.46, 56.33, 
55.85, 55.45, 46.27, 46.03, 42.87, 39.69, 30.72, 27.97, 27.18, 23.07, 22.92, 16.52, 





















dropwise to a solution of ester 26 (10.0 mg, 21.0 µmol) in dry dichloromethane (1.0 
mL) at -78 °C. After 20 min, a saturated solution of Rochelle’s salt (5 mL) was added 
and then the mixture was diluted with ethyl acetate (20 mL). The mixture was stirred 
vigorously for 2 h at room temperature. The layers were separated and the aqueous 
layer was extracted with ethyl acetate (3 x 20 mL). The organic layers were dried 
with sodium sulfate, concentrated, and the residue was purified by column 
chromatography on silica gel (silica, 70% to 90% ethyl acetate – hexanes) to afford 
the expected allylic alcohol (8.0 mg, 80%). 
Activated MnO2 (80.0 mg) was added to a solution of the allylic alcohol in dry 
dichloromethane (1.5 mL). The mixture was stirred at room temperature for 12 h, and 
then directly submitted to purification by column chromatography (70% ethyl acetate 
– hexane) to give pure aldehyde 27 (7.0 mg 88% yield) as an oil. 1H NMR (500 MHz, 
CDCl3); δ (ppm): 9.45 (d, J = 7.8 Hz, 1H), 7.18 ( d, J = 8.6 Hz, 2H), 6.89 ( d, J = 8.6 
Hz, 2H), 6.56 (dd, J = 15.4, 11.1 Hz, 1H), 5.92 (dd, J = 15.4, 7.8 Hz, 1H), 4.86 (d, J = 
9.1 Hz, 1H), 4.47 – 4.43 (d, J = 14.4 Hz, 1H), 4.38 (d, J = 14.4 Hz, 1H), 3.81 (s, 3H), 
3.67 – 3.59 (m, 1H), 3.27 (d, J = 9.7 Hz, 1H), 3.01 (s, 1H), 2.73 (d, J = 9.7 Hz, 1H), 
2.44 – 2.33 (m, 2H), 2.23 (d, J = 8.0 Hz, 1H), 2.05 (d, J = 9.4 Hz, 1H), 1.91 – 1.85 
(m, 1H), 1.49 (d, J = 0.9 Hz, 3H), 0.92 (s, 3H), 0.87 (d, J = 3.1 Hz, 3H), 0.75 (d, J = 
6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3); δ (ppm): 193.02, 175.58, 159.28, 154.32, 
134.92, 134.40, 131.43, 129.62, 127.89, 114.24, 71.33, 56.19, 55.98, 55.57, 55.27, 
46.33, 45.87, 42.51, 39.45, 29.70, 27.83, 26.98, 22.99, 22.84; HRMS-ESI (m/z): 
[M+Na] calcd for C26H35NO4Na, 448.2464; found, 448.2462. 
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(28). Aldehyde 27 (2.5 mg, 5.80 µmol) was dissolved in dry toluene (1.0 mL) and 
piperidium trifluoroacetate (1.5 mg, 7.50 µmol) was added. The mixture was heated 
to 75 °C for 2.5 h, and then finally cooled to 23 °C. The solution was directly applied 
on a silica column (silica, 60% ethyl acetate – hexanes) to afford product 28 (2.0 mg, 
47.0 µmol, 80%). 1H NMR (500 MHz, CDCl3); δ (ppm): 9.38 (d, J = 7.7 Hz, 1H), 
7.15 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 6.23 (dd, J = 15.6, 10.3 Hz, 1H), 
6.04 (dd, J = 15.5, 7.6 Hz, 1H), 4.97 (d, J = 9.1 Hz, 1H), 4.46 (d, J = 14.5 Hz, 1H), 
4.35 (d, J = 14.4 Hz, 1H), 3.82 (s, 3H), 3.59 (dd, J = 13.9, 7.1 Hz, 1H), 3.28 (d, J = 
9.5 Hz, 1H), 3.06 (s, 1H), 2.59 (d, J = 9.6 Hz, 1H), 2.39 (m, 1H), 2.28 (t, J = 10.9 Hz, 
1H), 2.07 – 1.94 (m, 2H), 1.89 (d, J = 11.2 Hz, 1H), 1.44 (d, J = 1.1 Hz, 3H), 1.08 (s, 
3H), 0.87 (d, J = 6.6 Hz, 3H), 0.77 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3); 
δ (ppm): 192.77, 175.36, 159.28, 155.66, 135.95, 135.57, 131.87, 129.47, 127.87, 
114.28, 70.10, 57.98, 55.28, 52.27, 49.82, 46.28, 45.94, 39.86, 35.96, 28.32, 26.70, 






























mmol) was added to a solution of dioxinone 23 (0.326 g, 1.38 mmol) and amine 32 
(0.300 g, 1.38 mmol) in toluene (25.0 mL), and the mixture was stirred and heated at 
reflux for 3 h. After cooling, the mixture was concentrated and the resultant red oil 
was purified by silica gel flash chromatography (silica, 20% ethyl acetate – hexanes) 
yielding the title compound 34 as a yellow oil (0.520 g, 95%). 1H NMR (500 MHz, 
CDCl3); δ (ppm): 7.30 – 7.15 (m, 1H), 7.10 – 7.03 (m, 2H), 6.88 – 6.80 (m, 2H), 6.46 
– 6.14 (m, 1H), 6.07 – 6.00 (m, 1H), 5.83 – 5.73 (m, 1H), 5.59 (d, J = 10.0, 1H), 5.28 
(d, J = 15.2, 1H), 5.22 – 4.90 (m, 2H), 4.48 (d, J = 3.5, 2H), 4.32 (s, 2H), 4.20 (d, J = 
2.2, 2H), 3.97 – 9.92 (d, J = 7.0, 2H), 3.80 – 3.75 (m, 5H), 2.74 – 2.60 (m, 1H), 1.79 – 
1.75 (m, 3H), 1.73 (d, J = 8.2, 3H), 1.03 – 0.95 (m, 6H). HRMS-ESI (m/z): [M+Na] 
calcd for C25H33NO3Na, 418.2358; found, 418.2343. 
 
(2E,4Z)-Methyl 6-((4E,6E)-N-(4-methoxybenzyl)-6,8-dimethyl-3-oxonona-4,6-
dienamido)-5-methylhexa-2,4-dienoate  (Z-33). Alkene 34 (0.520 g, 1.31 mmol) 
and methyl acrylate (35.0 µL, 3.94 mmol) were dissolved in dichloromethane (35.0 
mL), and Hoveyda-Grubbs second generation catalyst (20.0 mg, 33.0 µmol) was 
added in one portion. The reaction was stirred at 45 °C for 3 h and then concentrated. 
The residue was purified by column chromatography (silica, 20% to 30% ethyl 
acetate – hexanes) to give the desired product (Z)-33 (0.480 g, 81%) as a yellow oil. 
1H NMR (500 MHz, CDCl3); δ (ppm): 7.61 – 7.38 (m, 1H), 7.38 – 7.31 (m, 1H), 7.30 











J = 9.4 Hz, 1H), 5.53 (s, 1H), 5.52 – 5.42 (m, 1H), 4.66 (d, J = 10.2 Hz, 2H), 4.49 (d, 
J = 3.57 Hz, 2H), 4.45 (d, J = 4.8 Hz, 2H) 4.22 (d, J = 9.61 Hz, 2H), 4.00 (s, 2H), 3.96 
(dt, J = 4.3, 4.3, 8.1 Hz, 3H), 3.90 (s, 2H), 3.88 – 3.83 (m, 3H), 2.93 – 2.77 (m, 1H), 
2.05 (s, 3H), 2.01 – 1.98 (d, J = 6.9 Hz, 3H), 1.97 – 1.91 (M, 3H), 1.17 (dd, J = 6.5, 




pent-2-en-2-yl)-1,7-dioxooctahydro-1H-isoindol-4-yl)acrylate  (34). A solution of Z-
33 (24.0 mg, 53.0 µmol) in toluene (1.8 mL) was heated at reflux for 18 h. After cooling, 
the mixture was concentrated and the resultant red oil was purified by silica gel flash 
chromatography (silica, 20% to 60% ethyl acetate – hexanes) yielding the title compound 
34 as a yellow oil (14.4 mg, 60%). 1H NMR (500 MHz, CDCl3); δ (ppm): 7.15 (d, J = 8.6 
Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 6.36 (dd, J = 15.5, 9.8 Hz, 1H), 5.79 (d, J = 15.5 Hz, 
1H), 4.95 (dd, J = 9.2, 1.0 Hz, 1H), 4.47 (d, J = 14.5 Hz, 1H), 4.34 (d, J = 14.7 Hz, 1H), 
3.79 (s, 3H), 3.68 (s, 3H), 3.30 (d, J = 10.2 Hz, 1H), 2.97 (s, 1H), 2.62 (d, J = 10.2 Hz, 
1H), 2.52 – 2.28 (m, 5H), 1.43 (d, J = 1.0 Hz, 3H), 1.15 (s, 3H), 0.85 (d, J = 6.6 Hz, 3H), 
0.77 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3); δ (ppm): 204.46, 168.56, 165.76, 
159.21, 145.37, 137.07, 130.17, 129.53, 127.77, 124.57, 114.20, 63.88, 55.23, 52.19, 
51.57, 49.53, 47.71, 46.10, 44.66, 42.75, 28.10, 26.78, 22.59, 22.57, 11.66; HRMS-ESI 
















((E)-4-methylpent-2-en-2-yl)-1-oxooctahydro-1H-isoindol-4-yl)acrylate (S2). Sodium 
borohydride (15.0 mg, 0.400 mmol) was added to a stirred solution of cerium(III) 
chloride heptahydrate (61.0 mg, 0.160 mmol) and 34 (37.0 mg, 81.0 µmol) in anhydrous 
methanol (4.0 mL) at –78 °C. After 40 min, saturated aqueous ammonium chloride (4 
mL) was added. The aqueous layer was extracted with ethyl acetate (3 x 10 mL). The 
combined organic layers were washed with brine, dried with sodium sulfate, 
concentrated, and the residue was purified by column chromatography on silica gel 
(silica, 50% to 70% ethyl acetate – hexanes) to afford the desired alcohol S2 (30.0 mg, 
81%) as a white solid. 1H NMR (500 MHz, CDCl3); δ (ppm): 7.14 (d, J = 8.6 Hz, 2H), 
6.87 (d, J = 8.6 Hz, 2H), 6.34 (dd, J = 15.5, 10.5 Hz, 1H), 5.72 (d, J = 15.5 Hz, 1H), 4.93 
(dd, J = 9.1, 1.1 Hz, 1H), 4.42 (d, J = 14.5 Hz, 1H), 4.33 (d, J = 14.4 Hz, 1H), 3.81 (s, 
3H), 3.67 (s, 3H), 3.56 (ddd, J = 11.5, 9.7, 4.2 Hz, 1H), 3.24 (d, J = 9.8 Hz, 1H), 3.12 (s, 
1H), 2.59 (d, J = 9.8 Hz, 1H), 2.43 – 2.34 (m, 1H), 2.10 (t, J = 11.0 Hz, 1H), 1.97 (m, 
2H), 1.85 (ddd, J = 12.4, 4.0, 2.6 Hz, 1H), 1.42 (d, J = 1.1 Hz, 3H), 1.05 (s, 3H), 0.86 (d, 
J = 6.6 Hz, 3H), 0.76 (d, J = 6.6 Hz, 3H); 13C NMR (125 MHz, CDCl3); δ (ppm): 175.52, 
166.07, 159.21, 147.05, 135.66, 131.94, 129.50, 127.99, 123.84, 114.24, 70.14, 58.05, 
55.25, 52.37, 51.46, 49.56, 46.13, 45.91, 39.73, 36.05, 28.23, 26.68, 22.77, 22.72, 12.30; 



















en-2-yl)-1-oxo-2,3,3a,4,5,6-hexahydro-1H-isoindol-4-yl)acrylate  (35). Methane 
sulfonyl chloride (25.0 µL, 0.330 mmol) was added to the solution of alcohol S2 (30.0 
mg, 66.0 µmol) and triethylamine (92.0 µL, 0.660 mmol) in dichloromethane (5.0 mL) at 
0 °C. The mixture was stirred at 0 °C for 30 min. The reaction mixture was poured into a 
saturated aqueous solution of sodium bicarbonate and extracted with ethyl acetate. The 
combined organic leyers were washed with 1 M HCl, brine, dried over sodium sulfate, 
and filtered. The filtrate was concentrated under reduced pressure, and the residue was 
used directly in the next step.  
The residue was dissolved in toluene (4.0 mL) and treated with 1,8-
diazabicyclo(5.4.0)-undec-7-ene (93.0 µL, 0.660 mmol) at 25 °C. The reaction mixture 
was stirred at 80 °C for 6 h and then poured into a mixture of 1 M HCl and ethyl acetate. 
The organic layer was separated and washed with saturated aqueous solution of sodium 
bicarbonate, brine, then dried over sodium sulfate, and filtered. The filtrate was 
concentrated under reduced pressure, and the residue was purified by column 
chromatography on silica gel (silica, 30% ethyl acetate – hexanes) to afford 35 (23.0 mg, 
79%) as an oil. 1H NMR (500 MHz, CDCl3); δ (ppm): 7.14 (d, J = 8.6 Hz, 2H), 6.84 (d, J 
= 8.7 Hz, 2H), 6.74 (dd, J = 5.7, 4.7 Hz, 1H), 6.56 (dd, J = 15.5, 10.3 Hz, 1H), 5.77 (d, J 
= 15.5 Hz, 1H), 4.99 (d, J = 9.2 Hz, 1H), 4.63 (d, J = 14.6 Hz, 1H), 4.17 (d, J = 14.6 Hz, 









2. DBU, PhMe, 







2.41 (m, 1H), 2.38 (d, J = 10.7 Hz, 1H), 2.20 – 2.13 (m, 2H), 1.96 (ddd, J = 10.7, 8.9, 5.7 
Hz, 1H), 1.48 (d, J = 1.2 Hz, 3H), 1.14 (s, 3H), 0.88 (d, J = 6.6 Hz, 3H), 0.81 (d, J = 6.6 
Hz, 3H); 13C NMR (125 MHz, CDCl3); δ (ppm): 167.18, 166.21, 159.05, 148.05, 140.17, 
135.89, 132.03, 129.52, 129.35, 128.40, 122.55, 114.07, 55.24, 53.83, 51.48, 49.84, 49.51, 
46.06, 41.53, 29.28, 28.35, 26.84, 22.86, 22.72, 12.79; HRMS-ESI (m/z): [M+Na] calcd 
for C27H35NO4Na, 460.2464; found, 460.2442.   
 
(E)-3-((3aR,4R,5S,7R,7aR)-7-Hydroxy-2-(4-methoxybenzyl)-3a-methyl-5-((E)-4-
methylpent-2-en-2-yl)-1-oxooctahydro-1H-isoindol-4-yl)acrylaldehyde  (28).  
Diisobutylaluminum hydride (1 M in toluene, 0.2 mL, 0.200 mmol) was added 
dropwise to a solution of ester S2 (4.0 mg, 8.80 µmol) in dry dichloromethane (1.0 mL) 
at -78 °C. After 20 min, a saturated solution of Rochelle’s salt (5 mL) was added and then 
the mixture was diluted with ethyl acetate (20 mL). The mixture was stirred vigorously 
for 2 h at room temperature. The layers were separated and the aqueous layer was 
extracted with ethyl acetate (3 x 5 mL). The organic layers were dried with sodium 
sulfate, concentrated, and the residue was purified by column chromatography on silica 
gel (silica, 70% to 90% ethyl acetate – hexanes) to afford the expected allylic alcohol (4.0 
mg, 99%). 
Activated MnO2 (40.0 mg) was added to a solution of the allylic alcohol in dry 
dichloromethane (1.0 mL). The mixture was stirred at room temperature for 12 h, and 
















acetate) to give pure aldehyde 28 as an oil (4.0 mg 95% yield). The 1H and 13C NMR 
data were identical to the material prepared previously for substrate 28. 
 
(R)-4-Methylhex-5-enal (S3). (R)-3,7-Dimethylocta-1,6-diene was prepared 
according to a described synthetic procedure.79 Ozone was bubbled through a solution 
of citronellene 52 (3.00 g, 21.7 mmol) in CH2Cl2 (80 mL) at -78 °C for 3 h. The 
reaction was monitored by TLC, and once the starting material was consumed, 
dimethylsulfide (4.0 mL, 54.2 mmol) was added and the mixture was stirred at -30 °C 
for 1 h. The solution was warmed to 0 °C and fractionated directly by distillation at 
~200 mm Hg to isolate pure product S3 (2.06 g, 18.4 mmol, 85% yield), which was 
collected as the last fraction. [α]D
23 -6.7°  (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) 
δ (ppm): 9.77 (t, J=1.7 Hz, 1H), 5.63 (ddd, J=17.1, 10.4, 7.8 Hz, 1H), 5.01-4.95 (m, 
2H), 2.43 (dddd, J=8.4, 7.0, 3.0, 1.7 Hz, 2H), 2.15 (dddd, J=12.4, 8.1, 5.7, 1.2 Hz, 
1H), 1.74-1.55 (m, 2H), 1.03 (d, J=6.7 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
(ppm): 202.5, 143.2, 113.7, 41.7, 37.4, 28.4, 20.1. HRMS-ESI (m/z): [M+Na]+ calcd 
for C7H12ONa, 135.0786; found, 135.0789.  
 
(5R)-1,1,1-Trichloro-5-methylhept-6-en-2-ol (53). Sodium formate (0.260 g, 
3.87 mmol) and Me3SiCCl3 (11.1 g, 58.0 mmol) were added to a solution of (4R)-4-
methylhex-5-enal S3 (4.30 g, 38.7 mmol) in dry DMF (86 mL) at 23 °C and the 
O3, CH2Cl2












mixture was stirred for 1 h. A mixture of methanol and 1 M aqueous HCl (8 mL, 1:1, 
v/v) was added and the reaction mixture was stirred at 23 °C for 1 h. Water (10 mL) 
was added, the aqueous layer was separated and extracted with diethyl ether (4×10 
mL). The combined organic phase was washed with brine and dried over Na2SO4, 
concentrated and the crude product was purified by column chromatography on silica 
gel (10% diethyl ether in pentanes) to afford the alcohol 53 (8.42 g, 36.4 mmol, 94% 
yield). [α]D
23 -2.2°  (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 5.70 (dddd, 
J=17.4, 13.8, 10.3, 7.7 Hz, 1H), 5.08-4.89 (m, 2H), 4.06-3.94 (m, 1H), 2.64 (ddd, 
J=14.6, 5.7, 1.5 Hz, 1H), 2.26-2.15 (m, 1H), 2.14-2.01 (m, 1H), 1.74-1.55 (m, 2H), 
1.52-1.41 (m, 1H), 1.05-1.03 (m, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 143.9, 
143.6, 113.5, 113.2, 104.9, 104.2, 83.2, 82.9, 37.6, 37.5, 32.9, 32.7, 29.4, 29.2, 20.4, 
20.0. HRMS-ESI (m/z): [M-H]- calcd for C8H12Cl3O, 228.9954; found, 228.9952.  
 
(R)-1,1,1-Trichloro-5-methylhept-6-en-2-one (S4). Trifluoroacetic anhydride 
(5.5 mL, 38.8 mmol) in CH2Cl2 (30 mL) was added to a solution of dimethyl 
sulfoxide (3.3 mL, 46.6 mmol) in CH2Cl2 (30 mL) dropwise at -78 °C over 5 min. 
The mixture was stirred at -78 °C for 10 min. A solution of (5R)-1,1,1-trichloro-5-
methylhept-6-en-2-ol 53 (3.60 g, 15.5 mmol) in CH2Cl2 (15 mL) was added dropwise 
over 10 min at -78 °C and stirred for an additional 5 min. The reaction mixture was 
warmed to 23 °C and stirred for another 1 h. The solution was cooled to 0 °C and i-
Pr2NEt (13.5 mL, 77.7 mmol) was added dropwise. The mixture was warmed to 23 
°C for 1 h. The solution was diluted with diethyl ether (4 mL) and washed with 1 M 
(CF3CO)2O, DMSO, i-Pr2NEt 







HCl, and saturated aqueous NaHCO3. The aqueous layers were extracted with diethyl 
ether (3x4 mL). The combined organic layer was washed with brine, dried over 
Na2SO4, concentrated under atmospheric conditions and purified by column 
chromatography on silica gel (10% diethyl ether in pentanes) to deliver 
trichloromethyl ketone S4 (2.85 g, 12.4 mmol, 80% yield). [α]D
23 -3.6°  (c 1.0, CHCl3). 
1H NMR (500 MHz, CDCl3) δ (ppm) 5.65 (ddd, J=17.2, 10.3, 7.9 Hz, 1H), 5.10-4.93 
(m, 2H), 3.09-2.89 (m, 2H), 2.20 (p, J=7.0 Hz, 1H), 1.90-1.63 (m, 2H), 1.06 (d, J=6.7 
Hz, 2H): 13C NMR (125 MHz, CDCl3) δ (ppm): 190.8, 142.9, 114.2, 37.5, 31.8, 31.2, 
29.6, 20.2.  
 
(2R,5R)-1,1,1-trichloro-5-methylhept-6-en-2-ol (54). Dichloro(p-cymene) 
ruthenium(II) dimer (0.150 g, 0.246 mmol) and Et3N (69 µL, 0.492 mmol) were 
added to a solution of (1R,2R)-N-p-tosyl-1,2-diphenylethylenediamine (0.180 g, 
0.492 mmol) in DMF (5.0 mL) at 23 °C and the mixture was stirred for 1 h. In 
parallel, formic acid (1.2 mL, 49.2 mmol) and Et3N (2.7 mL, 19.7 mmol) were stirred 
at 23 °C for 10 min. A solution of substrate S4 (2.26 g, 9.84 mmol) in tert-butyl 
methyl ether (20 mL) was added to the formic acid-triethylamine mixture, followed 
by the solution of the catalyst. After stirring at 23 °C for 3 h, water (20 mL) was 
added. The layers were separated and the aqueous phase was extracted with ethyl 
acetate (3x10 mL). The combined organic phase was washed with brine, dried over 












silica gel (20% diethyl ether in pentanes) to afford the alcohol 54 (2.20 g, 9.44 mmol, 
96% yield, dr 10:1). [α]D
23 +25.3° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm) 
5.71 (ddd, J=17.1, 10.3, 7.6 Hz, 1H), 5.02-4.95 (m, 2H), 3.99 (ddd, J=9.6, 5.6, 1.9 
Hz, 1H), 2.21-2.17 (m, 1H), 2.11-2.02 (m, 2H), 1.69-1.56 (m, 2H), 1.51-1.39 (m, 1H), 
1.04 (dd, J=6.8 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 143.9, 113.2, 104.2, 
83.2, 37.6, 32.9, 29.4, 20.1.  
 
((((2R,5R)-1,1,1-Trichloro-5-methylhept-6-en-2-yl)oxy)methoxy)benzene (S5). 
Diisopropyl-ethylamine (13.8 mL, 79.0 mmol) was added to a solution of (2R,5R)-
1,1,1-trichloro-5-methylhept-6-en-2-ol 54 (3.02 g, 13.2 mmol), benzyloxymethyl 
chloride (7.2 mL, 52.1 mmol), and tetrabutylammonium iodide (0.48 g, 1.30 mmol) 
in CH2Cl2 (13.0 mL) at 0 °C and the mixture was stirred for 15 min. The solution was 
then heated at 45 °C for 12 h. The crude mixture was cooled to 23 °C, water (13 mL) 
was added, and the resulting mixture was extracted with CH2Cl2 (3x15 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, and 
concentrated. The residue was purified by column chromatography on silica gel (10% 
ethyl acetate in hexanes) to afford S5 (2.20 g, 9.44 mmol, 96% yield, dr 10:1). [α]D
23 
+82.1°  (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.37-7.36 (m, 4H), 
7.33-7.31 (m, 1H), 5.72-5.64 (m, 1 H), 5.13-5.11 (m, 1H), 5.04-4.94 (m, 3H), 4.83 (d, 
J=11.9 Hz, 1H), 4.65 (d, 11.3 Hz, 1H), 4.00 (d, 8.5 Hz, 1H), 2.19-2.10 (m, 2H), 1.82-
1.75 (m, 1H), 1.73-1.65 (m, 1H), 1.01 (d, J=6.7 Hz, 3H): 13C NMR (125 MHz, 
CDCl3) δ (ppm): 143.9, 137.3, 128.4, 127.8, 127.7, 113.2, 102.7, 97.1, 89.7, 70.6, 
BOMCl, i-Pr2NEt, TBAI








37.8, 32.8, 30.1, 20.4. HRMS-ESI (m/z): [M+Na]+ calcd for C16H21Cl3O2Na, 
373.0505; found, 373.0509. 
 
(4R,7R,E)-7-((Benzyloxy)methoxy)-8,8,8-trichloro-2,4-dimethyloct-2-enal 
(55). Hoveyda-Grubbs II catalyst (1,3-bis-(2,4,6,-trimethylphenyl)-2-imidazol 
idinylidene)-dichloro (o-isopropoxyphenylmethylene)ruthenium (28 mg, 44.3 µmol) 
was added to a degassed solution of S5 (0.520 g, 1.48 mmol) and metacrolein (2.3 
mL, 28.1 mmol) in CH2Cl2 (19.0 mL). The solution was heated at 65 °C for 10 h. The 
crude mixture was concentrated and immediately purified by column chromatography 
on silica gel (30% ethyl acetate in hexanes) to afford aldehyde 55 (0.390 g, 0.991 
mmol, 67% yield, E:Z 10:1), along with recovered starting material (90 mg, 0.256 
mmol, 17% yield). [α]D
23 +88.6° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 
7.37-7.36 (m, 4H), 7.33-7.31 (m, 1H), 5.72-5.64 (m, 1 H), 5.13-5.11 (m, 1H), 5.04-
4.94 (m, 3H), 4.83 (d, J=11.9 Hz, 1H), 4.65 (d, 11.3 Hz, 1H), 4.00 (d, 8.5 Hz, 1H), 
2.19-2.10 (m, 2H), 1.82-1.75 (m, 1H), 1.73-1.65 (m, 1H), 1.01 (d, J=6.7 Hz, 3H): 13C 
NMR (125 MHz, CDCl3) δ (ppm): 195.3, 158.9, 138.3, 137.1, 128.4, 127.9, 127.5, 
102.3, 97.2, 89.5, 70.5, 33.4, 32.6, 30.0, 19.4, 9.3.  
 
Cl3C
OBOM HG(II) 3 mol%
CHCl3, 65 oC, 12 h



























1,3-dien-1-yl)-2,2-dimethyl-4H-1,3-dioxin-4-one (57). A solution of diethyl ((2,2-
dimethyl-4-oxo-4H-1,3-dioxin-6-yl)methyl)phosphonate 56 (5.07 g, 18.1 mmol) in 
THF (40 mL) was added to a suspension of sodium hydride (60% in mineral oil, 
0.673 g, 16.8 mmol) in THF (80 mL) at 0 °C. After stirring at 0 °C for 30 min, the 
mixture was warmed to 23 °C and stirred for an additional 30 min. This mixture was 
added via cannula into a solution of (4R,7R,E)-7-((benzyloxy)methoxy)-8,8,8-
trichloro-2,4-dimethyloct-2-enal 55 (5.1 g, 13.0 mmol) in THF (140 mL) at -78 °C 
over 15 min. This solution was stirred at -78 °C for 30 min and then warmed to 23 °C 
and stirred for an additional 12 h. Brine (200 mL) was added, layers separated, and 
the aqueous layer was extracted with ethyl acetate (3x50 mL). The combined organic 
layers were washed with brine, dried over Na2SO4, and concentrated. The residue was 
purified by column chromatography on silica gel (30% ethyl acetate in hexanes) to 
afford dioxinone 57 (5.3 g, 10.2 mmol, 79% yield) as the only isomer. [α]D
23 +34.3°  (c 
1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.37-7.28 (m, 5H), 6.92 (d, 
J=15.6 Hz, 1H), 5.88 (d, J=9.8 Hz, 1H), 5.31 (s, 1H), 5.10 (d, J=7.2 Hz, 1H), 5.01 (d, 
J=7.3 Hz, 1H), 4.81 (d, J=11.8 Hz), 4.62 (d, J=11.8 Hz, 1H), 3.97 (dd, J=8.4, 2.3 Hz, 
1H), 2.56 (m, 1H), 2.08-1.99 (m, 1H), 1.78 (d, J=1.2 Hz, 3H), 1.72 (d, J=4.4 Hz, 6H), 
1.51-1.41 (m, 1H), 0.98 (d, J=6.6 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 
163.9, 162.0, 146.6, 142.8, 137.2, 132.1, 128.4, 127.8, 128.6, 117.6, 106.1, 102.5, 
97.2, 93.9, 89.6, 70.6, 33.3, 33.2, 30.1, 25.1, 25.0, 20.2, 12.3. HRMS-ESI (m/z): 





dienamide (59). Pyridinium p-toluenesulfonate (43 mg, 0.343 mmol) was added to a 
stirring solution of amine 58 (0.812 g, 3.43 mmol) and dioxinone 57 (1.78 g, 3.43 
mmol) in toluene (68 mL) in a sealed flask and heated at 110 °C for 4 h. The crude 
mixture was allowed to cool to room temperature and concentrated. The residue was 
purified by column chromatography on silica gel (20% ethyl acetate in hexanes) to 
afford the amide 59 (2.17 g, 3.19 mmol, 93% yield), which exists as a mixture of 
rotamers and tautomers as observed by NMR. 1H NMR (500 MHz, CDCl3) δ (ppm): 
7.35 (dd, J=5.3, 3.1 Hz, 4H), 7.32-7.30 (m, 2H), 7.20 (dd, J=8.4, 4.4 Hz, 2H), 7.14-
7.04 (m, 2H), 6.91-6.82 (m, 2H), 6.47-6.17 (m, 1H), 6.11-6.03 (m, 1H), 5.87-5.65 (m, 
1H), 5.53 (d, J=9.8 Hz, 1H), 5.29 (d, J=15.3 Hz, 1H), 5.18 (dd, J=26.6, 17.3 Hz, 1H), 
5.10 (dd, J=7.4, 1.8 Hz, 1H), 5.04-4.99 (m, 2H), 4.81 (dd, J=11.8, 2.0 Hz, 1H), 4.63 
(dd, J=11.8, 1.9 Hz, 1H), 4.52 (s, 1H), 4.34 (s, 1H), 4.22 (d, J=6.1 Hz, 1H), 4.01-3.94 
(m, 2H), 3.84-3.75 (m, 3H), 2.54 (tq, J=14.6, 7.1 Hz, 1H), 2.12-1.99 (m, 1H), 1.80-
1.72 (m, 6H), 1.53-1.40 (m, 2H), 0.97 (td, J=7.7, 6.4, 4.7 Hz, 3H).  
 

























methylhexa-2,4-dienoate (66). Hoveyda Grubbs II catalyst (0.102 g, 0.162 mmol) 
was added to a stirring degassed solution of methyl acrylate (1.2 mL, 13.0 mmol) and 
substrate 59 (2.2 g, 3.25 mmol) in CH2Cl2 (108 mL). The resulting solution was 
heated at 45 °C for 14 h. The crude mixture was cooled to room temperature and 
immediately concentrated. The residue was purified by column chromatography on 
silica gel (20% ethyl acetate in hexanes) to afford the amide 66 as a mixture of 
rotamers and tautomers (2.12 g, 2.88 mmol, 89% yield). 1H NMR (500 MHz, CDCl3) 
δ (ppm): 7.37-7.29 (m, 5H), 7.23-7.05 (m, 3H), 6.87 (dd, J=12.8, 8.4 Hz, 2H), 6.25-
6.11 (m, 1H), 5.94-5.70 (m, 2H), 5.53 (d, J=9.8 Hz, 1H), 5.34 (s, 1H), 5.10 (d, J=7.2 
Hz, 1H), 5.01 (d, J=7.2 Hz, 1H), 4.81 (d, J=11.9 Hz, 1H), 4.63 (d, J=11.9 Hz, 1H), 
4.52 (s, 1H), 4.38-4.22 (m, 3H), 4.06 (d, J=6.5 Hz, 1H), 4.00-3.96 (m, 1H), 3.81 (d, 
J=3.0 Hz, 4H), 3.78-3.68 (m, 3H), 2.53 (dq, J=15.1, 7.8 Hz, 1H), 2.11-1.99 (m, 1H), 
1.91-1.81 (m, 3H), 1.79-1.71 (m, 6H), 1.44 (ddd, J=14.9, 10.2, 6.2 Hz, 1H), 0.97 (dd, 
J=6.6, 4.7 Hz, 3H): HRMS-ESI (m/z): [M+Na]+ calcd for C38H46Cl3NO7Na, 
756.2238; found, 756.2257. 
 











10 mol% La(OTf)3, 12 mol% L1







octahydro-1H-isoindol-4-yl) acrylate (S6). Lanthanum(III) triflate (0.191 g, 0.325 
mmol) was added to a solution of 2,6-bis((3aS,8aR)-8,8a-dihydro-3aH-indeno[1,2-
d]oxazol-2-yl)pyridine L1 (0.154 g, 0.390 mmol) in ethyl acetate (20 mL). After 
stirring at 23 °C for 1 h, the catalyst was added to 66 (2.39 g, 3.25 mmol) in ethyl 
acetate (88 mL). The resulting solution was capped and heated at 45 °C for 24 h. The 
reaction mixture was cooled, concentrated, and the residue was purified by 
chromatography on silica gel (80% ethyl acetate in hexanes) to afford product S6 
(1.45 g, 1.98 mmol, 61% yield, 3:1 dr). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.37-
7.31 (m, 5H), 7.17 (dd, J=8.8, 2.2 Hz, 2H), 6.89-6.85 (m, 2H), 6.46-6.30 (m, 1H), 
5.80 (dd, J=15.6, 1.7 Hz, 1H), 5.08 (d, J=7.2 Hz, 1H), 4.98 (dd, J=12.7, 7.2 Hz, 1H), 
4.89 (ddd, J=19.3, 9.4, 1.6 Hz, 1H), 4.77 (t, J=11.4, 1H), 4.63 (t, J=11.2 Hz, 1H), 
4.48 (d, J=14.6 Hz, 1H), 4.35 (dd, J=14.6, 2.4 Hz, 1H), 3.92 (ddd, J=10.1, 8.4, 2.4 
Hz, 1H), 3.79 (d, J=2.1 Hz, 3H), 3.68 (d, J=1.5 Hz, 3H), 3.36-3.23 (m, 1H), 2.97 (d, 
J=2.6 Hz, 1H), 2.63 (dd, J=10.2, 5.5 Hz, 1H), 2.45-2.38 (m, 4H), 2.38-2.33 (m, 1H), 
2.29-2.19 (m, 1H), 1.96 (qdd, J=10.8, 5.5, 2.5 Hz, 1H), 1.75-1.55 (m, 4H), 1.45 (dd, 
J=15.6, 1.3 Hz, 3H), 1.34-1.22 (m, 2H), 1.16 (s, 3H), 0.8 (dd, J=45.2, 6.6 Hz, 3H): 
13C NMR (125 MHz, CDCl3) δ (ppm): 204.1, 168.4, 165.7, 159.2, 145.2, 137.2, 
135.1, 131.9, 129.5, 128.4, 127.8, 127.5, 124.5, 114.2, 102.6, 97.1, 89.6, 70.5, 63.8, 
55.2, 52.1, 51.5, 49.3, 47.9, 46.1, 44.6, 42.7, 33.4, 32.1, 30.1, 28.0, 20.5, 11.7. 





en-1-yl)octahydro-1H-isoindol-1-one (S7). Sodium borohydride (0.148 g, 3.99 
mmol) was added to a solution of S6 (2.45 g, 3.33 mmol) in MeOH and THF (1:1 v/v, 
167 mL) at -78 °C. After stirring at -78 °C for 30 min, the reaction mixture was 
quenched with saturated aqueous NH4Cl and warmed to 23 °C, and extracted with 
ethyl acetate. The combined organic phase was washed with brine, dried over Na2SO4 
and concentrated. The residue was purified by column chromatography on silica gel 
(70% ethyl acetate in hexanes) to deliver products S7 and S8 as a mixture (2.40 g, 
3.26 mmol, 98% yield). The mixture was separated by preparative HPLC (YMC Pak-
Sil; 2% i-PrOH in toluene; flow rate = 50.0 mL/min; detection at 290 nm; t1=27.8 min 
(S8); t2= 37.0 min (S7); t3=38.0 min (other isomers)) to provide S7 as a white 
crystalline solid (1.82 g, 2.43 mmol, 73% yield), S8 (0.55 g, 0.746 mmol, 22% yield), 
and a mixture of other isomers (0.140 g, 0.190 mmol, 6% yield). S7 [α]D
23 +5.2° (c 1.0, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.33 (d, J=4.5 Hz, 5H), 7.17 (dd, 
J=17.1, 8.6 Hz, 2H), 6.88 (d, J=7.9 Hz, 2H), 6.34 (dd, J=15.5, 10.4 Hz, 1H), 5.73 (d, 
J=15.5 Hz, 1H), 5.07 (d, J=7.2 Hz, 1H), 4.99 (d, J=7.2 Hz, 1H), 4.89-4.82 (m, 1H), 
4.78 (d, 11.9 Hz, 1H), 4.62 (d, J=11.9 Hz, 1H), 4.44 (d, J=14.6 Hz, 1H), 4.33 (d, 
J=14.5 Hz, 1H), 3.93 (dd, J=8.6, 2.3 Hz, 1H), 3.80 (s, 3H), 3.67 (s, 3H), 3.57 (d, 
NaBH4, THF/MeOH (1:1)















J=10.9 Hz, 1H), 3.25 (d, J=9.6 Hz, 1H), 2.60 (d, J=9.7 Hz, 1H), 2.25 (tt, J=8.4, 5.7 
Hz, 1H), 2.10 (t, J=10.9 Hz, 1H), 2.04-1.92 (m, 3H), 1.81 (d, J=12.3 Hz, 1H), 1.78-
1.56 (m, 3H), 1.43 (s, 3H), 1.31-1.24 (m, 1H), 1.06 (s, 3H): 13C NMR (125 MHz, 
CDCl3) δ (ppm): 165.9, 159.2, 146.9, 137.2, 133.7, 129.4, 128.4, 128.3, 127.7, 127.6, 
123.8, 114.2, 102.6, 97.0, 89.6, 70.5, 55.2, 52.3, 51.4, 49.3, 45.9, 39.7, 33.6, 32.0, 
30.2, 28.1, 20.6, 12.3. HRMS-ESI (m/z): [M+Na]+ calcd for C38H48Cl3O7NNa, 




hexahydro-1H-isoindol-4-yl)acrylate (S9). N,N’-Dicyclohexylcarbodiimide (0.463 
g, 2.24 mmol) and CuCl (0.444 g, 4.48 mmol) were sequentially added to a stirring 
solution of substrate S7 (0.330 g, 0.448 mmol) in dry toluene (22 mL). The reaction 
mixture was stirred at 110 °C for 1 h. The resulting mixture was cooled and saturated 
aqueous ammonium chloride (30 mL) was added. The mixture was stirred at 23 °C 
for 2 h. The aqueous layer was extracted with ethyl acetate (3x15 mL) and the 
combined organic phase was washed with brine, dried over Na2SO4 and concentrated 
under reduced pressure. The residue was purified by column chromatography (50% 
ethyl acetate in hexanes) to deliver product S9 (0.216 g, 0.336 mmol, 75% yield). 
[α]D












4H), 7.32-7.26 (m, 1H), 7.15 (d, 8.6 Hz, 2H), 6.85 (d, J=8.5 Hz, 2H), 6.73 (dd, J=7.6, 
2.8 Hz, 1H), 6.73 (dd, J=7.6, 2.8 Hz, 1H), 5.77 (d, J=15.5 Hz, 1H), 5.08 (d, J=7.1 Hz, 
1H), 5.00 (d, J=7.2 Hz, 1H), 4.92 (dd, J=9.5, 1.7 Hz, 1H), 4.79 (d, 11.8 Hz, 1H), 
4.64-4.58 (m, 1H), 4.20 (d, J=14.6 Hz, 1H), 3.95 (dd, J=8.5, 2.2 Hz, 1H), 3.95 (dd, 
J=8.5, 2.2 Hz, 1H), 3.79 (s, 3H), 3.68 (s, 3H), 3.09 (d, J=9.2 Hz, 1H), 2.55 (d, J=9.1 
Hz, 1H), 2.38 (t, J=10.7 Hz, 1H), 2.28 (ddd, J=14.6, 10.4, 6.9 Hz, 1H), 2.20-2.07 (m, 
2H), 2.03-1.90 (m, 2H), 1.66 (dtdd, J=27.1, 24.9, 11.3, 6.6 Hz, 3H), 1.47 (s, 3H), 1.31 
(ddt, J=10.4, 7.3, 3.0 Hz, 1H), 1.27-1.21 (m, 1H), 1.27-1.21 (m, 1H), 1.14 (s, 3H), 
0.80 (d, J=6.6 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 167.0, 166.1, 159.0, 
147.8, 140.2, 137.2, 134.0, 133.8, 129.2, 128.4, 128.3, 127.8, 127.6, 122.5, 114.0, 
102.6, 97.0, 89.6, 70.5, 55.2, 53.7, 51.4, 50.1, 49.4, 46.0, 41.5, 33.6, 32.2, 30.3, 29.4, 





isoindol-4-yl)acrylate (67). Substrate S9 (0.216 g, 0.300 mmol) was stirred in a 
solution of trifluoroacetic acid and CH2Cl2 (1:1, v/v, 30 mL) at 0 °C. After 10 min, 
the reaction mixture was warmed to 23 °C and stirred for additional 1 h. The crude 
mixture was concentrated, toluene (3x15 mL) was added, and the solution was 
concentrated again. The dilution-concentration using toluene was repeated three 
TFA, CH2Cl2









times. The residue was purified by column chromatography (50% ethyl acetate in 
hexanes) to deliver alcohol 67 (0.170 g, 0.282 mmol, 94% yield). [α]D
23 -48.1° (c 1.0, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.14 (d, J=8.5 Hz, 2H), 6.85 (d, J=8.6 
Hz, 2H), 6.78-6.72 (m, 1H), 6.57 (dd, J=15.5, 10.3 Hz, 1H), 5.79 (d, J=15.6 Hz, 1H), 
4.98 (dd, J=9.5, 1.7 Hz, 1H), 4.61 (d, J=14.6 Hz, 1H), 4.19 (d, J=14.6 Hz, 1H), 3.95 
(ddd, J=9.8, 5.6, 2.0 Hz, 1H), 3.80 (s, 3H), 3.69 (s, 3H), 3.09 (d, J=9.2 Hz, 1H), 2.95 
(dd, J=5.6, 1.4 Hz, 1H), 2.56 (d, J=9.2 Hz, 1H), 2.41 (t, J=10.7 Hz, 1H), 2.34 (tt, 
J=8.2, 5.5 Hz, 1H), 2.24-2.10 (m, 2H), 2.07-1.94 (m, 2H), 1.73-1.61 (m, 2H), 1.59-
1.51 (m, 1H), 1.50 (s, 1H), 1.33-1.23 (m, 1H), 1.15 (s, 3H), 0.86 (d, J=6.6 Hz, 3H): 
13C NMR (125 MHz, CDCl3) δ (ppm): 167.1, 166.1, 159.0, 147.8, 140.2, 134.0, 
133.9, 129.5, 129.2, 128.3, 122.6, 114.0, 104.3, 83.2, 55.2, 53.7, 51.5, 50.0, 49.5, 
46.0, 41.6, 33.7, 32.1, 29.6, 29.4, 28.4, 20.9, 13.0. HRMS-ESI (m/z): [M+Na]+ calcd 
for C30H38Cl3NO5Na, 620.1713; found, 620.1703. 
 
(S)-tert-Butyl 3-((1S,2R)-2-chlorocyclopropyl)-3-hydroxypropanoate (57). 
Diethylzinc (2.1 mL, 20.1 mmol) was added dropwise to a stirring solution of (S)-
tert-butyl 3-hydroxypent-4-enoate 5480 (1.57 g, 9.11 mmol) in CH2Cl2 (46 mL) at -40 
°C and the reaction mixture was stirred for 10 min. Diiodochloromethane81 (3.8 mL, 
40.1 mmol) was added dropwise and resulting mixture was stirred protected from 
light at -40 °C for 24 h. The reaction mixture was quenched with saturated aqueous 
sodium sulfite (20 mL) and allowed to warm to 23 °C and stirred for an additional 1 
h. Aqueous 1 M solution of HCl was added in portions until precipitates dissolved, 
CHI2Cl, Et2Zn
CH2Cl2, -40 oC, 24 h









the layers were separated, and the aqueous layer was extracted with CH2Cl2 (3x20 
mL). The combined organic layers were washed with brine, dried over Na2SO4 and 
concentrated. The residue was purified by column chromatography (2% ethyl acetate 
in dichloromethane) to deliver product 57 (1.13 g, 5.10 mmol, 56% yield). [α]D
23 -
13.4°  (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 3.61 (ddt, J=8.5, 6.4, 3.7 
Hz, 1H), 3.11 (d, J=3.9 Hz, 1H), 3.06 (ddd, J=6.8, 4.9, 3.2 Hz, 1H), 2.61-2.44 (m, 
2H), 1.37 (s, 9H), 1.47 (s, 9H), 1.38-1.28 (m, 1H), 1.03-0.91 (m, 2H): 13C NMR (125 
MHz, CDCl3) δ (ppm): 171.9, 81.6, 68.4, 41.6, 30.1, 28.0, 27.3, 13.0. HRMS-ESI 
(m/z): [M+Na]+ calcd for C10H17ClO3Na, 243.0764; found, 243.0754. 
 
(R)-tert-Butyl 3-((1R,2S)-2-chlorocyclopropyl)-3-hydroxypropanoate (S10). 
Diethylzinc (2.1 mL, 20.1 mmol) was added dropwise to a stirring solution of (R)-
tert-butyl 3-hydroxypent-4-enoate 53 (1.57 g, 9.11 mmol) in CH2Cl2 (46 mL) at -40 
°C and the reaction mixture was stirred for 10 min. DiiodochloromethaneError! 
Bookmark not defined. (3.8 mL, 40.1 mmol) was added dropwise and resulting 
mixture was protected from light and stirred at -40 °C for 24 h. The reaction mixture 
was quenched with saturated aqueous sodium sulfite (20 mL) and allowed to warm to 
23 °C and stirred for an additional 1 h. Aqueous 1 M solution of HCl was added in 
portions until precipitates dissolved, the layers were separated, and the aqueous layer 
was extracted with CH2Cl2 (3x20 mL). The combined organic layers were washed 
with brine, dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (2% ethyl acetate in dichloromethane) to deliver product S10 (1.13 
CHI2Cl, Et2Zn





H53% yield, dr 5:1
53 S10
 93 
g, 5.10 mmol, 56% yield). [α]D
23 +12.8°  (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 
(ppm): 3.61 (ddt, J=8.5, 6.4, 3.7 Hz, 1H), 3.11 (d, J=3.9 Hz, 1H), 3.06 (ddd, J=6.8, 
4.9, 3.2 Hz, 1H), 2.61-2.44 (m, 2H), 1.37 (s, 9H), 1.47 (s, 9H), 1.38-1.28 (m, 1H), 
1.03-0.91 (m, 2H): 13C NMR (125 MHz, CDCl3) δ (ppm): 171.9, 81.6, 68.4, 41.6, 
30.1, 28.0, 27.3, 13.0. HRMS-ESI (m/z): [M+Na]+ calcd for C10H17ClO3Na, 
243.0764; found, 243.0763. 
 
(S)-3-((1S,2R)-2-Chlorocyclopropyl)-3-((triethylsilyl)oxy)propanoic acid (23). 
Ester 47 (0.216 g, 0.300 mmol) was stirred in a solution of trifluoroacetic acid and 
CH2Cl2 (1:1, v/v, 30.0 mL) at 0 °C. After 10 min, the reaction mixture was warmed to 
23 °C and stirred for another 1 h. The crude mixture was concentrated, toluene (3x15 
mL) was added, and the solution was concentrated again. The dilution-concentration 
using toluene was repeated three times. This residue was used in the next step without 
purification.  
Chlorotriethylsilane (0.56 mL, 2.72 mmol) was added to a stirring solution of the 
hydroxyl acid and imidazole (0.231 g, 3.40 mmol) in CH2Cl2 (6.8 mL) at -10 °C. 
After stirring for 1 h, the reaction mixture was poured into aqueous acetate buffer 
(pH=4) and extracted with ethyl acetate (3x10 mL). The combined organic layers 
were washed with brine, dried over Na2SO4 and concentrated. The residue was 
purified by column chromatography (30% ethyl acetate in hexanes) to deliver product 
23 (0.122 g, 0.442 mmol, 65% yield). [α]D





1. TFA, CH2Cl2, 0 oC, 1 h






over 2 steps47 23
 94 
MHz, CDCl3) δ (ppm): 3.75 (q, J=6.3 Hz, 1H), 2.98 (dt, J=7.3, 3.5 Hz, 1H), 2.61 (d, 
J=6.1 Hz, 2H), 1.44 (dtd, J=9.9, 6.6, 3.2 Hz, 1H), 1.03-0.98 (m, 1H), 0.97-0.93 (m, 
9H), 0.90 (dt, J=7.5, 6.4 Hz, 1H), 0.73-0.52 (m, 6H): 13C NMR (125 MHz, CDCl3) δ 
(ppm): 176.7, 69.5, 42.6, 30.6, 28.2, 13.2, 6.7, 4.8. HRMS-ESI (m/z): [M-H]- calcd 
for C12H22ClO3Si, 277.1027; found, 277.1035. 
 
 (R)-3-((1R,2S)-2-Chlorocyclopropyl)-3-((triethylsilyl)oxy)propanoic acid 
(ent-68). Substrate 53 (0.216 g, 0.300 mmol) was stirred in a solution of 
trifluoroacetic acid and CH2Cl2 (1:1, v/v, 30.0 mL) at 0 °C. After 10 min, the reaction 
mixture was warmed to 23 °C and stirred for another 1 h. The crude mixture was 
concentrated and toluene (3x15 mL) was added and concentrated in triplicate. This 
residue was used in the next step without purification. Chlorotriethylsilane (0.56 mL, 
2.72 mmol) was added to a stirring solution of the hydroxy acid and imidazole (0.231 
g, 3.40 mmol) in CH2Cl2 (6.8 mL) at -10 °C. After 1 h, the reaction mixture was 
poured into aqueous acetate buffer (~100 mM, pH 4) and extracted with ethyl acetate 
(3x10 mL). The combined organic layers were washed with brine, dried over Na2SO4 
and concentrated. The residue was purified by column chromatography (30% ethyl 
acetate in hexanes) to deliver product ent-68 (0.122 g, 0.442 mmol, 65% yield). [α]D
23 
+47.4°  (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 3.75 (q, J=6.3 Hz, 1H), 
2.98 (dt, J=7.3, 3.5 Hz, 1H), 2.61 (d, J=6.1 Hz, 2H), 1.44 (dtd, J=9.9, 6.6, 3.2 Hz, 
1H), 1.03-0.98 (m, 1H), 0.97-0.93 (m, 9H), 0.90 (dt, J=7.5, 6.4 Hz, 1H), 0.73-0.52 











1. TFA, CH2Cl2, 0 oC, 1 h
2. TESCl, Im, CH2Cl2, -10 oC, 1 h
ent-68
 95 
6.7, 4.8. HRMS-ESI (m/z): [M-H]- calcd for C12H22ClO3Si, 277.1027; found, 
277.1029. 
 
(S)-3-(tert-butoxy)-1-((1S,2R)-2-chlorocyclopropyl)-3-oxopropyl acrylate (60). 
Acryloyl chloride (0.27 mL, 2.88 mmol) was added dropwise to a solution of alcohol 
47 and diisopropylethylamine (0.63 mL, 3.60 mmol) in CH2Cl2 (4.0 mL) at 0 °C. 
After 10 min. the resulting mixture warmed to 23 °C and stirred for an additional 1 h. 
The solution was diluted with CH2Cl2 (4.0 mL) and washed with water (5 mL). The 
organic phase was washed successively with 1 M aqueous solution of HCl and 
saturated aqueous solution of NaHCO3. The combined organic phase was washed 
with brine, dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (20% ethyl acetate in hexanes) to deliver acrylate 60 (0.188 g, 0.684 
mmol, 95% yield). [α]D
23 -76.2° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 
6.40 (dd, J=17.3, 1.4 H, 1H), 6.10 (dd, J=17.3, 10.4 Hz, 1H), 5.85 (dd, J=10.4, 1.3 
Hz, 1H), 4.78 (td, J=8.4, 5.2 Hz, 1H), 3.15 (ddd, J=7.3, 4.0, 3.1 Hz, 1H), 2.79-2.47 
(m, 2H), 1.48 (dddd, J=9.7, 8.6, 6.3, 3.2 Hz, 1H), 1.40 (s, 9H), 1.05 (ddd, J=9.9, 6.6, 
4.0 Hz, 1H), 0.96 (dt, J=7.5, 6.4 Hz, 1H): 13C NMR (125 MHz, CDCl3) δ (ppm): 
168.7, 165.1, 131.3, 128.1, 81.2, 71.6, 40.4, 30.8, 27.9, 25.9, 14.0. HRMS-ESI (m/z): 





















(61). Hoveyda-Grubbs II catalyst (1,3-Bis-(2,4,6-trimethylphenyl)-2-
imidazolidinylidene)dichloro(o-isopropoxyphenyl methy-lene)ruthenium (5.5 mg, 
8.80 µmol) was added to a solution of acrylate 60 (73.0 mg, 0.265 mmol) and 
substrate 59 (0.120 g, 0.177 mmol) in CH2Cl2 (1.8 mL) contained in a microwave 
vial. The resulting solution was heated in the microwave at 100 °C (4 atm) for 15 
min. The crude mixture was cooled to room temperature and concentrated. The 
residue was purified by column chromatography on silica gel (25% ethyl acetate in 
hexanes) to afford amide 61 (0.104 g, 0.113 mmol, 64% yield). 1H NMR (500 MHz, 
CDCl3) δ (ppm): 7.39-7.28 (m, 9H), 7.25-7.13 (m, 2H), 7.13-7.04 (m, 3H), 6.94-6.81 
(m, 3H), 6.24-6.11 (m, 2H), 5.91-5.69 (m, 3H), 5.53 (d, J=9.9 Hz, 1H), 5.10 (d, J=7.2 
Hz, 2H), 5.01 (d, J=7.2 Hz, 2H), 4.81 (d, J=11.9 Hz, 2H), 4.75 (ddd, J=11.0, 6.4, 2.1 
Hz, 1H), 4.63 (d, J=11.9 Hz, 2H), 4.55-4.44 (m, 1H), 4.31 (dd, J=10.5, 6.5 Hz, 4H), 




HG(II), CH2Cl2, microwave, 100 oC, 
15 min




















acrylate (62). Lanthanum(III) triflate (13 mg, 22.0 µmol) was added to a stirring 
solution of 2,6-bis((3aS,8aR)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)pyr idine 
L1 (8.7 mg, 22.0 µmol) in ethyl acetate (1.0 mL). After 1 h at 23 °C, the catalyst 
solution was added to 61 (0.100 g, 0.108 mmol) in ethyl acetate (4.6 mL). The 
resulting solution was capped and heated at 45 °C for 24 h. The reaction mixture was 
cooled, concentrated, and the residue was purified by chromatography on silica gel 
(80% ethyl acetate in hexanes) to afford product 62 as inseparable mixture of 
diastereomers (61.0 mg, 65.9 µmol, 61% yield, 3:1 dr). Major diastereomer: 1H NMR 
(500 MHz, CDCl3) δ (ppm): 7.35-7.30 (m, 4H), 7.26-7.23 (m, 1H), 7.15 (d, J=8.6 Hz, 
2H), 6.85 (d, J=8.6 Hz, 2H), 6.37 (dd, J=15.5, 2.7 Hz, 1H), 5.79 (d, J=15.4 Hz, 1H), 
5.08 (d, J=7.2 Hz, 1H), 4.98 (d, J=7.2 Hz, 1H), 4.86 (d, J=9.3 Hz, 1H), 4.78 (d, 
J=11.9 Hz, 1H), 4.71-4.65 (m, 1H), 4.61 (d, J=11.8 Hz, 1H), 4.56-4.29 (m, 2H), 3.93 
(dd, J=8.7, 2.3 Hz, 1H), 3.77 (s, 3H), 3.28 (d, J=10.3, 1H), 3.05 (dt, J=7.3, 3.8 Hz, 
1H), 2.96 (d, J=8.6 Hz, 1H), 2.69-2.51 (m, 3H), 2.48-2.37 (m, 1H), 2.36-2.30 (m, 
1H), 2.24 (ddd, J=13.6, 10.5, 6.8 Hz, 1H), 1.95 (tddd, J=19.5, 11.5, 5.1, 2.4 Hz, 1H), 





10 mol% La(OTf)3, 12 mol% L1



















1.72-1.56 (m, 2H), 1.44 (s, 3H), 1.35 (s, 9H), 1.12 (s, 3H), 1.03 (ddd, J=10.1, 6.7, 3.9 
Hz, 1H), 0.91 (ddt, J=10.6, 7.5, 6.4 Hz, 1H), 0.78 (d, J=6.6 Hz, 3H): minor 
diastereomer - 1H NMR (500 MHz, CDCl3) δ (ppm): 7.36-7.31 (m, 4H), 7.26-7.23 
(m, 1H), 7.17 (d, J=8.5 Hz, 2H), 6.86 (d, J=6.4 Hz, 2H), 6.39 (dd, J=15.5, 2.2 Hz, 
1H), 5.77 (d, J=15.5 Hz, 1H), 5.05 (d, J=7.2 Hz, 1H), 4.98 (d, J=7.2 Hz, 1H), 4.88 (d, 
J=7.5 Hz, 1H), 4.77 (d, J=11.9 Hz, 1H), 4.71-4.63 (m, 1H), 4.61 (d, J=11.8 Hz, 1H), 
4.54-4.25 (m, 2H), 3.97 (dd, J=8.7, 2.4 Hz, 1H), 3.77 (s, 3H), 3.28 (d, J=10.3 Hz, 
1H), 3.12-3.08 (m, 1H), 2.96 (d, J=8.6 Hz, 1H), 2.70-2.50 (m, 3H), 2.48-2.37 (m, 
3H), 2.37-2.30 (m, 1H), 2.24 (ddd, J=13.6, 10.5, 6.8 Hz, 1H), 1.95 (ddddt, J=19.5, 
14.1, 11.5, 5.3, 2.5 Hz, 1H), 1.72-1.55 (m, 2H), 1.44 (s, 3H), 1.38 (s, 9H), 1.17 (s, 
3H), 1.03 (ddd, J=10.1, 6.7, 3.9 Hz, 1H), 0.91 (ddt, J=10.6, 7.5, 6.4 Hz, 1H), 0.83 (d, 





indol-4-yl)acrylate (63). Sodium borohydride (12 mg, 0.324 mmol) was added to a 
solution of 62 (60 mg, 64.0 µmol) in methanol and THF (1:1 v/v, 3.2 mL) at -78 °C. 
After stirring for 20 min, the reaction mixture was quenched with saturated aqueous 
























-78 oC, 30 min
53% yield 22% yield
 99 
organic phase was washed with brine, dried over Na2SO4 and concentrated. The 
residue was purified by column chromatography on silica gel (70% ethyl acetate in 
hexanes) to deliver a mixture of products 63 and S11. Pure 63 was isolated by 
dissolving the mixture of products in 5% i-PrOH/hexane and separation by 
preparative HPLC (YMC Pak-Sil; 5% i-PrOH in hexane; flow rate = 20.0 mL/min; 
detection at 210 nm; t1= 17.5 min; t2= 20.0 min; t3= 21.2 min) to provide major 
diastereomer 63 as a white solid (31 mg, 33.9 µmol, 53% yield) and minor 
diastereomer S11 as a white solid (13 mg, 14.1 µmol, 22% yield). [α]D
23 -1.4°  (c 1.0, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.33 (d, J=4.4 Hz, 4H), 7.28-7.25 (m, 
1H), 7.15 (d, J=8.5 Hz, 2H), 6.87 (d, J=8.5 Hz, 2H), 6.38 (dd, J=15.4, 10.5 Hz, 1H), 
5.72 (d, J=15.4 Hz, 1H), 5.08 (d, J=7.2 Hz, 1H), 4.99 (d, J=7.3 Hz, 1H), 4.86 (dd, 
J=9.5, 1.6 Hz, 1H), 4.79 (d, J=11.9 Hz, 1H), 4.73-4.67 (m, 1H), 4.62 (d, J=11.9 Hz, 
1H), 4.38 (q, J=14.4 Hz, 2H), 3.94 (dd, J=8.6, 2.2 Hz, 1H), 3.80 (s, 3H), 3.57 (t, 
J=10.0 Hz, 1H), 3.24 (d, J=9.8 Hz, 1H), 3.05 (ddd, J=7.3, 4.0, 3.1 Hz, 1H), 2.64-2.50 
(m, 3H), 2.64-2.50 (m, 1H), 2.26 (ddd, J=9.1, 7.3, 4.3 Hz, 1H), 2.10 (t, J=11.0 Hz, 
1H), 2.05-1.92 (m, 3H), 1.85-1.77 (m, 1H), 1.75-1.56 (m, 2H), 1.44 (d, J=1.3 Hz, 
3H), 1.44-1.37 (m, 1H), 1.36 (s, 9H), 1.33-1.24 (m, 1H), 1.02 (s, 3H), 0.99-0.89 (m, 
1H), 0.78 (d, J=6.6 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 175.4, 168.7, 
164.8, 159.2, 148.0, 137.3, 134.0, 133.6, 129.6, 128.4, 127.9, 127.8, 127.6, 123.5, 
114.2, 102.6, 97.0, 89.7, 81.1, 71.7, 70.5, 69.9, 58.0, 55.2, 52.3, 49.2, 46.4, 45.9, 40.4, 
39.7, 35.8, 33.6, 32.1, 30.8, 30.3, 29.6, 28.1, 27.9, 26.9, 25.9, 20.9, 14.2, 12.1. 






yl) acrylate (64). N,N’-Dicyclohexylcarbodiimide (6.7 mg, 32.0 µmol) and CuCl (6.3 
mg, 14.0 µmol) were sequentially added to a solution of alcohol 63 (5.0 mg, 5.40 
µmol) in toluene (0.3 mL). The reaction mixture was stirred at 110 °C for 20 min. 
The resulting mixture was cooled and saturated aqueous ammonium chloride (30 mL) 
was added. The mixture was stirred at 23 °C for 2 h. The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (3x2 mL). The combined organic phase 
was washed with brine, dried over Na2SO4 and concentrated under reduced pressure. 
The residue was purified by column chromatography (5% acetone in 
dichloromethane) to deliver product 64 (4.0 mg, 4.3 µmol, 80% yield). 1H NMR (500 
MHz, CDCl3) δ (ppm): 7.33 (d, J=4.4 Hz, 4H), .28 (q, J=3.9 Hz, 1H), 7.14 (d, J=8.4 
Hz, 2H), 6.84 (d, J=8.5 Hz, 2H), 6.73 (dd, J=7.8, 2.7 Hz, 1H), 6.58 (dd, J=15.5, 10.4 
Hz, 1H), 5.76 (d, J=15.5 Hz, 5.08 (d, J=7.2 Hz, 1H), 5.00 (d, J=7.2 Hz, 1H), 4.93 (dd, 
J=9.5, 1.7 Hz, 1H), 4.79 (d, J=11.8 Hz, 1H), 4.72 (td, J=8.4, 5.4 Hz, 1H), 4.68-4.56 
(m, 2H), 4.16 (d, J=14.6 Hz, 1H), 3.96 (dd, J=8.4, 2.3 Hz, 1H), 3.78 (s, 3H), 3.48 
(dtd, J=10.7, 7.2, 4.1 Hz, 1H), 3.11-3.05 (m, 2H), 2.58 (qd, J=15.5, 6.7 Hz, 2H), 2.51 



















1H), 2.08 (td, J=8.9, 8.4, 3.7 Hz, 1H), 2.02-1.90 (m, 3H), 1.73-1.65 (m, 3H), 1.65-
1.57 (m, 1H), 1.47 (s, 3H), 1.45-1.40 (m, 1H), 1.35 (s, 9H), 1.28-1.22 (m, 2H), 1.12 
(s, 3H), 1.04 (ddd, J=10.1, 6.5, 4.0 Hz, 1H), 0.93 (q, J=6.8 Hz, 1H), 0.82 (d, J=6.6 





(60). Benzyloxymethyl ether 64 (29 mg, 31.0 µmol) was stirred in a solution of 
trifluoroacetic acid and CH2Cl2 (1:1, v/v, 2.6 mL) at 0 °C. After stirring for 10 min, 
the reaction mixture was warmed to 23 °C and stirred for 3 h. The crude mixture was 
concentrated and the residue was purified by column chromatography (10% methanol 
in chloroform) to deliver hydroxy acid 60 (21.5 mg, 29.5 µmol, 95% yield). 1H NMR 
(500 MHz, CDCl3) δ (ppm): 7.15 (d, J=7.8 Hz, 2H), 6.85 (d, J=8.0 Hz, 2H), 6.78 (t, 
J=5.2 Hz, 1H), 6.59 (dd, J=15.5, 10.2 Hz, 1H), 5.77 (d, J=15.5 Hz, 1H), 4.98 (d, 
J=9.3 Hz, 1H), 4.74 (q, J=7.2 Hz, 1H), 4.59 (d, J=14.5 Hz, 1H), 4.24 (d, J=14.4 Hz, 
1H), 3.98 (d, J=10.1 Hz, 1H), 3.79 (s, 3H), 3.11 (d, J=9.0 Hz, 2H), 2.77-2.67 (m, 2H), 
2.59 (d, J=9.3 Hz, 1H), 2.42 (t, J=10.6, 1H), 2.23-2.14 (m, 2H), 1.99 (ddd, J=11.5, 



















(s, 3H), 1.07 (ddd, J=10.3, 6.5, 4.0 Hz, 1H), 1.01 (d, J=6.3 Hz, 1H), 0.96 (q, J=6.8 




4-yl)acrylic acid (65). 2,4,6-trichlorobenzoyl chloride (0.26 mL, 1.64 mmol) was 
added to a solution of acid 60 (30 mg, 41.0 µmol) and pyridine (0.20 mL, 2.46 mmol) 
in toluene (2.7 mL) at 0 °C. After 45 min, 4-(dimethylamino)pyridine (20 mg, 0.164 
mmol) was added to the reaction mixture at 0 °C. After 10 min, the reaction mixture 
was warmed to 50 °C and stirred for 5 h. Brine was added, layers separated, and the 
aqueous layer was extracted with ethyl acetate (3x5 mL). The combined organic 
layers were dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (50% ethyl acetate in hexanes) to deliver product 65 (16 mg, 22.5 
µmol, 55% yield). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.17 (d, J=8.5 Hz, 2H), 6.86 
(d, J=8.6 Hz, 2H), 6.72 (dd, J=7.9, 2.1 Hz, 1H), 6.63 (dd, J=16.0, 7.7 Hz, 1H), 5.70 
(dd, J=16.1, 1.2 Hz, 1H), 5.39 (dd, J=8.2, 3.6 Hz, 1H), 4.83-4.81 (m, 1H), 4.69-4.47 
(m, 2H), 4.22 (d, J=14.5 Hz, 1H), 3.80 (s, 3H), 3.20 (ddd, J=7.3, 4.1, 3.1 Hz, 1H), 
2.97 (d, J=9.2 Hz, 1H), 2.89-2.79 (m, 2H), 2.72-2.62 (m, 2H), 2.62-2.52 (m, 1H), 
2.44 (dd, J=14.0, 8.0 Hz, 1H), 2.08 (ddd, J=10.3, 6.0, 3.9 Hz, 1H), 1.85-1.76 (m, 2H), 
















1H), 1.42-1.34 (m, 1H), 1.34-1.29 (m, 1H), 1.27 (s, 3H), 1.13 (ddt, J=10.2, 6.6, 3.0 
Hz, 1H), 1.00-0.94 (m, 1H), 0.93 (d, J=6.8 Hz, 3H).  





4-yl)acrylate (63a). Sodium hydroxide (0.108 g, 2.71 mmol) was added to a solution 
of ester S7 (20 mg, 27.1 µmol) in methanol and water (7:1, v/v, 2.7 mL) and the 
reaction mixture was stirred at 23 °C for 24 h. The reaction mixture was diluted with 
ether (3 mL) and 1 M aqueous HCl was added (3 mL). The layers were separated and 
the aqueous layer was extracted with diethyl ether (3x5 mL). The combined organic 
layers were washed with brine, dried over MgSO4 and concentrated. 2,4,6-
Trichlorobenzoyl chloride (5.4 µL, 34.5 µmol) was added to a solution of the 
resulting hydroxyl acid (10 mg, 13.8 µmol) and pyridine (6.7 µL, 82.9 µmol) in 
toluene (1.4 mL) at 0 °C. After 45 min, a solution of alcohol 57 (14 mg, 62.2 µmol) 
and 4-(dimethylamino)pyridine (17 mg, 0.138 mmol) in toluene (0.5 mL) was added 
at 0 °C. After 10 min, the reaction mixture was warmed to 23 °C and stirred for an 
1. NaOH, MeOH, 23 oC, 24 h
2.
    57, 2,4,6-trichlorobenzoyl chloride  
























additional 1 h. Brine was added, layers separated, and the aqueous layer was extracted 
with ethyl acetate (3x5 mL), the combined organic layers were dried over Na2SO4 and 
concentrated. The residue was purified by column chromatography (50% ethyl 
acetate in hexanes) to deliver product 63a (9.6 mg, 10.4 µmol, 71% yield over two 
steps). This compound had 1H and 13C NMR data identical to those observed 





4-yl)acrylate (24). 2,4,6-Trichloro-benzoyl chloride (40 µL, 0.254 mmol) was added 
to a solution of acid 23 (34 mg, 0.122 mmol) and pyridine (49 µL, 0.611 mmol) in 
toluene (2.0 mL) at 0 °C. After 45 min, a solution of alcohol 67 (61 mg, 0.102 mmol) 
and 4-(dimethylamino)pyridine (31 mg, 0.254 mmol) in toluene (2.0 mL) was added 
at 0 °C. After another 10 min, the reaction mixture was warmed to 23 °C and stirred 
for an additional 1 h. Brine was added, layers separated, and the aqueous layer was 
extracted with ethyl acetate (3x5 mL). The combined organic layers were dried over 
Na2SO4 and concentrated. The residue was purified by column chromatography (50% 
ethyl acetate in hexanes) to deliver 24 (84 mg, 98.4 µmol, 97% yield). [α]D
23 -39.5°  (c 
1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.14 (d, J=8.5 Hz, 2H), 6.85 (d, 
2,4,6-trichlorobenzoyl chloride, Pyr





















J=8.5 Hz, 2H), 6.75 (dd, J=7.3, 3.1 Hz, 1H), 6.56 (dd, J=15.5, 10.2 Hz, 1H), 5.78 (d, 
J=15.5 Hz, 1H), 5.46 (dd, J=10.1, 2.1 Hz, 1H), 4.96 (dd, J=9.5, 1.7 Hz, 1H), 4.62 (d, 
14.6 Hz, 1H), 4.18 (d, J=14.6 Hz, 1H), 3.97-3.86 (m, 1H), 3.80 (s, 3H), 3.69 (s, 3H), 
3.09 (d, J=9.2 Hz, 1H), 3.03-2.96 (m, 1H), 2.76-2.64 (m, 2H), 2.55 (d, J=9.2 Hz, 1H), 
2.40 (t, J=10.7 Hz, 1H), 2.29 (qd, J=8.4, 5.6 Hz, 1H), 2.15 (ddt, J=12.4, 9.1, 4.1 Hz, 
2H), 2.12-1.97 (m, 2H), 1.80-1.68 (m, 1H), 1.52-1.43 (m, 4H), 1.36 (ddd, J=13.4, 
10.9, 5.4 Hz, 1H), 1.29-1.19 (m, 1H), 1.15 (s, 3H), 0.94 (t, J=7.9 Hz, 11H), 0.83 (d, 
J=6.6 Hz, 3H), 0.59 (q, J=7.8 Hz, 6H): 13C NMR (125 MHz, CDCl3) δ (ppm): 169.7, 
167.0, 166.1, 159.0, 147.8, 140.2, 134.1, 133.7, 129.5, 129.2, 128.3, 122.62, 114.0, 
99.9, 81.1, 68.0, 55.2, 53.7, 51.4, 50.1, 49.4, 46.0, 42.5, 41.5, 32.8, 32.0, 30.2, 29.4, 
28.6, 28.4, 27.8, 20.7, 13.2, 12.8, 6.8, 4.8. HRMS-ESI (m/z): [M+Na]+ calcd for 




methyloct-2-en-2-yl)-2,3,3a,4,5,6-hexahydro-1H-isoindol-4-yl)acrylic acid (25). 
Lithium chloride (2.48 g, 58.6 mmol) was added to a solution of substrate 24 (84 mg, 
97.6 µmol) in DMF (5.0 mL) in a microwave vial. The vial was sealed and the 
mixture was heated in the microwave reactor at 160 °C for 70 min. The 
heterogeneous mixture was cooled to 23 °C, diluted with ethyl acetate (3 mL) and 
LiCl, DMF






















water (5 mL), and stirred until all precipitates dissolved. The resulting solution was 
extracted with ethyl acetate (3x5 mL) and the combined organic layers were washed 
with brine, dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (50% ethyl acetate in hexanes) to deliver 25 (67 mg, 79.1 µmol, 81% 
yield) and a byproduct of only the triethylsilyl ether cleavage (hydroxy methyl ester) 
(13 mg, 17.4 µmol, 18% yield). [α]D
23 -3.1° (c 1.0, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ (ppm): 7.14 (d, J=8.6 Hz, 2H), 6.85 (d, J=8.6 Hz, 2H), 6.77 (t, J=5.1 Hz, 
1H), 6.64 (dd, J=15.4, 10.3 Hz, 1H), 5.78 (d, J=15.5 Hz, 1H), 5.48 (dd, J=10.2, 2.2 
Hz, 1H), 4.95 (d, J=9.2 Hz, 1H), 4.63 (d, J=14.6 Hz, 1H), 4.18 (d, J=14.6 Hz, 1H), 
3.79 (s, 3H), 3.72 (td, J=7.2, 4.4 Hz, 1H), 3.16-3.04 (m, 2H), 2.79-2.68 (m, 2H), 2.57 
(d, J=9.2 Hz, 1H), 2.44 (t, J=10.6 Hz, 1H), 2.34-2.27 (m, 1H), 2.17 (dt, J=9.5, 3.4 Hz, 
2H), 2.08 (ddd, J=10.7, 6.5, 2.2 Hz, 1H), 2.03-1.98 (m, 1H), 1.75 (dtd, J=15.0, 10.3, 
4.9 Hz, 1H), 1.50 (s, 3H), 1.40 (dtd, J=9.7, 6.7, 3.2 Hz, 1H), 1.32 (ddd, J=17.1, 8.2, 
4.4 Hz, 2H), 1.24-1.19 (m, 1H), 1.15 (s, 3H), 1.06-0.97 (m, 2H), 0.88 (d, J=7.2 Hz, 
1H), 0.85 (d, J=6.6 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 170.8, 167.1, 
159.0, 149.8, 140.1, 134.2, 133.5, 129.5, 128.1, 114.1, 99.7, 97.7, 81.2, 68.1, 60.3, 
55.2, 53.8, 49.4, 46.1, 41.6, 40.9, 32.7, 31.9, 30.0, 29.6, 28.4, 27.4, 21.0, 20.7, 14.1, 


























19bH)-trione (26). 2,4,6-Trichlorobenzoyl chloride (0.26 mL, 1.64 mmol) was added 
to a solution of acid 25 (30 mg, 41.0 µmol) and pyridine (0.20 mL, 2.46 mmol) in 
toluene (2.7 mL) at 0 °C. After 45 min, 4-(dimethylamino)pyridine (20 mg, 0.164 
mmol) was added at 0 °C. After 10 min, the reaction mixture was warmed to 50 °C 
and stirred for 5 h. After cooling to room temperature, brine was added and the 
mixture was extracted with ethyl acetate (3x5 mL). The combined organic layers 
were dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (50% ethyl acetate in hexanes) to deliver 26 (16 mg, 22.5 µmol, 55% 
yield). [α]D
23 +3.2° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.17 (d, 
J=8.5 Hz, 2H), 6.86 (d, J=8.6 Hz, 2H), 6.72 (dd, J=7.9, 2.1 Hz, 1H), 6.63 (dd, J=16.0, 
7.7 Hz, 1H), 5.70 (dd, J=16.1, 1.2 Hz, 1H), 5.39 (dd, J=8.2, 3.6 Hz, 1H), 4.83-4.81 
(m, 1H), 4.69-4.47 (m, 2H), 4.22 (d, J=14.5 Hz, 1H), 3.80 (s, 3H), 3.20 (ddd, J=7.3, 
4.1, 3.1 Hz, 1H), 2.97 (d, J=9.2 Hz, 1H), 2.89-2.79 (m, 2H), 2.72-2.62 (m, 2H), 2.62-
2.52 (m, 1H), 2.44 (dd, J=14.0, 8.0 Hz, 1H), 2.08 (ddd, J=10.3, 6.0, 3.9 Hz, 1H), 
1.85-1.76 (m, 2H), 1.71 (s, 3H), 1.60 (dddd, J=12.2, 6.9, 4.8, 1.8 Hz, 1H), 1.53 (tdd, 
J=9.9, 6.9, 4.8 Hz, 1H), 1.42-1.34 (m, 1H), 1.34-1.29 (m, 1H), 1.27 (s, 3H), 1.13 (ddt, 
J=10.2, 6.6, 3.0 Hz, 1H), 1.00-0.94 (m, 1H), 0.93 (d, J=6.8 Hz, 3H): 13C NMR (125 
MHz, CDCl3) δ (ppm): 167.6, 166.9, 164.6, 159.1, 148.0, 141.1, 134.1, 130.6, 129.6, 
129.2, 128.3, 123.4, 114.1, 99.6, 81.0, 71.6, 64.3, 55.2, 53.7, 49.7, 46.6, 46.0, 42.3, 
 108 
38.6, 32.7, 31.5, 31.4, 30.6, 30.4, 28.8, 26.8, 25.6, 20.9, 19.1, 19.0, 18.7, 14.2, 13.6. 





2,3-Dichloro-5,6-dicyano-p-benzoquinone (64 mg, 0.280 mmol) was added to a 
solution of substrate 26 (20 mg, 28.0 µmol) and water (2.5 µL (measured and injected 
with a 10 µL Hamilton syringe), 0.140 mmol) in 1,4-dioxane (2.8 mL). The solution 
was heated at 100 °C for 8 h. After cooling to 23 °C, CH2Cl2 (2.0 mL) was added 
followed by a mixture of saturated aqueous solutions of Na2S2O3 and NaHCO3 (1:1, 
4.0 mL). The mixture was stirred at 23 °C for 30 min. The biphasic solution was 
extracted with ethyl acetate (3x4 mL). The combined organic layers were washed 
with brine and dried over Na2SO4 and concentrated. The residue was purified by 
column chromatography (100% ethyl acetate) to deliver 1 (15.0 mg, 25.2 µmol, 90% 
yield). [α]D
23 +36.5° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 6.74 (d, 
J=7.2 Hz, 1H), 6.72 (d, J=7.7 Hz, 1H), 5.76 (d, J=16.0 Hz, 1H), 5.63 (s, 1H), 5.40 
(dd, J=8.1, 3.6 Hz, 1H), 4.86 (d, J=9.2 Hz, 1H), 4.66 (ddd, J=9.3, 7.5, 5.6 Hz, 1H), 
3.25-3.18 (m, 1H), 3.14 (d, J=8.9 Hz, 1H), 2.87 (dd, J=7.9, 5.6 Hz, 3H), 2.77-2.69 




















1.78 (m, 2H), 1.74 (d, J=1.6 Hz, 3H), 1.54 (tdd, J=14.3, 7.1, 4.5 Hz, 2H), 1.42 (s, 
4H), 1.34 (ddd, J=13.7, 9.5, 5.2 Hz, 1H), 1.13 (ddd, J=10.2, 6.5, 4.1 Hz, 1H), 1.00-
0.95 (m, 1H), 0.94 (d, J=6.8 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 169.7, 
167.6, 164.6, 147.9, 140.1, 134.0, 130.7, 130.2, 123.5, 99.6, 81.1, 71.5, 49.8, 46.5, 





4-yl)acrylate (S12). 2,4,6-Trichloro-benzoyl chloride (39 µL, 0.246 mmol) was 
added to a solution of acid ent-68 (33 mg, 0.118 mmol) and pyridine (48 µL, 0.590 
mmol) in toluene (2.0 mL) at 0 °C. After 45 min, a solution of alcohol 67 (59 mg, 
98.6 µmol) and 4-(dimethylamino)pyridine (30 mg, 0.246 mmol) in toluene (2.0 mL) 
was added at 0 °C. After another 10 min, the reaction mixture was warmed to 23 °C 
and stirred for an additional 1 h. Brine was added, layers separated, and the aqueous 
layer was extracted with ethyl acetate (3x5 mL). The combined organic layers were 
dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (50% ethyl acetate in hexanes) to deliver S12 (71 mg, 82.8 µmol, 
84% yield). [α]D
























J=8.5 Hz, 2H), 6.85 (d, J=8.6 Hz, 2H), 6.74 (dd, J=7.4, 3.1 Hz, 1H), 6.56 (dd, J=15.6, 
10.3 Hz, 1H), 5.78 (d, J=15.5 Hz, 1H), 5.45 (dd, J=10.0, 2.2 Hz, 1H), 4.97 (dd, 9.6, 
1.6 Hz, 1H), 4.62 (d, J=14.6 Hz, 1H), 4.19 (d, J=14.6 Hz, 1H), 3.86 (q, J=6.0 Hz, 
1H), 3.80 (s, 3H), 3.69 (s, 3H), 3.09 (d, J=9.1 Hz, 1H), 2.99 (dt, J=7.4, 3.7 Hz, 1H), 
2.70 (dd, J=5.9, 1.2 Hz, 2H), 2.56 (d, J=9.2 Hz, 1H), 2.40 (t, J=10.7 Hz, 1H), 2.30 (tt, 
J=9.0, 5.7 Hz, 1H), 2.17 (dddd, J=19.7, 16.6, 9.7, 4.1 Hz, 2H), 2.12-1.97 (m, 2H), 
1.80-1.68 (m, 1H), 1.55-1.43 (m, 3H), 1.36 (td, J=12.0, 11.1, 5.5 Hz, 1H), 1.29-1.18 
(m, 1H), 1.15 (s, 3H), 0.94 (t, J=8.0 Hz, 10H), 0.83 (d, J=6.6 Hz, 3H), 0.60 (q, J=7.6 
Hz, 6H): 13C NMR (125 MHz, CDCl3) δ (ppm): 169.9, 167.0, 166.1, 159.0, 147.8, 
140.3, 134.2, 133.7, 129.5, 129.1, 128.3, 122.6, 114.0, 100.0, 81.2, 68.5, 55.2, 53.7, 
51.4, 50.1, 49.4, 46.0, 42.4, 41.5, 33.0, 32.1, 30.5, 29.4, 28.6, 28.4, 28.0, 20.8, 13.2, 





methyloct-2-en-2-yl)-2,3,3a,4,5,6-hexahydro-1H-isoindol-4-yl)acrylic acid (S13). 
Lithium chloride (1.95 g, 46.1 mmol) was added to a solution of substrate S12 (66 
mg, 76.7 µmol) in DMF (4.0 mL) in a microwave vial. The mixture was sealed and 
























cooled to 23 °C and diluted with ethyl acetate (3 mL) and water (5 mL). The mixture 
was stirred until all precipitate dissolved. The resulting solution was extracted with 
ethyl acetate (3x5 mL) and the combined organic layers were washed with brine, 
dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (50% ethyl acetate in hexanes) to deliver S13 (47 mg, 64.4 µmol, 
84% yield) and a byproduct of only the triethylsilyl ether cleavage (hydroxy methyl 
ester) (6 mg, 7.7 µmol, 10% yield). [α]D
23 -3.1° (c 1.0, CHCl3). 1H NMR (500 MHz, 
CDCl3) δ (ppm): 7.14 (d, J=8.6 Hz, 2H), 6.85 (d, J=8.6 Hz, 2H), 6.77 (t, J=5.1 Hz, 
1H), 6.64 (dd, J=15.4, 10.3 Hz, 1H), 5.78 (d, J=15.5 Hz, 1H), 5.48 (dd, J=10.2, 2.2 
Hz, 1H), 4.95 (d, J=9.2 Hz, 1H), 4.63 (d, J=14.6 Hz, 1H), 4.18 (d, J=14.6 Hz, 1H), 
3.79 (s, 3H), 3.72 (td, J=7.2, 4.4 Hz, 1H), 3.16-3.04 (m, 2H), 2.79-2.68 (m, 2H), 2.57 
(d, J=9.2 Hz, 1H), 2.44 (t, J=10.6 Hz, 1H), 2.34-2.27 (m, 1H), 2.17 (dt, J=9.5, 3.4 Hz, 
2H), 2.08 (ddd, J=10.7, 6.5, 2.2 Hz, 1H), 2.03-1.98 (m, 1H), 1.75 (dtd, J=15.0, 10.3, 
4.9 Hz, 1H), 1.50 (s, 3H), 1.40 (dtd, J=9.7, 6.7, 3.2 Hz, 1H), 1.32 (ddd, J=17.1, 8.2, 
4.4 Hz, 2H), 1.24-1.19 (m, 1H), 1.15 (s, 3H), 1.06-0.97 (m, 2H), 0.88 (d, J=7.2 Hz, 
1H), 0.85 (d, J=6.6 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 170.8, 167.1, 
159.0, 149.8, 140.1, 134.2, 133.5, 129.5, 128.1, 114.1, 99.7, 97.7, 81.2, 68.1, 60.3, 
55.2, 53.8, 49.4, 46.1, 41.6, 40.9, 32.7, 31.9, 30.0, 29.6, 28.4, 27.4, 21.0, 20.7, 14.1, 


























19bH)-trione (S14). 2,4,6-Trichlorobenzoyl chloride (0.24 mL, 1.53 mmol) was 
added to a solution of acid S13 (28 mg, 38.2 µmol) and pyridine (0.19 mL, 2.29 
mmol) in toluene (2.5 mL) at 0 °C. After 45 min, 4-(dimethylamino)pyridine (19 mg, 
0.153 mmol) was added to the reaction mixture at 0 °C. After another 10 min, the 
reaction mixture was warmed to 50 °C for 5 h. Brine was added to the resulting 
solution and the mixture was extracted with ethyl acetate (3x5 mL). The combined 
organic layers were dried over Na2SO4 and concentrated. The residue was purified by 
column chromatography (50% ethyl acetate in hexanes) to deliver substrate S14 (14 
mg, 19.5 µmol, 51% yield). [α]D
23 +12.9° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) 
δ (ppm): 7.18 (d, J=8.6 Hz, 2H), 6.86 (d, J=8.6 Hz, 2H), 6.71 (dd, J=7.9 2.6 Hz, 1H), 
6.48 (dd, J=15.3, 11.1 Hz, 1H), 5.72 (d, J=15.3 Hz, 1H), 5.72 (d, J=15.3 Hz, 5.53 (dd, 
J=10.7, 2.4 Hz, 1H), 4.97-4.81 (m, 2H), 4.63 (d, J=14.6 Hz, 1H), 4.20 (d, J=14.6 Hz, 
1H), 3.80 (s, 3H), 3.26-3.14 (m, 2H), 2.93-2.84 (m, 1H), 2.77 (dd, J=16.2, 2.6 Hz, 
1H), 2.66 (d, J=8.8 Hz, 1H), 2.45-2.32 (m, 3H), 2.04 (dddd, J=12.9, 8.8, 6.5, 2.6 Hz, 
1H), 1.99-1.87 (m, 2H), 1.69-1.58 (m, 1H), 1.53 (s, 3H), 1.42 (dddd, J=9.6, 6.5, 4.8, 
2.1 Hz, 1H), 1.15 (s, 3H), 1.09 (tdt, J=11.6, 8.3, 3.8 Hz, 3H), 0.98 (dt, J=7.4, 6.4 Hz, 
1H), 0.93 (d, J=6.5 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 169.1, 167.1, 
164.7, 159.1, 147.1, 140.9, 134.2, 131.6, 129.6, 129.2, 128.3, 125.0, 114.1, 99.6, 80.5, 
71.5, 55.2, 54.1, 53.2, 46.7, 46.1, 42.3, 39.1, 31.6, 31.5, 31.1, 31.0, 28.4, 27.3, 25.6, 
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2,3-Dichloro-5,6-dicyano-p-benzoquinone (64.0 mg, 0.280 mmol) was added to a 
solution of substrate S14 (16 mg, 22.4 µmol) and water (2.0 µL, (measured and 
injected with a 10 µL Hamilton syringe) 0.111 mmol) in 1,4-dioxane (2.2 mL). The 
solution was heated at 100 °C for 8 h. After cooling to 23 °C, CH2Cl2 (2.0 mL) was 
added followed by a mixture of saturated aqueous solutions of Na2S2O3 and NaHCO3 
(1:1, 4.0 mL). The mixture was stirred at 23 °C for 30 min. The biphasic solution was 
extracted with ethyl acetate (3x4 mL). The combined organic layers were washed 
with brine and dried over Na2SO4 and concentrated. The residue was purified by 
column chromatography (100% ethyl acetate) to deliver 43 (10 mg, 20.2 µmol, 90% 
yield). [α]D
23 +62.3° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 6.73 (dd, 
J=8.0, 2.6 Hz, 1H), 6.55 (dd, 15.3, 11.1 Hz, 1H), 5.79 (d, J=15.2 Hz, 1H), 5.59-5.52 
(m, 2H), 5.00-4.87 (m, 2H), 3.35 (d, J=8.7 Hz, 1H), 3.35 (d, J=8.7 Hz, 1H), 3.24 (dt, 
J=7.4, 3.6 Hz, 1H), 2.97-2.85 (m, 2H), 2.79 (dd, J=16.2, 2.4 Hz, 1H), 2.52-2.33 (m, 




















2H), 1.71 (qd, J=11.6, 10.3, 2.2 Hz, 1H), 1.57 (d, J=1.5 Hz, 3H), 1.49-1.41 (m, 1H), 
1.30 (s, 3H), 1.23-1.15 (m, 1H), 1.14-1.05 (m, 2H), 1.00 (q, J=6.8 Hz, 1H), 1.00 (q, 
J=6.8 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 169.8, 169.1, 164.7, 147.0, 
139.9, 134.0, 131.8, 130.2, 125.2, 99.6, 80.6, 71.5, 54.1, 49.2, 46.6, 44.4, 39.1, 31.7, 
31.6, 31.2, 31.0, 28.1, 27.3, 25.6, 19.6, 18.5, 14.1. HRMS-ESI (m/z): [M+Na]+ calcd 
for C27H33Cl4NO5Na, 614.1011; found, 614.0989. 
 
tert-Butyl 3-((1S,2R)-2-chlorocyclopropyl)-3-oxopropanoate (S15). Jones 
reagent (2.0 M, 0.75 mL, 1.42 mmol) was added dropwise to a solution of alcohol 57 
(0.210 g, 0.951 mmol) in acetone (9.5 mL). The mixture was stirred for 20 min at 23 
°C. Methanol (4 mL) was added and stirring was continued for 30 min. After addition 
of water (4 mL), the mixture was extracted with diethyl ether (3x30 mL). The 
combined organic phase was washed with brine, dried over MgSO4, concentrated and 
residue was purified by column chromatography on silica gel (30% diethyl ether in 
pentanes) to deliver keto ester S15 (0.156 g, 0.713 mmol, 75%). [α]D
23 -14.3° (c 1.0, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 3.51 (s, 2H), 3.31 (ddd, J=7.6, 4.9, 2.8 
Hz, 1H), 2.42 (ddd, J=8.9, 5.9, 2.7 Hz, 1H), 1.66 (dt, J=7.4, 5.8 Hz, 1H), 1.48 (s, 9H), 
1.45-1.38 (m, 1H): 13C NMR (125 MHz, CDCl3) δ (ppm): 200.0, 165.7, 82.3, 51.7, 
35.8, 30.8, 27.9, 21.0. HRMS-ESI (m/z): [M+Na]+ calcd for C10H15ClO3Na, 
241.0607; found, 241.0605. 
Jones reagent













(R)-tert-Butyl 3-((1S,2R)-2-chlorocyclopropyl)-3-hydroxypropanoate (S16). 
Dichloro(p-cymene)ruthenium(II) dimer (11 mg, 17.8 µmol) and Et3N (0.40 mL, 2.85 
mmol) were added to a solution of (1R,2R)-(-)-N-p-tosyl-1,2-
diphenylethylenediamine (13 mg, 35.6 µmol) in DMF (0.36 mL) at 23 °C. The 
mixture was stirred for 1 h. In parallel, a mixture of HCO2H (0.18 mL, 7.13 mmol) 
and Et3N (0.40 mL, 2.85 mmol) was prepared at 23 °C for 10 min. A solution of S15 
(0.156 g, 0.713 mmol) in tert-butyl methyl ether (1.4 mL) was added to the formic 
acid-triethylamine mixture followed by the solution of the preformed catalyst. The 
mixture was stirred at 23 °C for 3 h. Water (10 mL) was added, layers separated, and 
the aqueous layer extracted with ethyl acetate (3x10 mL). The combined organic 
phase was washed with brine, dried over Na2SO4 and concentrated. The residue was 
purified by column chromatography on silica gel (20% ethyl acetate in hexanes) to 
afford the alcohol S16 (0.150 g, 0.684 mmol, 96% yield, dr 5:1). [α]D
23 -1.2°  (c 1.0, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 3.74 (ddt, J=9.2, 6.2, 3.0 Hz, 1H), 
3.06 (q, J=1.8 Hz, 1H), 2.98 (ddd, J=7.2, 3.8, 3.2 Hz, 1H), 2.64-2.34 (m, 2H), 1.47 (s, 
9H), 1.31 (dtd, J=9.6, 6.4, 3.2 Hz, 1H), 1.14-1.04 (m, 1H), 0.99 (ddd, J=9.9, 6.3, 3.8 
Hz, 1H): 13C NMR (125 MHz, CDCl3) δ (ppm): 171.9, 81.6, 68.4, 41.6, 30.1, 28.0, 

















(R)-3-((1S,2R)-2-Chlorocyclopropyl)-3-((triethylsilyl)oxy)propanoic acid (71). 
Ester S16 (0.111 g, 0.502 mmol) was stirred in a solution of trifluoroacetic acid and 
CH2Cl2 (1:1, v/v, 1.3 mL) at 0 °C. After 10 min, the reaction mixture was warmed to 
23 °C and stirred for another hour. The mixture was concentrated, toluene was added 
(15 mL), and the solution was concentrated again. The dilution-concentration 
protocol was repeated trice. Chlorotriethylsilane (0.2 mL, 0.975 mmol) was added to 
a stirring solution of the resulting crude hydroxy acid (73.0 mg, 0.443 mmol) and 
imidazole (75.0 mg, 1.10 mmol) in CH2Cl2 (4.4 mL) at -10 °C. After 1 h, the reaction 
mixture was poured into acetate buffer (pH=4, 5 mL) and the aqueous layer was 
extracted with ethyl acetate (3x5 mL). The combined organic layers were washed 
with brine, dried over Na2SO4 and concentrated. To hydrolyze a residual amount of 
the silyl ester, a mixture of the crude oil and NaHCO3 (0.186 g, 2.21 mmol) in 
methanol (2.0 mL) was stirred at 23 °C for 20 min. Water (20 mL) was added, the 
mixture was acidified with 1 M aqueous HCl to pH ~ 4, and then extracted with 
dichloromethane (3x6 mL). The combined organic layers were washed with brine, 
dried over Na2SO4 and concentrated, delivering 71 which was used without further 
purification (0.111 g, 0.398 mmol, 90% yield over two steps). [α]D
23 -40.2°  (c 1.0, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 3.99 (q, J=6.0 Hz, 1H), 2.91 (dt, 
J=7.3, 3.6 Hz, 1H), 2.74-2.51 (m, 2H), 1.50-1.39 (m, 1H), 1.06-0.86 (m, 9H), 0.68-





1. TFA, CH2Cl2, 0 oC, 1 h






over 2 stepsS16 71
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4-yl)acrylate (S16). 2,4,6-Trichloro-benzoyl chloride (0.14 mL, 0.917 mmol) was 
added to a solution of acid 71 (64 mg, 0.229 mmol) and pyridine (0.14 mL, 1.72 
mmol) in toluene (4.6 mL) at 0 °C. After 45 min, a solution of alcohol 67 (0.164 g, 
0.275 mmol) and 4-(dimethylamino)pyridine (70 mg, 0.573 mmol) in toluene (4.6 
mL) was added at 0 °C. After 10 min, the reaction mixture was warmed to 23 °C and 
stirred for an additional 1 h. Brine was added, the layer were separated, and the 
aqueous layer was extracted with ethyl acetate (3x5 mL). The combined organic 
layers were dried over Na2SO4 and concentrated. The residue was purified by column 
chromatography (50% ethyl acetate in hexanes) to deliver S16 (0.184 g, 0.215 mmol, 
94% yield). [α]D
23 -26.4° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.15 (d, 
J=8.6 Hz, 2H), 6.85 (d, J=8.6 Hz, 2H), 6.75 (dd, J=7.4, 3.0 Hz, 1H), 6.56 (dd, J=15.5, 
10.3 Hz, 1H), 5.78 (dd, J=15.6, 0.7 Hz, 1H), 5.46 (dd, J=10.1, 2.2 Hz, 1H), 4.97 (dd, 
J=9.6, 1.6 Hz, 1H), 4.62 (d, J=14.5 Hz, 1H), 4.19 (d, J=14.6 Hz, 1H), 4.05 (q, J=6.0 
























1H), 2.76-2.60 (m, 2H), 2.56 (d, J=9.2 Hz, 1H), 2.40 (t, J=10.7 Hz, 1H), 2.30 (dtt, 
J=9.7, 6.3, 3.9 Hz, 1H), 2.23-2.11 (m, 2H), 2.09-1.98 (m, 2H), 1.73 (dtd, J=14.9, 
10.6, 4.9 Hz, 1H), 1.49 (s, 3H), 1.44 (ddd, J=9.9, 6.7, 5.6, 3.3 Hz, 1H), 1.36 (ddt, 
J=13.2, 10.8, 5.2 Hz, 1H), 1.30-1.19 (m, 2H), 1.15 (s, 3H), 1.04 (dt, J=7.2, 6.3 Hz, 
1H), 0.94 (t, J=8.0 Hz, 9H), 0.84 (d, J=6.6 Hz, 3H), 0.59 (q, J=8.0 Hz, 6H): 13C NMR 
(125 MHz, CDCl3) δ (ppm): 169.7, 167.0, 166.0, 159.0, 147.7, 140.2, 134.2, 133.7, 
129.5, 129.2, 128.3, 122.6, 114.0, 99.9, 81.1, 67.5, 55.2, 53.6, 51.4, 50.1, 49.4, 46.0, 
42.5, 41.5, 33.0, 32.0, 30.2, 29.4, 28.6, 28.4, 28.1, 20.8, 13.1, 12.8, 6.7, 6.5, 5.7, 4.9. 




methyloct-2-en-2-yl)-2,3,3a,4,5,6-hexahydro-1H-isoindol-4-yl)acrylic acid (S17). 
Lithium chloride (5.29 g, 0.124 mol) was added to a solution of S16 (0.179 g, 0.208 
mmol) in DMF (10.4 mL) in a microwave vial. The vial was sealed and the mixture 
was heated in a microwave reactor at 160 °C for 70 min. The heterogeneous mixture 
was cooled to 23 °C and diluted with ethyl acetate (200 mL) and water (20 mL). The 
biphasic mixture was stirred until all solids dissolved. The layers were separated and 
the aqueous layer extracted with ethyl acetate (3x30 mL) and the combined organic 
























purified by column chromatography (50% ethyl acetate in hexanes) to deliver 
hydroxy acid S17 (92 mg, 0.127 mmol, 61% yield) and a byproduct of only the 
triethylsilyl ether cleavage (hydroxy methyl ester)  (27 mg, 37.4 µmol, 18% yield). 
[α]D
23 -30.1° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ (ppm): 7.14 (d, J=8.5 Hz, 
2H), 6.85 (d, J=8.6 Hz, 2H), 6.77 (q, J=5.2, 4.4 Hz, 1H), 6.69-6.57 (m, 1H), 5.78 (dd, 
J=15.8, 3.6 Hz, 1H), 5.48 (dd, J=10.2, 2.2 Hz, 1H), 4.95 (dd, J=9.2, 2.0 Hz, 1H), 4.63 
(dd, J=14.7, 2.7 Hz, 1H), 4.18 (dd, J=14.7, 3.9 Hz, 1H), 3.86 (ddd, J=9.3, 6.4, 3.4 Hz, 
1H), 3.79 (s, 3H), 3.09 (dd, J=9.4, 3.3 Hz, 1H), 3.00 (dt, J=7.3, 3.5 Hz, 1H), 2.82-
2.67 (m, 2H), 2.57 (d, J=9.2 Hz, 1H), 2.44 (td, J=10.8, 4.9 Hz, 1H), 2.31 (tt, J=9.1, 
6.4 Hz, 1H), 2.17 (dd, J=7.5, 4.9 Hz, 2H), 2.08-2.05 (m, 1H), 2.00 (ddt, J=14.7, 7.4, 
2.9 Hz, 1H), 1.76 (dtd, J=13.9, 10.5, 5.1 Hz, 1H), 1.51 (s, 3H), 1.37 (dq, J=9.8, 3.3 
Hz, 1H), 1.31 (ddd, J=11.4, 7.9, 5.5 Hz, 1H), 1.25 (t, J=7.1 Hz, 2H), 1.23-1.19 (m, 
1H), 1.15 (s, 3H), 1.11 (q, J=6.8 Hz, 1H), 1.01 (ddd, J=9.9, 6.3, 3.8 Hz, 1H), 0.85 (d, 
J=6.8 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ (ppm): 170.8, 167.1, 159.1, 149.9, 
140.0, 137.8, 134.1, 133.6, 129.5, 129.0, 128.1, 125.2, 114.1, 99.7, 81.2, 67.4, 55.2, 
53.8, 49.7, 49.4, 46.1, 41.6, 41.0, 32.7, 31.9, 29.9, 29.4, 28.4, 27.3, 21.4, 20.6, 13.4, 


























19bH)-trione (S18). 2,4,6-Trichlorobenzoyl chloride (0.68 mL, 4.37 mmol) was 
added to a solution of acid S17 (80 mg, 0.109 mmol) and pyridine (0.53 mL, 2.29 
mmol) in toluene (7.3 mL) at 0 °C. After 45 min, 4-(dimethylamino)pyridine (53 mg, 
0.437 mmol) was added at 0 °C. After 10 min, the reaction mixture was kept at 23 °C 
for 12 h. Brine was added, the layers were separated, and the aqueous layer was 
extracted with ethyl acetate (3x10 mL). The combined organic layers were dried over 
Na2SO4 and concentrated. The residue was purified by column chromatography (50% 
ethyl acetate in hexanes) to deliver S18 (39 mg, 54.5 µmol, 50% yield). [α]D
23 +19.0° 
(c 1.0, CHCl3). 1H NMR (600 MHz, CDCl3) δ (ppm): 7.16 (d, J=8.6 Hz, 2H), 6.85 (d, 
J=8.6 Hz, 2H), 6.71 (dd, J=8.0, 2.6 Hz, 1H), 6.46 (dd, J=15.3, 11.1 Hz, 1H), 5.70 (d, 
J=15.2 Hz, 1H), 5.53 (dd, J=10.8, 2.4 Hz, 1H), 5.01 (ddd, J=10.9, 8.8, 3.1 Hz, 1H), 
4.85 (dd, J=8.9, 1.9 Hz, 1H), 4.65 (d, 14.6 Hz, 1H), 4.15 (d, J=14.6 Hz, 1H), 3.79 (s, 
3H), 3.16 (d, J=9.0 Hz, 1H), 3.00-2.94 (m, 1H), 2.94-2.83 (m, 2H), 2.61 (d, J=8.9 Hz, 
1H), 2.44-2.33 (m, 3H), 2.08-1.99 (m, 1H), 1.92 (dddd, J=19.5, 16.6, 10.0, 4.4 Hz, 
2H), 1.69-1.59 (m, 1H), 1.53 (s, 3H), 1.41 (ddt, J=11.8, 6.4, 3.1 Hz, 1H), 1.24-1.19 
(m, 2H), 1.12 (s, 3H), 1.06 (tdd, J=8.6, 6.3, 3.9 Hz, 2H), 0.92 (d, J=6.5 Hz, 3H): 13C 
NMR (125 MHz, CDCl3) δ (ppm): 169.0, 167.1, 164.6, 159.0, 147.2, 140.9, 134.0, 
131.7, 129.6, 129.3, 128.3, 124.9, 114.0, 99.6, 80.5, 70.9, 55.2, 53.9, 53.1, 46.6, 46.1, 
42.2, 39.5, 31.6, 31.5, 31.2, 29.6, 28.3, 27.3, 25.8, 19.6, 18.5, 15.1. HRMS-ESI (m/z): 
[M+Na]+ calcd for C35H41Cl4NO6Na, 734.1586; found, 734.1566. 
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Muironolide A (44). 2,3-Dichloro-5,6-dicyano-p-benzoquinone (118 mg, 0.518 
mmol) was added to a solution of S18 (37 mg, 51.9 µmol) and water (4.7 µL 
(measured and injected into solution with a 10 µL Hamilton syringe), 0.259 mmol) in 
1,4-dioxane (5.2 mL). The solution was heated at 100 °C for 8 h. After cooling to 23 
°C, CH2Cl2 (2.0 mL) was added followed by a mixture of saturated aqueous solutions 
of Na2S2O3 and NaHCO3 (1:1, 4.0 mL).  The mixture was stirred at 23 °C for 30 min. 
The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3x10 mL). The combined organic layers were washed with brine, dried over Na2SO4 
and concentrated. The residue was purified by column chromatography (100% ethyl 
acetate) to deliver muironolide A, 44 (21 mg, 35.3 µmol, 68% yield) and recovered 
starting material S18 (6 mg, 8.4 µmol, 16%). The recovered starting material was 
resubmitted to the same reaction conditions shown above to deliver an additional 
amount of muironolide A, 44 (4 mg, 6.86 µmol, 82% yield) for a total of 25 mg (42.2 
µmol, 81% overall yield). [α]D
23 +42.3° (c 1.0, CHCl3). 1H NMR (500 MHz, CDCl3) δ 
(ppm): 6.72 (dd, J=8.0 2.6 Hz, 1H), 6.53 (dd, J=15.2, 11.1 Hz, 1H), 5.93 (s, 1H), 5.76 
(d, J=15.3 Hz, 1H), 5.54 (dd, J=10.7, 2.5 Hz, 1H), 5.03 (ddd, J=11.3, 8.8, 3.0 Hz, 
1H), 4.88 (dd, J=9.0, 1.8 Hz, 1H), 3.33 (d, J=8.8 Hz, 1H), 3.01-2.96 (m, 1H), 2.96-
















dioxane, 100 oC, 8 h
81% yield
S18 muironolide A (44)
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2.7 Hz, 1H), 2.00-1.86 (m, 2H), 1.74-1.66 (m, 1H), 1.56 (s, J=1.4 Hz, 3H), 1.46-1.39 
(m, 1H), 1.28 (s, 3H), 1.25 (td, J=6.3, 2.1 Hz, 1H), 1.21-1.14 (m, 1H), 1.09 (dqd, 
J=11.8, 5.9, 4.9, 2.9 Hz, 2H), 0.94 (d, J=6.5 Hz, 3H): 13C NMR (125 MHz, CDCl3) δ 
(ppm): 170.0, 169.0, 164.6, 147.1, 140.0, 133.9, 131.8, 130.3, 125.1, 99.6, 80.6, 71.0, 
54.0, 49.3, 46.6, 44.4, 39.5, 31.7, 31.6, 31.2, 30.4, 28.1, 27.3 25.8, 19.6, 18.5, 15.2. 
HRMS-ESI (m/z): [M+Na]+ calcd for C27H33Cl4NO5Na, 614.1011; found, 614.1006. 






44, d (J) 
synthetic  
1, d (J) 
syntheti
c 43, d (J) 





















2.73  2.45 
(11.8) 
5     








7     
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8     








10 1.92  1.93 1.81  1.94 












12     
13 4.88 
(9.12) 




14 2.42  2.42 2.6 2.45 
15 1.16 1.17 1.42 1.18 
15’ 1.05 1.09 1.34 1.11 
16 1.95 1.93 1.54 1.96 









18     
19     
20 2.90 2.91 2.87 2.79 
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22 1.44 (9.4, 




























25 1.28 1.28 1.42 1.30 
26 1.56 1.56 1.74 1.59 






13C NMR chemical shifts for natural muironolide A and synthetic compounds 1, 










c 43, d 
1 164.4 164.6 164.6 164.7 
2 124.8 125.1 123.5 125.2 
3 146.9 147.1 147.9 147.0 
4 53.6 54.0 49.8 54.1 
5 44.0 44.4 44.4 44.4 
6 49.0 49.3 49.8 49.2 
7 169.7 170.0 169.7 169.8 
8 139.7 140.0 140.1 139.9 
9 130.0 130.0 130.2 130.2 
10 31.3 31.6 31.4 31.6 
11 46.2 46.6 46.5 46.6 
12 133.8 133.9 134.0 134.0 
13 131.6 131.8 130.7 131.8 
14 30.8 31.2 30.5 31.2 
15 31.4 31.7 32.8 31.7 
16 27.1 27.3 26.8 27.3 
17 80.3 80.6 81.1 80.6 
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18 99.3 99.6 99.6 99.6 
19 168.9 169.0 167.6 169.1 
20 39.4 39.5 38.7 39.1 
21 70.8 71.0 71.5 71.5 
22 25.6 25.8 25.6 25.6 
23 30.0 30.4 31.5 31.0 
24 14.7 15.2 14.2 14.1 
25 27.7 28.1 28.6 28.1 
26 19.1 19.6 18.7 19.6 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5 Number of Scans 16
6 Relaxation Delay 1.0000
7 Acquisition Date 2015-01-21T15:29:06
8 Spectrometer Frequency (599.63, 150.79)









































































5 Number of Scans 0
6 Relaxation Delay 1.0000
7 Acquisition Date 2015-01-23T13:41:24
8 Spectrometer Frequency (599.63, 150.79)

























































































































































































































































































































































































































































































































































































































































































































































































































5 Number of Scans 128
6 Relaxation Delay 1.0000
7 Acquisition Date 2015-01-26T11:42:40
8 Spectrometer Frequency (599.63, 150.79)


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5 Number of Scans 296
6 Relaxation Delay 1.0000
7 Acquisition Date 2015-03-14T12:29:50
8 Spectrometer Frequency (599.63, 150.79)




































































5 Number of Scans 32
6 Relaxation Delay 1.0000
7 Acquisition Date 2015-03-13T11:47:51
8 Spectrometer Frequency (599.63, 599.63)










General Procedure for the Metal Catalyzed IMDA Reaction in Table 1. 
 
(E)-methyl 3-((3aR,4R,5S,7aR)-2-(4-methoxybenzyl)-3a-methyl-5-((E)-4-
methylpent -2-en-2-yl)-1,7-dioxooctahydro-1H-isoindol-4-yl)acrylate (34). The β-
keto amide Z-33 was prepared according to a described synthetic procedure. A metal 
salt in Table 1 (10 mol%) was added to a solution of Z-33 (17.6 µmol, 1.0 equiv) in 
solvent (0.6 mL). Et3N (2.0 equiv) was added to the reaction mixture and was heated 
for a duration specified in Table 1. The crude mixture was quenched with ethyl 
acetate (2 mL) and water (3 mL). The layers were separated and the aqueous layer 
was extracted with ethyl acetate (3x1 mL). The combined organic layers were washed 
with brine, dried with sodium sulfate, and concentrated in vacuo. The crude oil was 
purified by column chromatography (silica, 80% ethyl acetate – hexanes) to give 
isoindolinone 34. 1H NMR (500 MHz, CDCl3); δ (ppm): 7.15 (t, J = 7.9 Hz, 2H), 6.84 
(d, J = 8.5 Hz, 2H), 6.64 (dd, J = 15.3, 11.0 Hz, 1H), 5.62 (d, J = 15.3 Hz, 1H), 4.70 (t, 
J = 12.6 Hz, 1H), 4.53 (d, J = 14.4 Hz, 1H), 4.28 (d, J = 14.4 Hz, 1H), 4.19 – 4.11 (m, 
2H), 3.77 (s, 3H), 3.22 (d, J = 10.2 Hz, 1H), 3.03 (s, 1H), 2.86 (d, J = 10.2 Hz, 1H), 
2.55 – 2.48 (m, 2H), 2.46 – 2.30 (m, 3H), 1.46 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H), 1.04 



















    Table A: Ligand screening for IMDA reaction 
 
entry ligand conv., % dr ee 
1 L1 79% >30:1 40% 
2 L2 65% 8:1 17% 
3 L3 87% >30:1 0% 
4 L4 85% >30:1 0% 
5 L5 86% 30:1 4% 
6 L6 87% 30:1 20% 








Ligand 11 mol%, 
MXn 10 mol%, 
































8 L8 87% 30:1 0% 
9 L9 83% >30:1 8% 
 
(E)-methyl 3-((3aR,4R,5S,7aR)-2-(4-methoxybenzyl)-3a-methyl-5-((E)-4-
methylpent -2-en-2-yl)-1,7-dioxooctahydro-1H-isoindol-4-yl)acrylate (34).82  The 
β-keto amide Z-33 was prepared according to a described synthetic procedure. 
La(OTf)3 (10 mol%) was added to a solution of ligand in Table A (11 mol%) in ethyl 
acetate (0.2 mL) and stirred for 30 min at 23 °C. The preformed catalyst and Et3N 
(2.0 equiv) was added to 5 (17.6 µmol, 1.0 equiv) in ethyl acetate (0.4 mL) and was 
heated to 45 °C for 24 h. The crude mixture was quenched with ethyl acetate (2 mL) 
and water (3 mL). The layers were separated and the aqueous layer was extracted 
with ethyl acetate (3 x 1 mL). The combined organic layers were washed with brine, 
dried with sodium sulfate, and concentrated in vacuo. The crude oil was purified by 
column chromatography (silica, 80% ethyl acetate – hexanes) to give isoindoledione 
34. 1H NMR (500 MHz, CDCl3); δ (ppm): 7.15 (t, J = 7.9 Hz, 2H), 6.84 (d, J = 8.5 Hz, 
2H), 6.64 (dd, J = 15.3, 11.0 Hz, 1H), 5.62 (d, J = 15.3 Hz, 1H), 4.70 (t, J = 12.6 Hz, 
1H), 4.53 (d, J = 14.4 Hz, 1H), 4.28 (d, J = 14.4 Hz, 1H), 4.19 – 4.11 (m, 2H), 3.77 (s, 
3H), 3.22 (d, J = 10.2 Hz, 1H), 3.03 (s, 1H), 2.86 (d, J = 10.2 Hz, 1H), 2.55 – 2.48 (m, 
2H), 2.46 – 2.30 (m, 3H), 1.46 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H), 1.04 (s, 3H), 0.86 (d, 
J = 6.6 Hz, 3H), 0.78 (d, J = 6.6 Hz, 3H).  
General Procedure for the synthesis of Ln(terpy)(NO3)3(H2O)n. 
Ln(NO3)3(H2O)n (Ln = Dy, Sm, Eu) (0.2 mmol, 1.0 equiv) was added to a solution of 
2,2’:6’,2”-terpyridine (0.2 mmol, 1.0 equiv) in ethanol (4.0 mL) at 23 °C for 1 h to 
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form a white suspension. The suspension was filtered and washed with ethanol (3 x 4 
mL) and dried in vacuo to give Ln(terpy)(NO3)3(H2O)n. This material was used 
without further purification of characterization.  
General Procedure for the synthesis of Ln(terpy)(NO3)2(pyracac) or 
Ln(terpy)(NO3)2(dbacac). 1-(Pyrrolidin-1-yl)butane-1,3-dione (0.3 mmol, 3.0 eqiv) 
or N,N-dibenzyl-3-oxobutanamide (0.3 mmol, 3.0 equiv) was added to a solution of 
Ln(terpy)(NO3)2(H2O)n (Ln = Dy, Sm, Eu) (0.1 mmol, 1.0 equiv) in MeCN-EtOH 
(1:1, 0.8 mL) at 23 °C followed by Et3N (0.2 mmol, 2.0 equiv). The mixture was 
stirred for 1 h at 23 °C. The stir bar was removed and the solution was allowed to 
slowly evaporate at 23 °C for about 36 h to form colorless crystals suitable for X-ray 
crystallography.  
X-ray Data Collection, structure solution and Refinement 
The crystal was mounted on a glass fiber and transferred to a Bruker Kappa 
APEX II CCD diffractometer. The APEX2 software program was used to determine 
the unit cell parameters and data collection. The data were collected at 100K using 
Oxford Cryostream Plus system. The raw frame data were processed using APEX2 
program. The absorption correction was applied using program SADABS. 
Subsequent calculations were carried out using SHELXTL program. 
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ORTEP drawing of Dy(terpy)(NO3)2(pyacac) with 50% probability ellipsoids and 
H atoms and solvent have been omitted for clarity.  
X-ray Crystallographic Data for Dy(terpy)(NO3)2(pyacac).  
__________________________________________________________________ 
Identification code  ky2108_0m 
Empirical formula  C26 H26 Dy N7 O7 
Formula weight  711.04 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 9.1631(3) Å a= 90°. 
 b = 27.7638(10) Å b= 93.537(2)°. 
 c = 10.7721(4) Å g = 90°. 
 
Volume 2735.23(17) Å3 
Z 4 
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Density (calculated) 1.727 Mg/m3 
Absorption coefficient 2.790 mm-1 
F(000) 1412 
Crystal size 0.300 x 0.200 x 0.050 mm3 
Theta range for data collection 1.467 to 28.282°. 
Index ranges -10<=h<=12, -37<=k<=37, -14<=l<=12 
Reflections collected 27116 
Independent reflections 6786 [R(int) = 0.0453] 
Completeness to theta = 25.242° 100.0 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6786 / 0 / 372 
Goodness-of-fit on F2 1.047 
Final R indices [I>2sigma(I)] R1 = 0.0292, wR2 = 0.0547 
R indices (all data) R1 = 0.0426, wR2 = 0.0578 
Extinction coefficient n/a 
Largest diff. peak and hole 0.528 and -1.384 e.Å-3 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for Dy(terpy)(NO3)2(pyacac).  U(eq) is defined as one third of  the trace of 
the orthogonalized Uij tensor. 
__________________________________________________________________ 
 x y z U(eq) 
__________________________________________________________________ 
C(1) 10776(3) 1654(1) 10211(3) 21(1) 
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C(2) 12075(3) 1885(1) 10532(3) 24(1) 
C(3) 12141(3) 2375(1) 10402(3) 24(1) 
C(4) 10913(3) 2622(1) 9945(3) 22(1) 
C(5) 9634(3) 2369(1) 9648(3) 16(1) 
C(6) 8249(3) 2614(1) 9211(3) 17(1) 
C(7) 8120(4) 3114(1) 9212(3) 23(1) 
C(8) 6785(4) 3320(1) 8861(3) 26(1) 
C(9) 5625(4) 3025(1) 8506(3) 23(1) 
C(10) 5812(3) 2529(1) 8489(3) 16(1) 
C(11) 4613(3) 2196(1) 8092(3) 15(1) 
C(12) 3306(3) 2358(1) 7519(3) 20(1) 
C(13) 2249(3) 2026(1) 7143(3) 23(1) 
C(14) 2506(3) 1544(1) 7337(3) 22(1) 
C(15) 3823(3) 1407(1) 7930(3) 20(1) 
C(16) 5652(3) -89(1) 7922(3) 20(1) 
C(17) 6553(3) 271(1) 8679(3) 14(1) 
C(18) 7359(3) 116(1) 9722(3) 16(1) 
C(19) 8312(3) 418(1) 10473(3) 15(1) 
C(20) 8953(3) -254(1) 11963(3) 20(1) 
C(21) 10062(3) -251(1) 13081(3) 24(1) 
C(22) 10051(4) 264(1) 13535(3) 26(1) 
C(23) 9933(3) 552(1) 12339(3) 21(1) 
C(24) 4603(4) 654(1) 5164(3) 28(1) 
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C(25) 6149(4) 674(1) 4962(4) 36(1) 
Dy(1) 7294(1) 1413(1) 9064(1) 11(1) 
N(1) 9562(3) 1887(1) 9779(2) 17(1) 
N(2) 7117(3) 2325(1) 8852(2) 14(1) 
N(3) 4863(3) 1725(1) 8308(2) 16(1) 
N(4) 9018(3) 244(1) 11499(2) 17(1) 
N(5) 8510(3) 1443(1) 6647(2) 21(1) 
N(6) 5871(3) 1431(1) 11404(2) 20(1) 
N(7) 3382(4) 630(1) 5314(3) 41(1) 
O(1) 6518(2) 706(1) 8246(2) 15(1) 
O(2) 8552(2) 862(1) 10215(2) 17(1) 
O(3) 7218(2) 1583(1) 6790(2) 22(1) 
O(4) 9233(2) 1302(1) 7612(2) 26(1) 
O(5) 9035(3) 1445(1) 5619(2) 34(1) 
O(6) 5463(2) 1136(1) 10565(2) 19(1) 
O(7) 6837(2) 1738(1) 11121(2) 24(1) 
O(8) 5372(3) 1427(1) 12434(2) 35(1) 
_______________________________________________________________ 
Bond lengths [Å] and angles [°] for Dy(terpy)(NO3)2(pyacac). 
_______________________________________________________________  
C(1)-N(1)  1.345(4) 
C(1)-C(2)  1.378(4) 
C(1)-H(1)  0.9500 
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C(2)-C(3)  1.369(5) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.381(5) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.386(4) 
C(4)-H(4)  0.9500 
C(5)-N(1)  1.348(4) 
C(5)-C(6)  1.490(4) 
C(6)-N(2)  1.349(4) 
C(6)-C(7)  1.393(4) 
C(7)-C(8)  1.381(5) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.376(5) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.388(4) 
C(9)-H(9)  0.9500 
C(10)-N(2)  1.359(4) 
C(10)-C(11)  1.479(4) 
C(11)-N(3)  1.348(4) 
C(11)-C(12)  1.387(4) 
C(12)-C(13)  1.381(5) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.372(5) 
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C(13)-H(13)  0.9500 
C(14)-C(15)  1.383(4) 
C(14)-H(14)  0.9500 
C(15)-N(3)  1.344(4) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.503(4) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-O(1)  1.294(3) 
C(17)-C(18)  1.375(4) 
C(18)-C(19)  1.427(4) 
C(18)-H(18)  0.9500 
C(19)-O(2)  1.286(3) 
C(19)-N(4)  1.335(4) 
C(20)-N(4)  1.473(4) 
C(20)-C(21)  1.527(4) 
C(20)-H(20A)  0.9900 
C(20)-H(20B)  0.9900 
C(21)-C(22)  1.512(5) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-C(23)  1.515(4) 
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C(22)-H(22A)  0.9900 
C(22)-H(22B)  0.9900 
C(23)-N(4)  1.469(4) 
C(23)-H(23A)  0.9900 
C(23)-H(23B)  0.9900 
C(24)-N(7)  1.142(5) 
C(24)-C(25)  1.448(5) 
C(25)-H(25A)  0.9800 
C(25)-H(25B)  0.9800 
C(25)-H(25C)  0.9800 
Dy(1)-O(2)  2.2428(19) 
Dy(1)-O(1)  2.2500(19) 
Dy(1)-O(7)  2.452(2) 
Dy(1)-O(4)  2.458(2) 
Dy(1)-N(3)  2.479(2) 
Dy(1)-O(3)  2.491(2) 
Dy(1)-O(6)  2.521(2) 
Dy(1)-N(1)  2.539(2) 
Dy(1)-N(2)  2.546(2) 
Dy(1)-N(5)  2.896(2) 
Dy(1)-N(6)  2.909(2) 
N(5)-O(5)  1.234(3) 
N(5)-O(4)  1.261(3) 
 198 
N(5)-O(3)  1.264(3) 
N(6)-O(8)  1.226(3) 
N(6)-O(6)  1.260(3) 


























































































































































































Anisotropic displacement parameters  (Å2x 103) for Dy(terpy)(NO3)2(pyacac).  
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + 
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...  + 2 h k a* b* U12 ] 
__________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
__________________________________________________________________ 
C(1) 17(2)  24(2) 22(2)  -2(1) -1(1)  0(1) 
C(2) 14(2)  38(2) 19(2)  -6(2) 2(1)  -4(2) 
C(3) 18(2)  32(2) 22(2)  -14(2) 4(1)  -11(2) 
C(4) 24(2)  19(2) 25(2)  -7(1) 7(1)  -7(1) 
C(5) 17(2)  20(2) 12(1)  -4(1) 6(1)  -4(1) 
C(6) 22(2)  17(2) 12(1)  -3(1) 7(1)  -4(1) 
C(7) 34(2)  16(2) 21(2)  -1(1) 10(1)  -6(1) 
C(8) 38(2)  12(2) 28(2)  2(1) 8(2)  2(2) 
C(9) 30(2)  16(2) 23(2)  6(1) 5(1)  7(1) 
C(10) 20(2)  18(2) 12(1)  1(1) 7(1)  -1(1) 
C(11) 16(2)  17(2) 12(1)  3(1) 4(1)  4(1) 
C(12) 21(2)  26(2) 14(2)  4(1) 5(1)  12(1) 
C(13) 17(2)  39(2) 15(2)  1(1) 1(1)  9(2) 
C(14) 14(2)  31(2) 23(2)  -3(1) 0(1)  0(1) 
C(15) 14(1)  20(2) 25(2)  1(1) 3(1)  -1(1) 
C(16) 28(2)  16(2) 15(2)  0(1) -4(1)  -4(1) 
C(17) 12(1)  17(2) 14(1)  -3(1) 4(1)  2(1) 
C(18) 20(2)  11(1) 15(2)  2(1) 0(1)  -2(1) 
C(19) 15(1)  17(2) 14(1)  2(1) 3(1)  2(1) 
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C(20) 24(2)  18(2) 18(2)  6(1) -1(1)  4(1) 
C(21) 24(2)  29(2) 18(2)  4(1) 0(1)  6(2) 
C(22) 27(2)  32(2) 18(2)  3(1) -4(1)  0(2) 
C(23) 23(2)  24(2) 16(2)  0(1) -6(1)  1(1) 
C(24) 41(2)  20(2) 21(2)  -6(1) -11(2)  4(2) 
C(25) 41(2)  29(2) 36(2)  -6(2) -3(2)  -4(2) 
Dy(1) 10(1)  11(1) 12(1)  0(1) 0(1)  0(1) 
N(1) 14(1)  18(1) 18(1)  -3(1) 2(1)  -1(1) 
N(2) 17(1)  14(1) 12(1)  0(1) 3(1)  2(1) 
N(3) 14(1)  18(1) 17(1)  2(1) 4(1)  1(1) 
N(4) 20(1)  15(1) 17(1)  2(1) -4(1)  2(1) 
N(5) 25(1)  19(1) 21(1)  -2(1) 8(1)  -8(1) 
N(6) 21(1)  19(1) 20(1)  0(1) 4(1)  2(1) 
N(7) 43(2)  41(2) 38(2)  -12(2) -6(2)  6(2) 
O(1) 16(1)  13(1) 15(1)  2(1) -3(1)  0(1) 
O(2) 17(1)  15(1) 18(1)  4(1) -4(1)  -2(1) 
O(3) 26(1)  22(1) 17(1)  5(1) 5(1)  8(1) 
O(4) 14(1)  48(2) 16(1)  -4(1) 0(1)  -2(1) 
O(5) 38(1)  49(2) 18(1)  -2(1) 14(1)  -6(1) 
O(6) 19(1)  20(1) 17(1)  -1(1) 1(1)  -3(1) 
O(7) 29(1)  20(1) 23(1)  -4(1) 7(1)  -9(1) 
O(8) 43(2)  42(2) 21(1)  -5(1) 16(1)  -5(1) 
__________________________________________________________________ 
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Hydrogen coordinates ( x 104) and isotropic  displacement parameters         (Å2 x 
103) for Dy(terpy)(NO3)2(pyacac). 
__________________________________________________________________  
 x  y  z  U(eq) 
__________________________________________________________________  
H(1) 10735 1314 10298 25 
H(2) 12908 1708 10839 28 
H(3) 13021 2544 10623 29 
H(4) 10945 2961 9836 27 
H(7) 8938 3310 9450 28 
H(8) 6670 3660 8866 31 
H(9) 4698 3161 8272 27 
H(12) 3141 2693 7387 24 
H(13) 1347 2130 6750 28 
H(14) 1797 1310 7072 27 
H(15) 3999 1074 8076 24 
H(16A) 4675 44 7723 30 
H(16B) 5570 -387 8401 30 
H(16C) 6125 -158 7150 30 
H(18) 7275 -212 9957 19 
H(20A) 9234 -487 11325 24 
H(20B) 7961 -333 12217 24 
H(21A) 9764 -476 13733 29 
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H(21B) 11045 -344 12832 29 
H(22A) 10964 342 14035 31 
H(22B) 9205 324 14041 31 
H(23A) 9462 868 12464 26 
H(23B) 10907 605 12013 26 
H(25A) 6431 386 4509 53 
H(25B) 6710 689 5766 53 
H(25C) 6353 962 4475 53 
__________________________________________________________________ 













































































ORTEP drawing of Sm(terpy)(NO3)2(pyacac) with 50% probability ellipsoids and 
H atoms and solvent have been omitted for clarity.  
X-ray Crystallographic Data for Sm(terpy)(NO3)2(pyacac).  
__________________________________________________________________  
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Identification code  ky03042014_0m 
Empirical formula  C31 H36 N7 O10 Sm 
Formula weight  817.02 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 9.7347(2) Å a= 90°. 
  b = 11.5779(3) Å
 b=92.4370(10)°. 
 c = 29.1920(6) Å g = 90°. 
Volume 3287.18(13) Å3 
Z 4 
Density (calculated) 1.651 Mg/m3 
Absorption coefficient 1.855 mm-1 
F(000) 1652 
Crystal size 0.15 x 0.1 x 0.1 mm3 
Theta range for data collection 1.396 to 28.289°. 
Index ranges -11<=h<=12, -15<=k<=10, -38<=l<=38 
Reflections collected 22466 
Independent reflections 8135 [R(int) = 0.0295] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
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Max. and min. transmission 0.7457 and 0.6450 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8135 / 0 / 444 
Goodness-of-fit on F2 1.064 
Final R indices [I>2sigma(I)] R1 = 0.0319, wR2 = 0.0618 
R indices (all data) R1 = 0.0425, wR2 = 0.0648 
Extinction coefficient n/a 
Largest diff. peak and hole 1.161 and -1.511 e.Å-3 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for Sm(terpy)(NO3)2(pyacac).  U(eq) is defined as one third of  the trace of 
the orthogonalized Uij tensor. 
__________________________________________________________________  
 x y z U(eq) 
__________________________________________________________________  
C(1) 2047(3) 318(3) 296(1) 30(1) 
C(2) 3542(3) 244(3) 466(1) 27(1) 
C(3) 4583(3) 1088(3) 1169(1) 23(1) 
C(4) 4418(3) 1549(3) 1654(1) 26(1) 
C(5) 5349(3) 868(3) 1984(1) 24(1) 
C(6) 4865(4) -321(4) 2102(1) 43(1) 
C(7) 2073(3) 558(3) 1109(1) 28(1) 
C(8) 1269(4) -37(3) 715(1) 34(1) 
C(9) 5740(3) 6644(2) 1481(1) 14(1) 
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C(10) 6359(3) 8235(3) 968(1) 19(1) 
C(11) 7721(3) 8874(3) 923(1) 22(1) 
C(12) 8324(3) 8901(3) 1416(1) 23(1) 
C(13) 7951(3) 7726(3) 1605(1) 21(1) 
C(14) 6101(3) 5889(3) 1855(1) 15(1) 
C(15) 5387(3) 4929(2) 1967(1) 16(1) 
C(16) 5907(3) 4198(3) 2364(1) 22(1) 
C(18) -197(3) 5845(2) 548(1) 12(1) 
C(19) -1587(3) 5976(3) 415(1) 16(1) 
C(20) -2563(3) 5369(3) 648(1) 19(1) 
C(21) -2145(3) 4655(3) 1003(1) 18(1) 
C(22) -748(3) 4564(2) 1124(1) 15(1) 
C(23) -227(3) 3777(3) 1494(1) 17(1) 
C(24) 1583(3) 3249(3) 1987(1) 21(1) 
C(25) 832(3) 2360(3) 2172(1) 25(1) 
C(26) -494(3) 2178(3) 2004(1) 27(1) 
C(27) -1036(3) 2894(3) 1662(1) 23(1) 
C(28) 885(2) 6428(2) 289(1) 12(1) 
C(29) 3205(3) 6792(3) 226(1) 16(1) 
C(30) 2984(3) 7440(3) -166(1) 17(1) 
C(31) 1647(3) 7575(3) -336(1) 17(1) 
C(32) 585(3) 7060(2) -108(1) 16(1) 
N(1) 3482(3) 606(2) 950(1) 22(1) 
 216 
N(2) 6615(2) 7476(2) 1366(1) 16(1) 
N(6) 1800(2) 7318(2) 1764(1) 22(1) 
N(7) 3588(2) 3588(2) 561(1) 16(1) 
N(4) 208(2) 5172(2) 904(1) 12(1) 
N(3) 1085(2) 3942(2) 1649(1) 17(1) 
N(5) 2197(2) 6290(2) 456(1) 12(1) 
O(1) 5706(2) 1173(2) 998(1) 28(1) 
O(2) 6408(2) 1255(2) 2139(1) 40(1) 
O(3) 4612(2) 6561(2) 1239(1) 16(1) 
O(4) 4269(2) 4539(2) 1757(1) 21(1) 
O(5) 1620(2) 7293(2) 1333(1) 22(1) 
O(6) 2477(2) 3477(2) 778(1) 20(1) 
O(7) 4363(2) 4416(2) 684(1) 21(1) 
O(8) 3850(2) 2936(2) 249(1) 21(1) 
O(9) 2172(2) 6375(2) 1958(1) 29(1) 
O(10) 1638(2) 8207(2) 1984(1) 35(1) 
Sm(1) 2725(1) 5329(1) 1238(1) 13(1) 
__________________________________________________________________ 
Bond lengths [Å] and angles [°] for Sm(terpy)(NO3)2(pyacac). 
__________________________________________________________________  
C(1)-C(2)  1.520(4) 
C(1)-C(8)  1.521(5) 
C(1)-H(3)  0.9900 
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C(1)-H(1)  0.9900 
C(2)-N(1)  1.477(4) 
C(2)-H(12)  0.9900 
C(2)-H(13)  0.9900 
C(3)-O(1)  1.225(4) 
C(3)-N(1)  1.347(4) 
C(3)-C(4)  1.528(4) 
C(4)-C(5)  1.515(4) 
C(4)-H(6)  0.9900 
C(4)-H(7)  0.9900 
C(5)-O(2)  1.195(4) 
C(5)-C(6)  1.499(5) 
C(6)-H(2)  0.9800 
C(6)-H(5)  0.9800 
C(6)-H(4)  0.9800 
C(7)-N(1)  1.468(4) 
C(7)-C(8)  1.529(5) 
C(7)-H(8)  0.9900 
C(7)-H(9)  0.9900 
C(8)-H(11)  0.9900 
C(8)-H(10)  0.9900 
C(9)-O(3)  1.283(3) 
C(9)-N(2)  1.337(4) 
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C(9)-C(14)  1.432(4) 
C(10)-N(2)  1.471(3) 
C(10)-C(11)  1.529(4) 
C(10)-H(21)  0.9900 
C(10)-H(20)  0.9900 
C(11)-C(12)  1.533(4) 
C(11)-H(19)  0.9900 
C(11)-H(18)  0.9900 
C(12)-C(13)  1.517(4) 
C(12)-H(16)  0.9900 
C(12)-H(17)  0.9900 
C(13)-N(2)  1.478(3) 
C(13)-H(14)  0.9900 
C(13)-H(15)  0.9900 
C(14)-C(15)  1.358(4) 
C(14)-H(25)  0.9500 
C(15)-O(4)  1.307(3) 
C(15)-C(16)  1.505(4) 
C(16)-H(23)  0.9800 
C(16)-H(22)  0.9800 
C(16)-H(24)  0.9800 
C(18)-N(4)  1.346(3) 
C(18)-C(19)  1.399(3) 
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C(18)-C(28)  1.484(4) 
C(19)-C(20)  1.383(4) 
C(19)-H(32)  0.9500 
C(20)-C(21)  1.375(4) 
C(20)-H(31)  0.9500 
C(21)-C(22)  1.394(4) 
C(21)-H(30)  0.9500 
C(22)-N(4)  1.349(3) 
C(22)-C(23)  1.486(4) 
C(23)-N(3)  1.351(3) 
C(23)-C(27)  1.392(4) 
C(24)-N(3)  1.346(4) 
C(24)-C(25)  1.384(4) 
C(24)-H(29)  0.9500 
C(25)-C(26)  1.378(4) 
C(25)-H(28)  0.9500 
C(26)-C(27)  1.384(4) 
C(26)-H(26)  0.9500 
C(27)-H(27)  0.9500 
C(28)-N(5)  1.356(3) 
C(28)-C(32)  1.391(4) 
C(29)-N(5)  1.344(3) 
C(29)-C(30)  1.378(4) 
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C(29)-H(36)  0.9500 
C(30)-C(31)  1.382(4) 
C(30)-H(33)  0.9500 
C(31)-C(32)  1.388(4) 
C(31)-H(34)  0.9500 
C(32)-H(35)  0.9500 
N(6)-O(10)  1.226(3) 
N(6)-O(5)  1.263(3) 
N(6)-O(9)  1.274(3) 
N(6)-Sm(1)  2.931(3) 
N(7)-O(8)  1.219(3) 
N(7)-O(7)  1.263(3) 
N(7)-O(6)  1.282(3) 
N(7)-Sm(1)  2.969(2) 
N(4)-Sm(1)  2.605(2) 
N(3)-Sm(1)  2.595(2) 
N(5)-Sm(1)  2.571(2) 
O(3)-Sm(1)  2.3256(19) 
O(4)-Sm(1)  2.2795(18) 
O(5)-Sm(1)  2.536(2) 
O(6)-Sm(1)  2.536(2) 
O(7)-Sm(1)  2.548(2) 


































































































































































































































Anisotropic displacement parameters  (Å2x 103) for Sm(terpy)(NO3)2(pyacac).  The 
anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h 
k a* b* U12 ] 
__________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
__________________________________________________________________  
C(1) 41(2)  20(2) 30(2)  1(1) -8(1)  3(2) 
C(2) 34(2)  20(2) 28(2)  -2(1) -1(1)  6(1) 
C(3) 25(2)  16(2) 28(2)  5(1) -1(1)  5(1) 
C(4) 23(2)  26(2) 29(2)  -2(1) -1(1)  4(1) 
C(5) 22(1)  26(2) 24(2)  -2(1) 1(1)  0(1) 
C(6) 43(2)  46(2) 41(2)  15(2) -1(2)  -10(2) 
C(7) 20(2)  33(2) 32(2)  7(1) 0(1)  -3(1) 
C(8) 30(2)  29(2) 41(2)  10(2) -8(1)  -8(1) 
C(9) 14(1)  12(1) 16(1)  -6(1) -2(1)  1(1) 
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C(10) 20(1)  15(2) 22(1)  2(1) -5(1)  -2(1) 
C(11) 19(1)  20(2) 26(2)  1(1) -1(1)  -6(1) 
C(12) 20(1)  24(2) 25(2)  0(1) -3(1)  -7(1) 
C(13) 19(1)  23(2) 20(1)  0(1) -7(1)  -3(1) 
C(14) 11(1)  22(2) 12(1)  -2(1) -1(1)  0(1) 
C(15) 14(1)  18(2) 15(1)  0(1) -1(1)  4(1) 
C(16) 21(1)  25(2) 19(1)  5(1) -6(1)  -3(1) 
C(18) 11(1)  12(1) 13(1)  -5(1) 0(1)  0(1) 
C(19) 12(1)  15(2) 20(1)  -1(1) -1(1)  2(1) 
C(20) 10(1)  20(2) 26(1)  -6(1) -1(1)  1(1) 
C(21) 13(1)  21(2) 21(1)  -8(1) 4(1)  -3(1) 
C(22) 16(1)  14(1) 16(1)  -5(1) 1(1)  -2(1) 
C(23) 17(1)  18(2) 15(1)  -2(1) 4(1)  -2(1) 
C(24) 18(1)  28(2) 18(1)  1(1) 0(1)  1(1) 
C(25) 27(2)  30(2) 18(1)  7(1) 3(1)  -1(1) 
C(26) 29(2)  31(2) 23(2)  5(1) 5(1)  -7(1) 
C(27) 19(1)  29(2) 22(1)  2(1) 1(1)  -4(1) 
C(28) 10(1)  11(1) 14(1)  -4(1) -1(1)  1(1) 
C(29) 12(1)  20(2) 17(1)  -3(1) -1(1)  0(1) 
C(30) 17(1)  18(2) 16(1)  -2(1) 2(1)  -2(1) 
C(31) 21(1)  14(2) 15(1)  1(1) -1(1)  2(1) 
C(32) 12(1)  17(2) 19(1)  -2(1) -4(1)  4(1) 
N(1) 23(1)  20(1) 24(1)  1(1) 1(1)  0(1) 
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N(2) 14(1)  17(1) 15(1)  -1(1) -5(1)  -1(1) 
N(6) 16(1)  26(2) 24(1)  -9(1) 0(1)  3(1) 
N(7) 10(1)  20(1) 16(1)  2(1) -4(1)  2(1) 
N(4) 11(1)  13(1) 14(1)  -3(1) 0(1)  1(1) 
N(3) 18(1)  19(1) 13(1)  -1(1) 1(1)  1(1) 
N(5) 10(1)  14(1) 13(1)  -1(1) -1(1)  0(1) 
O(1) 22(1)  32(1) 30(1)  7(1) 4(1)  3(1) 
O(2) 27(1)  35(2) 57(2)  1(1) -13(1)  -1(1) 
O(3) 14(1)  15(1) 18(1)  0(1) -6(1)  0(1) 
O(4) 19(1)  19(1) 25(1)  6(1) -8(1)  -5(1) 
O(5) 24(1)  26(1) 18(1)  -5(1) -4(1)  6(1) 
O(6) 14(1)  19(1) 26(1)  -4(1) 4(1)  -5(1) 
O(7) 12(1)  17(1) 35(1)  -5(1) 4(1)  -4(1) 
O(8) 18(1)  24(1) 20(1)  -6(1) 0(1)  7(1) 
O(9) 41(1)  27(1) 18(1)  -3(1) -1(1)  0(1) 
O(10) 37(1)  36(2) 32(1)  -20(1) -2(1)  8(1) 
Sm(1)11(1)  15(1) 12(1)  0(1) -3(1)  0(1) 
__________________________________________________________________
Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for Sm(terpy)(NO3)2(pyacac). 
__________________________________________________________________  




H(3) 1855 -217 37 37 
H(1) 1803 1114 199 37 
H(12) 3897 -554 441 33 
H(13) 4128 771 292 33 
H(6) 4666 2378 1668 31 
H(7) 3450 1468 1740 31 
H(2) 5562 -702 2302 65 
H(5) 4716 -771 1820 65 
H(4) 4002 -266 2261 65 
H(8) 1711 1343 1163 34 
H(9) 2032 104 1396 34 
H(11) 1274 -887 754 40 
H(10) 305 237 691 40 
H(21) 5602 8782 1022 23 
H(20) 6124 7779 689 23 
H(19) 7568 9665 803 26 
H(18) 8334 8453 718 26 
H(16) 9334 9008 1422 28 
H(17) 7909 9529 1594 28 
H(14) 8647 7139 1532 25 
H(15) 7860 7756 1941 25 
H(25) 6899 6074 2039 18 
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H(23) 5199 4147 2592 33 
H(22) 6739 4548 2504 33 
H(24) 6121 3421 2254 33 
H(32) -1856 6474 169 19 
H(31) -3511 5445 563 23 
H(30) -2801 4228 1166 22 
H(29) 2495 3375 2105 26 
H(28) 1222 1887 2409 30 
H(26) -1030 1568 2121 33 
H(27) -1951 2785 1543 28 
H(36) 4125 6694 341 20 
H(33) 3730 7784 -315 20 
H(34) 1457 8016 -606 20 
H(35) -338 7137 -222 19 
__________________________________________________________________ 































































































ORTEP drawing of Eu(terpy)(NO3)2(pyacac) with 50% probability ellipsoids and 
H atoms and solvent have been omitted for clarity.  
X-ray Crystallographic Data for Eu(terpy)(NO3)2(pyacac).  
_________________________________________________________________ 
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Identification code  ky_2_227_n_0m 
Empirical formula  C23 H23 Eu N6 O8 
Formula weight  663.43 
Temperature  107(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.452(3) Å a= 87.037(7)°. 
 b = 9.782(3) Å b= 74.201(7)°. 
 c = 13.752(4) Å g = 87.784(7)°. 
Volume 1221.4(6) Å3 
Z 2 
Density (calculated) 1.804 Mg/m3 
Absorption coefficient 2.629 mm-1 
F(000) 660 
Crystal size 0.100 x 0.050 x 0.050 mm3 
Theta range for data collection 2.085 to 26.552°. 
Index ranges -11<=h<=11, -12<=k<=12, -11<=l<=17 
Reflections collected 8252 
Independent reflections 5028 [R(int) = 0.0415] 
Completeness to theta = 25.242° 99.4 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5028 / 0 / 344 
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Goodness-of-fit on F2 1.020 
Final R indices [I>2sigma(I)] R1 = 0.0483, wR2 = 0.1078 
R indices (all data) R1 = 0.0700, wR2 = 0.1179 
Extinction coefficient n/a 
Largest diff. peak and hole 2.135 and -1.831 e.Å-3 
 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for Eu(terpy)(NO3)2(pyacac).  U(eq) is defined as one third of  the 
trace of the orthogonalized Uij tensor. 
__________________________________________________________________  
 x y z U(eq) 
__________________________________________________________________  
C(1) 5869(8) 1717(7) 6521(5) 24(2) 
C(2) 7384(8) 1771(7) 6114(5) 22(2) 
C(3) 7972(8) 3004(7) 5715(5) 24(2) 
C(4) 7060(7) 4139(6) 5759(5) 18(1) 
C(5) 5559(7) 4023(6) 6210(5) 16(1) 
C(6) 4542(7) 5231(6) 6338(5) 16(1) 
C(7) 5064(8) 6570(6) 6128(5) 21(1) 
C(8) 4080(8) 7659(7) 6244(5) 22(2) 
C(9) 2616(8) 7414(7) 6564(5) 23(2) 
C(10) 2137(7) 6069(7) 6769(5) 18(1) 
C(11) 545(7) 5752(7) 7125(5) 18(1) 
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C(12) -556(8) 6722(7) 7089(5) 23(2) 
C(13) -2001(8) 6361(8) 7455(5) 27(2) 
C(14) -2348(7) 5050(8) 7840(5) 23(2) 
C(15) -1190(7) 4146(7) 7828(5) 22(2) 
C(16) -1796(7) -182(7) 8503(6) 25(2) 
C(17) -175(7) 130(6) 8234(5) 17(1) 
C(18) 743(7) -695(7) 8654(5) 19(1) 
C(19) 2280(7) -480(6) 8493(5) 18(1) 
C(20) 4612(7) -1211(7) 8867(6) 22(2) 
C(21) 4927(8) -2359(7) 9571(5) 24(2) 
C(22) 3964(7) -3494(7) 9423(6) 25(2) 
C(23) 2548(7) -2753(7) 9373(5) 21(2) 
Eu(1) 2181(1) 2554(1) 7350(1) 14(1) 
N(1) 4964(6) 2809(5) 6594(4) 18(1) 
N(2) 3088(6) 5005(5) 6662(4) 15(1) 
N(3) 217(6) 4462(6) 7478(4) 18(1) 
N(4) 1847(6) 3430(6) 9389(4) 22(1) 
N(5) 2199(6) 1713(6) 5305(4) 20(1) 
N(6) 3062(6) -1413(5) 8895(4) 17(1) 
O(1) 2953(5) 560(4) 8032(3) 19(1) 
O(2) 207(5) 1197(5) 7619(4) 22(1) 
O(3) 2976(5) 3701(5) 8664(3) 25(1) 
O(4) 882(5) 2730(5) 9165(4) 25(1) 
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O(5) 1683(6) 3811(6) 10242(4) 34(1) 
O(6) 2890(5) 988(5) 5840(4) 27(1) 
O(7) 2086(7) 1352(5) 4500(4) 37(1) 
O(8) 1658(5) 2851(4) 5665(3) 20(1) 
__________________________________________________________________  
Bond lengths [Å] and angles [°] for Eu(terpy)(NO3)2(pyacac). 
__________________________________________________________________  
C(1)-N(1)  1.333(8) 
C(1)-C(2)  1.390(10) 
C(1)-H(1)  0.9500 
C(2)-C(3)  1.372(10) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.373(10) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.392(9) 
C(4)-H(4)  0.9500 
C(5)-N(1)  1.353(8) 
C(5)-C(6)  1.481(9) 
C(6)-N(2)  1.347(8) 
C(6)-C(7)  1.406(9) 
C(7)-C(8)  1.373(9) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.360(10) 
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C(8)-H(8)  0.9500 
C(9)-C(10)  1.397(9) 
C(9)-H(9)  0.9500 
C(10)-N(2)  1.336(8) 
C(10)-C(11)  1.489(9) 
C(11)-N(3)  1.345(8) 
C(11)-C(12)  1.390(9) 
C(12)-C(13)  1.374(10) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.378(10) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.378(10) 
C(14)-H(14)  0.9500 
C(15)-N(3)  1.328(9) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.514(9) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-O(2)  1.306(8) 
C(17)-C(18)  1.382(9) 
C(18)-C(19)  1.431(9) 
C(18)-H(18)  0.9500 
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C(19)-O(1)  1.267(7) 
C(19)-N(6)  1.343(8) 
C(20)-N(6)  1.475(8) 
C(20)-C(21)  1.519(9) 
C(20)-H(20A)  0.9900 
C(20)-H(20B)  0.9900 
C(21)-C(22)  1.518(9) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-C(23)  1.514(9) 
C(22)-H(22A)  0.9900 
C(22)-H(22B)  0.9900 
C(23)-N(6)  1.474(8) 
C(23)-H(23A)  0.9900 
C(23)-H(23B)  0.9900 
Eu(1)-O(2)  2.268(4) 
Eu(1)-O(1)  2.300(4) 
Eu(1)-O(3)  2.471(5) 
Eu(1)-O(4)  2.474(5) 
Eu(1)-O(8)  2.498(5) 
Eu(1)-N(3)  2.559(5) 
Eu(1)-N(1)  2.569(6) 
Eu(1)-O(6)  2.569(5) 
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Eu(1)-N(2)  2.620(5) 
Eu(1)-N(4)  2.906(6) 
Eu(1)-N(5)  2.966(6) 
N(4)-O(5)  1.216(8) 
N(4)-O(4)  1.272(7) 
N(4)-O(3)  1.273(7) 
N(5)-O(7)  1.212(7) 
N(5)-O(8)  1.273(7) 


















































































































































































Anisotropic displacement parameters  (Å2x 103) for Eu(terpy)(NO3)2(pyacac).  
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
__________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
 253 
__________________________________________________________________  
C(1) 31(4)  17(3) 24(4)  3(3) -8(3)  6(3) 
C(2) 26(4)  18(3) 20(4)  -3(3) -4(3)  9(3) 
C(3) 19(3)  35(4) 19(4)  -5(3) -2(3)  -3(3) 
C(4) 23(3)  16(3) 16(3)  3(3) -7(3)  -3(3) 
C(5) 25(3)  14(3) 11(3)  -4(2) -6(3)  -2(3) 
C(6) 22(3)  16(3) 10(3)  -3(2) -5(3)  3(3) 
C(7) 33(4)  13(3) 17(3)  -2(3) -10(3)  4(3) 
C(8) 34(4)  15(3) 17(3)  -2(3) -8(3)  -2(3) 
C(9) 34(4)  15(3) 22(4)  -5(3) -12(3)  11(3) 
C(10) 20(3)  23(3) 10(3)  -2(3) -2(3)  9(3) 
C(11) 26(4)  22(3) 12(3)  -7(3) -12(3)  4(3) 
C(12) 28(4)  28(4) 16(3)  -8(3) -10(3)  10(3) 
C(13) 33(4)  31(4) 23(4)  -11(3) -17(3)  14(3) 
C(14) 17(3)  41(4) 13(3)  -14(3) -5(3)  2(3) 
C(15) 24(4)  28(4) 15(3)  -4(3) -8(3)  4(3) 
C(16) 21(4)  22(4) 31(4)  0(3) -7(3)  -1(3) 
C(17) 18(3)  14(3) 18(3)  -3(3) -3(3)  1(2) 
C(18) 14(3)  25(4) 13(3)  0(3) 2(3)  -3(3) 
C(19) 28(4)  10(3) 14(3)  -2(3) -2(3)  0(3) 
C(20) 19(3)  25(4) 24(4)  0(3) -6(3)  0(3) 
C(21) 24(4)  24(4) 25(4)  4(3) -10(3)  2(3) 
C(22) 20(4)  17(3) 36(4)  6(3) -8(3)  0(3) 
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C(23) 22(3)  16(3) 24(4)  5(3) -8(3)  1(3) 
Eu(1) 16(1)  14(1) 14(1)  2(1) -6(1)  0(1) 
N(1) 24(3)  14(3) 18(3)  0(2) -9(2)  4(2) 
N(2) 24(3)  12(3) 14(3)  -3(2) -11(2)  4(2) 
N(3) 19(3)  24(3) 12(3)  0(2) -7(2)  5(2) 
N(4) 31(3)  21(3) 16(3)  2(2) -11(3)  -1(3) 
N(5) 26(3)  16(3) 17(3)  4(2) -7(3)  -6(2) 
N(6) 15(3)  15(3) 22(3)  1(2) -8(2)  -1(2) 
O(1) 20(2)  16(2) 21(2)  6(2) -8(2)  -1(2) 
O(2) 18(2)  20(2) 27(3)  4(2) -6(2)  -1(2) 
O(3) 26(3)  36(3) 14(2)  1(2) -6(2)  -12(2) 
O(4) 23(3)  34(3) 19(3)  5(2) -8(2)  -7(2) 
O(5) 47(3)  41(3) 14(3)  -3(2) -8(2)  -8(3) 
O(6) 32(3)  22(3) 26(3)  -3(2) -8(2)  6(2) 
O(7) 69(4)  23(3) 29(3)  -5(2) -27(3)  -3(3) 
O(8) 27(3)  16(2) 19(2)  2(2) -9(2)  4(2) 
__________________________________________________________________ 
Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for Eu(terpy)(NO3)2(pyacac). 
__________________________________________________________________  
 x  y  z  U(eq) 
__________________________________________________________________  
H(1) 5456 853 6762 29 
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H(2) 7994 976 6111 26 
H(3) 8999 3071 5412 29 
H(4) 7451 4999 5482 22 
H(7) 6091 6720 5908 25 
H(8) 4417 8569 6103 26 
H(9) 1920 8155 6648 28 
H(12) -313 7621 6815 28 
H(13) -2764 7017 7442 33 
H(14) -3340 4783 8102 28 
H(15) -1412 3237 8087 26 
H(16A) -2366 557 8898 37 
H(16B) -1969 -1048 8903 37 
H(16C) -2101 -258 7882 37 
H(18) 325 -1455 9079 23 
H(20A) 4739 -303 9114 27 
H(20B) 5263 -1292 8173 27 
H(21A) 5980 -2644 9375 29 
H(21B) 4648 -2082 10282 29 
H(22A) 4422 -3964 8789 30 
H(22B) 3787 -4177 9998 30 
H(23A) 2041 -3241 8957 25 
H(23B) 1873 -2649 10057 25 
__________________________________________________________________ 
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ORTEP drawing of Dy(terpy)(NO3)2(dbacac) with 50% probability ellipsoids and 
H atoms and solvent have been omitted for clarity.  
X-ray Crystallographic Data for Dy(terpy)(NO3)2(dbacac).  
Identification code  ky_2_154_0m 
Empirical formula  C35 H33 Dy N6 O8.50 
Formula weight  836.17 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 19.2296(9) Å a= 90°. 
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 b = 9.2999(4) Å b= 
112.085(2)°. 
 c = 21.3594(9) Å g = 90°. 
Volume 3539.5(3) Å3 
Z 4 
Density (calculated) 1.569 Mg/m3 
Absorption coefficient 2.172 mm-1 
F(000) 1676 
Crystal size 0.250 x 0.100 x 0.050 mm3 
Theta range for data collection 1.217 to 32.428°. 
Index ranges -22<=h<=29, -14<=k<=9, -32<=l<=32 
Reflections collected 34853 
Independent reflections 12568 [R(int) = 0.0468] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7464 and 0.5470 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12568 / 10 / 454 
Goodness-of-fit on F2 1.193 
Final R indices [I>2sigma(I)] R1 = 0.0686, wR2 = 0.1227 
R indices (all data) R1 = 0.1224, wR2 = 0.1361 
Extinction coefficient n/a 
Largest diff. peak and hole 2.270 and -1.180 e.Å-3 
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Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for Dy(terpy)(NO3)2(dbacac).  U(eq) is defined as one third of  the 
trace of the orthogonalized Uij tensor. 
__________________________________________________________________  
 x y z U(eq) 
__________________________________________________________________ 
C(1) 7335(3) -746(6) 3784(3) 29(1) 
C(2) 7297(4) -1913(7) 3360(3) 37(2) 
C(3) 7744(4) -1880(7) 2990(3) 40(2) 
C(4) 8213(4) -710(7) 3046(3) 34(1) 
C(5) 8221(3) 399(6) 3474(2) 24(1) 
C(6) 8694(3) 1704(6) 3541(2) 22(1) 
C(7) 9230(3) 1774(7) 3246(3) 31(1) 
C(8) 9639(4) 3023(8) 3315(3) 39(2) 
C(9) 9519(3) 4154(7) 3673(3) 32(1) 
C(10) 8985(3) 4017(6) 3966(2) 22(1) 
C(11) 8827(3) 5210(6) 4355(3) 23(1) 
C(12) 9222(4) 6488(7) 4478(4) 39(2) 
C(13) 9045(4) 7551(8) 4853(4) 50(2) 
C(14) 8479(4) 7301(6) 5078(3) 42(2) 
C(15) 8104(4) 6023(6) 4930(3) 33(1) 
C(16) 7503(3) 2805(6) 6012(3) 23(1) 
C(17) 6963(3) 1685(7) 5852(3) 34(1) 
 262 
C(18) 6698(4) 942(9) 5251(3) 43(2) 
C(19) 6097(5) -156(13) 5135(5) 88(4) 
C(20) 7647(3) 2813(6) 7223(3) 29(1) 
C(21) 7026(4) 3541(7) 7387(3) 35(1) 
C(22) 6386(4) 4060(9) 6887(4) 49(2) 
C(23) 5801(5) 4647(10) 7038(5) 63(2) 
C(24) 7098(5) 3645(7) 8052(3) 45(2) 
C(25) 6486(6) 4263(8) 8194(4) 54(2) 
C(26) 5864(6) 4726(9) 7684(5) 61(2) 
C(27) 8182(3) 4758(6) 6761(3) 25(1) 
C(28) 8989(3) 4568(6) 7219(3) 26(1) 
C(29) 9424(3) 3496(7) 7097(3) 31(1) 
C(30) 10164(4) 3312(8) 7524(4) 49(2) 
C(31) 10483(5) 4224(10) 8072(5) 68(3) 
C(32) 10067(5) 5322(9) 8176(4) 71(3) 
C(33) 9322(5) 5496(8) 7754(3) 47(2) 
C(34) 5351(15) 5290(30) 4883(15) 130(10) 
C(35) 4779(16) 6030(30) 5095(16) 127(10) 
C(36) 5170(20) 7030(50) 5660(20) 280(30) 
C(37) 5970(20) 6690(50) 5813(18) 208(18) 
Dy(1) 7772(1) 2522(1) 4589(1) 20(1) 
N(1) 7778(2) 405(5) 3840(2) 22(1) 
N(2) 8590(2) 2801(4) 3907(2) 16(1) 
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N(3) 8271(3) 4981(5) 4581(2) 26(1) 
N(4) 7755(3) 3415(5) 6633(2) 24(1) 
N(5) 9175(3) 1398(5) 5572(2) 24(1) 
N(6) 6543(3) 4121(5) 3626(2) 27(1) 
O(1) 9753(3) 926(5) 5991(2) 42(1) 
O(2) 8583(3) 645(4) 5320(2) 32(1) 
O(3) 9121(2) 2693(4) 5368(2) 28(1) 
O(4) 6685(2) 4209(6) 4255(2) 41(1) 
O(5) 6922(2) 3186(5) 3449(2) 26(1) 
O(6) 6075(2) 4896(5) 3220(2) 33(1) 
O(7) 7746(2) 3305(4) 5582(2) 22(1) 
O(8) 6929(2) 1096(5) 4762(2) 38(1) 
O(9) 6072(14) 5890(30) 5271(15) 197(11) 
 
Bond lengths [Å] and angles [°] for Dy(terpy)(NO3)2(dbacac). 
_____________________________________________________  
C(1)-N(1)  1.345(7) 
C(1)-C(2)  1.397(9) 
C(1)-H(1)  0.9500 
C(2)-C(3)  1.370(10) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.389(9) 
C(3)-H(3)  0.9500 
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C(4)-C(5)  1.375(8) 
C(4)-H(4)  0.9500 
C(5)-N(1)  1.356(7) 
C(5)-C(6)  1.491(8) 
C(6)-N(2)  1.345(6) 
C(6)-C(7)  1.397(8) 
C(7)-C(8)  1.380(9) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.369(9) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.395(8) 
C(9)-H(9)  0.9500 
C(10)-N(2)  1.342(6) 
C(10)-C(11)  1.485(8) 
C(11)-N(3)  1.345(7) 
C(11)-C(12)  1.382(8) 
C(12)-C(13)  1.392(10) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.367(11) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.364(9) 
C(14)-H(14)  0.9500 
C(15)-N(3)  1.333(7) 
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C(15)-H(15)  0.9500 
C(16)-O(7)  1.265(6) 
C(16)-N(4)  1.355(6) 
C(16)-C(17)  1.419(8) 
C(17)-C(18)  1.375(9) 
C(17)-H(17)  0.9500 
C(18)-O(8)  1.288(7) 
C(18)-C(19)  1.492(10) 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(20)-N(4)  1.462(7) 
C(20)-C(21)  1.524(9) 
C(20)-H(20A)  0.9900 
C(20)-H(20B)  0.9900 
C(21)-C(24)  1.377(8) 
C(21)-C(22)  1.378(10) 
C(22)-C(23)  1.392(10) 
C(22)-H(22)  0.9500 
C(23)-C(26)  1.343(12) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.442(11) 
C(24)-H(24)  0.9500 
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C(25)-C(26)  1.349(12) 
C(25)-H(25)  0.9500 
C(26)-H(26)  0.9500 
C(27)-N(4)  1.463(7) 
C(27)-C(28)  1.502(8) 
C(27)-H(27A)  0.9900 
C(27)-H(27B)  0.9900 
C(28)-C(33)  1.382(8) 
C(28)-C(29)  1.387(8) 
C(29)-C(30)  1.383(9) 
C(29)-H(29)  0.9500 
C(30)-C(31)  1.387(12) 
C(30)-H(30)  0.9500 
C(31)-C(32)  1.367(13) 
C(31)-H(31)  0.9500 
C(32)-C(33)  1.386(11) 
C(32)-H(32)  0.9500 
C(33)-H(33)  0.9500 
C(34)-C(35)#1  1.25(4) 
C(34)-O(9)  1.435(10) 
C(34)-C(35)  1.506(10) 
C(34)-C(34)#1  1.69(6) 
C(35)-C(34)#1  1.25(4) 
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C(35)-C(36)  1.487(10) 
C(36)-C(37)  1.495(10) 
C(37)-O(9)  1.449(10) 
Dy(1)-O(8)  2.229(4) 
Dy(1)-O(7)  2.260(3) 
Dy(1)-O(5)  2.447(4) 
Dy(1)-O(2)  2.467(4) 
Dy(1)-N(3)  2.482(5) 
Dy(1)-O(4)  2.492(4) 
Dy(1)-O(3)  2.506(4) 
Dy(1)-N(2)  2.528(4) 
Dy(1)-N(1)  2.540(4) 
Dy(1)-N(6)  2.893(5) 
Dy(1)-N(5)  2.920(5) 
N(5)-O(1)  1.216(6) 
N(5)-O(2)  1.271(6) 
N(5)-O(3)  1.273(6) 
N(6)-O(6)  1.223(6) 
N(6)-O(4)  1.267(6) 
























































































































































































































Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1       
Anisotropic displacement parameters  (Å2x 103) for Dy(terpy)(NO3)2(dbacac).  
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + 
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...  + 2 h k a* b* U12 ] 
__________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
__________________________________________________________________  
C(1) 33(3)  26(3) 22(2)  3(2) 3(2)  -3(2) 
C(2) 41(4)  25(3) 30(3)  -1(3) -1(3)  -10(3) 
C(3) 51(4)  31(3) 29(3)  -14(3) 7(3)  -4(3) 
C(4) 40(4)  41(4) 20(2)  -6(2) 10(2)  5(3) 
C(5) 25(3)  27(3) 15(2)  0(2) 2(2)  6(2) 
C(6) 24(3)  21(3) 19(2)  0(2) 6(2)  4(2) 
C(7) 28(3)  40(4) 25(3)  -1(3) 12(2)  10(3) 
C(8) 27(3)  57(4) 41(3)  7(3) 21(3)  2(3) 
C(9) 31(3)  34(3) 35(3)  8(3) 16(3)  -6(3) 
C(10) 18(2)  25(3) 19(2)  4(2) 4(2)  -3(2) 
C(11) 22(3)  20(3) 22(2)  6(2) 1(2)  3(2) 
C(12) 26(3)  29(3) 54(4)  4(3) 8(3)  -4(3) 
C(13) 47(4)  22(3) 59(4)  -2(4) -6(3)  -2(4) 
C(14) 73(5)  11(3) 33(3)  -1(2) 10(3)  4(3) 
C(15) 56(4)  19(3) 26(3)  6(2) 17(3)  11(3) 
C(16) 18(2)  32(4) 21(2)  2(2) 9(2)  6(2) 
C(17) 31(3)  48(4) 28(3)  -2(3) 18(3)  -10(3) 
C(18) 31(3)  68(5) 37(3)  -12(3) 19(3)  -20(3) 
C(19) 83(7)  133(10) 68(6)  -45(6) 50(5)  -80(7) 
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C(20) 38(3)  27(3) 22(2)  3(2) 13(2)  0(2) 
C(21) 53(4)  30(3) 32(3)  -6(3) 28(3)  -13(3) 
C(22) 47(4)  59(5) 51(4)  0(4) 28(4)  10(4) 
C(23) 56(5)  71(6) 70(6)  -4(5) 33(5)  15(5) 
C(24) 78(5)  31(4) 38(3)  -7(3) 36(4)  -17(4) 
C(25)109(7)  30(4) 52(4)  -10(3) 64(5)  -21(4) 
C(26) 80(6)  37(4) 94(7)  -10(5) 63(6)  -8(4) 
C(27) 36(3)  23(3) 21(2)  3(2) 16(2)  6(2) 
C(28) 34(3)  23(3) 18(2)  1(2) 8(2)  -3(2) 
C(29) 27(3)  29(3) 35(3)  5(3) 10(3)  6(2) 
C(30) 34(4)  38(4) 70(5)  20(4) 12(4)  3(3) 
C(31) 41(5)  58(6) 75(6)  25(5) -13(4)  -2(4) 
C(32) 73(6)  42(5) 53(5)  -2(4) -26(4)  -7(4) 
C(33) 60(5)  42(4) 31(3)  -5(3) 9(3)  -3(4) 
Dy(1) 20(1)  25(1) 16(1)  0(1) 8(1)  0(1) 
N(1) 24(2)  20(2) 16(2)  2(2) 3(2)  -2(2) 
N(2) 20(2)  10(2) 17(2)  2(1) 4(2)  2(1) 
N(3) 39(3)  17(2) 21(2)  3(2) 12(2)  6(2) 
N(4) 27(2)  29(3) 17(2)  3(2) 10(2)  5(2) 
N(5) 31(3)  23(2) 21(2)  6(2) 12(2)  9(2) 
N(6) 25(2)  30(3) 25(2)  2(2) 9(2)  -3(2) 
O(1) 41(3)  43(3) 36(2)  20(2) 8(2)  23(2) 
O(2) 47(3)  15(2) 24(2)  3(2) 2(2)  -3(2) 
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O(3) 23(2)  25(2) 32(2)  11(2) 6(2)  0(2) 
O(4) 39(3)  62(3) 23(2)  4(2) 12(2)  20(2) 
O(5) 26(2)  32(2) 19(2)  2(2) 7(2)  6(2) 
O(6) 27(2)  36(2) 31(2)  11(2) 5(2)  9(2) 
O(7) 27(2)  23(2) 19(2)  1(2) 11(2)  1(2) 
O(8) 32(2)  57(3) 30(2)  -16(2) 18(2)  -21(2) 
__________________________________________________________________
Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for Dy(terpy)(NO3)2(dbacac). 
__________________________________________________________________ 
 x  y  z  U(eq) 
__________________________________________________________________ 
H(1) 7031 -766 4047 35 
H(2) 6972 -2702 3330 44 
H(3) 7734 -2655 2697 48 
H(4) 8524 -676 2790 41 
H(7) 9310 978 3003 37 
H(8) 10003 3098 3115 47 
H(9) 9797 5020 3721 39 
H(12) 9608 6638 4309 46 
H(13) 9313 8434 4950 60 
H(14) 8348 8008 5336 50 
H(15) 7704 5869 5082 40 
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H(17) 6769 1429 6185 41 
H(19A) 5662 97 4730 132 
H(19B) 5949 -186 5527 132 
H(19C) 6286 -1102 5073 132 
H(20A) 8124 2896 7619 34 
H(20B) 7528 1777 7142 34 
H(22) 6343 4015 6429 59 
H(23) 5362 4988 6686 75 
H(24) 7539 3318 8407 54 
H(25) 6520 4345 8648 65 
H(26) 5462 5117 7786 73 
H(27A) 7944 5460 6968 30 
H(27B) 8160 5161 6325 30 
H(29) 9211 2884 6717 37 
H(30) 10454 2560 7443 59 
H(31) 10988 4086 8372 82 
H(32) 10290 5970 8541 85 
H(33) 9037 6260 7833 56 
__________________________________________________________________ 












































































































Symmetry transformations used to generate equivalent atoms:  












































Alcohol (S19). n-Butyllithium (2.37 M in hexanes, 15.5 mL, 36.8 mL) was added to a 
solution of 114 (11.06 g, 37.6 mmol) in dry THF (41 mL) at −78 °C and the solution was 
stirred for 30 min. A solution of 102 (7.4o g, 7.35 mmol) in dry THF (20 mL total with 
rinses) was added dropwise. After 1 h, chlorotrimethylsilane (4.7 mL, 36.8 mmol), 
freshly distilled from CaH2, was added dropwise. The reaction mixture was stirred at −78 
°C for 20 min, at 0 °C for 20 min, then warmed to 23 °C and stirred for 12 h. The 
solution was quenched with water and diluted with ethyl acetate (3x100 mL), and the 
combined organic layers were washed with 1 M aqueous HCl (2x50 mL). The aqueous 
layer was brought to pH>9 using NaOH and extracted with ethyl acetate (3x100 mL) to 
recover the chiral amine. The organic layer was dried with sodium sulfate and 
concentrated. The crude oil was submitted to the next step without further purification.  
The crude residue was dissolved in dry ether (258 ml) and lithium aluminum hydride 
(2.89 g, 72.4 mmol) was added carefully at 0 °C. The reaction mixture was warmed to 23 
°C and stirred for 18 h. The mixture was then heated at reflux for 1 h, then cooled to 23 
°C, and then to 0 °C. An additional 100 mL of ether was added. Water (2.9 ml) was 
added carefully with vigorous stirring. After 5 min, 3 M aqueous NaOH (2.9 ml) was 
added. After an additional 5 min, water (8.7 ml) was added and the mixture was allowed 
to stir at 23 °C for 1 h. The white precipitate was filtered off, and washed with 





























chromatography (silica, 20% ethyl acetate – hexanes) afforded S19 (9.98 g, 10.03 mmol, 
78%). 1H NMR (600 MHz, CDCl3) δ (ppm): 7.44 (dd, J = 6.5, 3.2 Hz, 2H), 7.31 (dd, J = 
4.6, 2.2 Hz, 8H), 7.24 – 7.20 (m, 2H), 6.87 – 6.82 (m, 2H), 5.56 – 5.52 (m, 2H), 5.47 (s, 
1H), 4.82 – 4.75 (m, 2H), 4.50 – 4.43 (m, 3H), 4.37 (s, 2H), 4.15 – 4.09 (m, 3H), 4.06 
(dd, J = 11.6, 1.7 Hz, 1H), 3.78 (s, 5H), 3.71 – 3.55 (m, 5H), 3.49 – 3.36 (m, 4H), 3.35 – 
3.27 (m, 2H), 3.24 – 3.19 (m, 1H), 2.05 (d, J = 7.6 Hz, 4H), 1.30 – 1.25 (m, 4H), 1.00 – 
0.92 (m, 7H), 0.91 – 0.83 (m, 3H), 0.78 (dd, J = 6.9, 2.6 Hz, 6H), 0.51 (d, J = 5.7 Hz, 
2H), 0.43 – 0.36 (m, 2H). 
 
Alcohol (S20). Benzoyl chloride (2.5 mL, 21.5 mmol) was added to a solution S19 
(9.99 g, 10.07 mmol) in pyridine (26.3 mL) and the mixture was heated at 80 °C for 1 h. 
The solution was cooled to 23 °C, quenched with methanol (2.2 mL, 52.6 mmol) and 
stirred for 10 min. The mixture was diluted with dichloromethane (500 mL). The organic 
layer was washed with 1 M HCl (2x200 mL), water, saturated aqueous sodium 
bicarbonate, dried with sodium sulfate, and concentrated. The crude ester was submitted 
to the next step without further purification. 
The residue was dissolved in dichloromethane (160 mL) and water (6.4 mL), 
followed by addition of 2,3-dichloro-5,6-dicyano-p-benzoquinone (2.77 g, 12.18 mmol), 
and the mixture was stirred vigorously for 1.5 h at 23 °C. The reaction mixture was 
diluted with dichloromethane and washed with a 1:1 mixture of saturated aqueous sodium 






















with dichloromethane, and the combined organic layers were dried with sodium sulfate, 
and concentrated. To help improve separation between the desired alcohol and p-
methoxybenzaldehyde, the crude alcohol was then was dissolved in MeOH (288 mL), 
followed by addition of sodium borohydride (1.94 g, 51.4 mmol), at 0 °C. The solution 
was stirred for 10 min and then quenched with water. The solution was diluted with ethyl 
acetate, and washed with water. The aqueous layers were then extracted with ethyl 
acetate (2x300mL). The combined organic layers were washed with brine, dried with 
sodium sulfate, concentrated, and the residue was purified by column chromatography 
(silica, 20% ethyl acetate – hexanes) to afford S20  (8.44 g, 8.66 mmol, 88%). 1H NMR 
(600 MHz, CDCl3); δ (ppm): 8.06 – 8.02 (m, 2H), 7.46 – 7.42 (m, 2H), 7.42 – 7.38 (m, 
2H), 7.29 – 7.27 (m, 3H), 7.31 (dt, J = 6.7, 1.4 Hz, 3H), 5.59 (dd, J = 15.4, 10.5 Hz, 1H), 
5.44 (s, 1H), 4.61 (s, 2H), 4.46 (q, J = 12.1 Hz, 2H), 4.36 (d, J = 11.6 Hz, 1H), 4.24 (d, J 
= 11.7 Hz, 1H), 4.05 (dd, J = 11.4, 1.4 Hz, 1H), 3.96 (td, J = 8.1, 4.3 Hz, 1H), 3.61 (ddd, 
J = 10.8, 9.5, 8.0 Hz, 3H), 3.46 (q, J = 5.7 Hz, 2H), 3.42 – 3.36 (m, 1H), 3.31 – 3.20 (m, 
2H), 2.62 – 2.56 (m, 1H), 1.53 – 1.34 (m, 7H), 1.12 – 1.02 (m, 19H), 0.98 (t, J = 7.5 Hz, 
3H), 0.89 – 0.83 (m, 2H), 0.76 (d, J = 6.9 Hz, 3H), 0.72 (d, J = 6.8 Hz, 3H). 
 
 
Diol (S21). Ozone was bubbled through a solution of S20 (7.4 g, 7.58 mmol), N-
methylmorpholine-N-oxide (3.55 g, 30.34 mmol), in dichloromethane (161 mL) at -78 
°C. The progress of the reaction was monitored by TLC. After the starting material was 























ammonium chloride was added at 23 °C. Dilute with dichloromethane and water. The 
aqueous layer was extracted with dichloromethane (4x110 mL). The combined organic 
layers were dried with sodium sulfate and concentrated. The crude residue was dissolved 
in ethanol (108 mL), cooled to -10 °C, and sodium borohydride (0.287 g, 7.58 mmol) was 
added. Additional sodium borohydride was added after 30 min and 1 h 30 min (1 equiv 
for each addition). After 2 h the solution was diluted with dichloromethane and quenched 
carefully with saturated aqueous solution of ammonium chloride. The aqueous layer was 
extracted with dichloromethane (5x100 ml). The combined organic layers were dried 
with sodium sulfate, concentrated, and the residue was purified by column 
chromatography (silica, 75% ethyl acetate − hexanes) to give S21  (5.61 g, 5.91 mmol, 
78%). H NMR (500 MHz, CDCl3); δ (ppm): 8.08 – 7.98 (m, 2H), 7.54 (ddt, J = 8.7, 7.3, 
1.3 Hz, 1H), 7.46 – 7.36 (m, 3H), 7.35 – 7.30 (m, 3H), 5.44 (s, 1H), 4.92 – 4.79 (m, 2H), 
4.58 – 4.40 (m, 3H), 4.07 – 3.97 (m, 3H), 3.93 (h, J = 6.6 Hz, 1H), 3.66 – 3.56 (m, 2H), 
3.49 (s, 1H), 3.32 – 3.19 (m, 2H), 1.87 – 1.34 (m, 10H), 1.12 – 1.00 (m, 13H), 0.97 – 
0.84 (m, 2H), 0.76 (d, J = 7.0 Hz, 3H), 0.68 (d, J = 6.8 Hz, 2H). 
 
Aldehyde (120). Dimethylsulfoxide (4.4 mL, 61.80 mmol) was added to a solution of 
oxalyl chloride (2.61 mL, 30.90 mmol) in dichloromethane (137 mL) at -78 °C. After 20 
min, a solution of S21 (11.76 g, 12.36 mmol) in dichloromethane (137 ml total with 
rinses) was added dropwise, and the mixture was stirred for 25 min. Triethylamine (12.9 























was brought to 0 °C and stirred for 20 min. The reaction was quenched with 1 M aqueous 
HCl (200 mL). The aqueous layer was extracted with ethyl acetate (3x100 mL). The 
combined organic layers were washed with water and saturated aqueous sodium 
bicarbonate, dried with sodium sulfate, and concentrated to give the crude dialdehyde, 
which was used without further purification. 
The crude dialdehyde was dissolved in dry toluene (773 mL) and dibenzylammonium 
trifluoroacetate (11.31 g, 36.33 mmol) was added. The mixture was stirred at 23 °C for 
12 h, then heated at 36 °C for 8 h, and then finally cooled to 23 °C and stirred for an 
additional 8 h. The solution was directly applied on a silica column (silica, 15% ethyl 
acetate – hexanes) to afford 120 (9.77 g, 10.51 mmol, 85%). 1H NMR (500 MHz, 
CDCl3); δ (ppm): 9.49 (s, 1H), 8.07 – 7.98 (m, 2H), 7.56 – 7.50 (m, 1H), 7.41 – 7.36 (m, 
3H), 7.35 – 7.21 (m, 2H), 7.16 (dd, J = 14.3, 7.3 Hz, 6H), 6.89 (dd, J = 3.4, 1.7 Hz, 1H), 
5.46 (s, 1H), 4.87 – 4.74 (m, 2H), 4.48 – 4.38 (m, 2H), 4.38 – 4.31 (m, 2H), 4.12 – 4.02 
(m, 2H), 4.02 – 3.93 (m, 2H), 3.67 – 3.58 (m, 1H), 3.59 – 3.50 (m, 2H), 3.25 (ddd, J = 
42.2, 9.4, 6.9 Hz, 3H), 2.25 (dd, J = 16.0, 10.5 Hz, 2H), 1.99 (dd, J = 7.5, 4.1 Hz, 1H), 
1.93 (dt, J = 12.7, 6.1 Hz, 1H), 1.88 – 1.74 (m, 3H), 1.15 – 0.97 (m, 18H), 0.91 – 0.81 
(m, 3H), 0.77 (dd, J = 10.0, 6.9 Hz, 4H). 
 
MOM Ether (S22). Sodium borohydride (1.67 g, 42.04 mmol) was added to a 
solution of 120 (9.77 g, 10.51 mmol) in ethanol (188 mL) at -70 °C. The mixture was 























dichloromethane and quenched carefully with a saturated aqueous solution of ammonium 
chloride. The aqueous layer was extracted with dichloromethane (3x100 mL). The 
combined organic layers were dried with sodium sulfate, and concentrated to give the 
crude alcohol, which was used without further purification. 
The residue was dissolved in dichloromethane (58 ml), and di-isopropylethylamine 
(55.1 mL, 316.42 mmol), chloromethyl methyl ether (8.0 mL, 105.12 mmol), and tetra-n-
butylammonium iodide (0.368 g, 0.998 mmol) were added at 0 °C. The reaction mixture 
was stirred for 14 h at 23 °C. The reaction mixture was diluted with dichloromethane 
(400 mL). The organic layer was washed with 1 M aqueous HCl (2x200 mL), water, 
saturated aqueous sodium bicarbonate, dried with sodium sulfate, concentrated, and the 
residue was purified by column chromatography (silica, 20% ethyl acetate – hexanes) to 
give S22 (9.09 g, 9.56 mmol, 91%). 1H NMR (500 MHz, CDCl3); δ (ppm): 8.03 (dd, J = 
8.3, 1.4 Hz, 2H), 7.52 (ddt, J = 8.7, 7.3, 1.4 Hz, 1H), 7.45 – 7.34 (m, 4H), 7.33 – 7.26 (m, 
6H), 5.44 (s, 1H), 4.82 – 4.73 (m, 2H), 4.65 – 4.56 (m, 2H), 4.48 – 4.38 (m, 2H), 4.36 – 
4.30 (m, 2H), 4.06 (d, J = 2.7 Hz, 2H), 3.98 – 3.94 (m, 2H), 3.93 – 3.81 (m, 2H), 3.63 – 
3.50 (m, 3H), 3.35 (s, 3H), 3.33 – 3.28 (m, 1H), 2.87 (s, 1H), 2.87 (s, 1H), 1.99 (d, J = 
7.1 Hz, 2H), 1.96 – 1.89 (m, 2H), 1.85 – 1.75 (m, 2H), 1.63 (dd, J = 14.3, 6.2 Hz, 1H), 
1.14 – 1.00 (m, 18H), 0.94 – 0.85 (m, 3H), 0.80 (d, J = 6.9 Hz, 3H), 0.76 (d, J = 6.8 Hz, 
3H). 
 





















mmol) was added to a solution of S22 (8.76 g, 8.98 mmol) in THF (160 mL) at 23 °C. 
After 1 h and 10 min the reaction was quenched with a saturated aqueous solution of 
ammonium chloride. The aqueous layer was extracted with ethyl acetate (3x200 mL). 
The combined organic layers were washed with brine, dried with sodium sulfate, 
concentrated, and the residue was purified by column chromatography (silica, 20% ethyl 
acetate – hexanes then 60% ethyl acetate – hexanes) to give S23 (7.12 g, 8.14 mmol, 
96%). 1H NMR (600 MHz, CDCl3); δ (ppm): 8.07 – 7.94 (m, 2H), 7.53 (td, J = 7.3, 1.4 
Hz, 1H), 7.47 – 7.35 (m, 3H), 7.35 – 7.28 (m, 5H), 5.75 (d, J = 3.7 Hz, 1H), 5.46 (s, 1H), 
4.77 (d, J = 6.7 Hz, 1H), 4.67 (d, J = 6.7 Hz, 1H), 4.61 (d, J = 1.0 Hz, 2H), 4.52 – 4.40 
(m, 2H), 4.34 (d, J = 1.9 Hz, 2H), 3.97 – 3.86 (m, 4H), 3.82 (t, J = 9.1 Hz, 1H), 3.75 – 
3.61 (m, 2H), 3.54 – 3.44 (m, 1H), 3.38 – 3.29 (m, 3H), 3.25 (dd, J = 9.3, 6.6 Hz, 1H), 
2.83 (s, 1H), 2.57 (t, J = 7.1 Hz, 1H), 2.04 (s, 3H), 1.94 – 1.75 (m, 3H), 1.61 (dd, J = 
14.3, 6.7 Hz, 1H), 0.98 – 0.87 (m, 2H), 0.83 (d, J = 6.9 Hz, 2H), 0.79 (d, J = 6.8 Hz, 2H). 
 
 
Alkene (121). Dimethylsulfoxide (1.5 mL, 20.86 mmol) was added to a solution of 
oxalyl chloride (0.9 mL, 10.43 mmol) in dichloromethane (98 mL) at -78 °C. After 20 
min, a solution of S23 (7.12 g, 8.69 mmol) in dichloromethane (49 mL total with rinses) 
was then added dropwise, and the mixture was stirred for 25 min. 
Triethylamine (4.4 mL, 31.29 mmol) was added at -78 °C and after 10 min the 
mixture was brought to 0 °C and stirred for 20 min. The reaction was quenched with 1 M 





















The combined organic layers were washed with water and saturated aqueous sodium 
bicarbonate, dried with sodium sulfate, and concentrated to give the crude aldehyde, 
which was used without further purification. 
Potassium bis(trimethylsilyl)amide (0.5 M in toluene, 34.8 ml, 17.38 mmol) was 
added to a mixture of methyltriphenylphosphonium bromide (8.07 g, 22.60 mmol) in 
toluene (87 mL) at 0 °C. After 45 min, a solution of the crude aldehyde dissolved in 
toluene (51 mL total with rinses) was added dropwise. After 30 min the solution was 
allowed to warm to 23 °C and stirred for 1 h. Quench with a saturated aqueous solution 
of ammonium chloride. The aqueous layer was extracted with ethyl acetate (3x150 mL). 
The combined organic layers were washed with brine, dried with sodium sulfate, 
concentrated, and the residue was purified by column chromatography (silica, 20% ethyl 
acetate – hexanes) to give 121 (6.49 g, 7.91 mmol, 91%). 1H NMR (600 MHz, CDCl3); δ 
(ppm): 8.05 – 8.01 (m, 1H), 7.55 – 7.50 (m, 1H), 7.46 – 7.42 (m, 1H), 7.41 – 7.37 (m, 
1H), 7.34 – 7.28 (m, 4H), 6.08 (ddd, J = 17.1, 10.5, 6.5 Hz, 1H), 5.74 (d, J = 2.6 Hz, 1H), 
5.55 – 5.41 (m, 2H), 5.28 (dt, J = 10.6, 1.1 Hz, 1H), 4.72 (d, J = 6.5 Hz, 1H), 4.67 (d, J = 
6.4 Hz, 1H), 4.64 – 4.56 (m, 2H), 4.50 – 4.41 (m, 1H), 4.40 – 4.32 (m, 1H), 4.11 – 4.04 
(m, 1H), 3.95 (s, 1H), 3.87 (dd, J = 9.2, 4.1 Hz, 1H), 3.65 – 3.47 (m, 2H), 3.38 – 3.29 (m, 
3H), 3.24 (dd, J = 9.3, 6.6 Hz, 1H), 2.86 (s, 1H), 1.92 (dt, J = 13.3, 6.5 Hz, 1H), 1.88 – 
1.81 (m, 1H), 1.78 (dt, J = 13.1, 6.4 Hz, 1H), 1.63 (dd, J = 14.4, 6.7 Hz, 1H), 0.93 – 0.85 



















Alcohol (S24). Lithium aluminum hydride (1.84 g, 48.56 mmol) was carefully added 
to a solution of 121 (6.49 g, 7.96 mmol) in dry ether (185 mL) at -78 °C. The reaction 
mixture stirred for 1 h and additional lithium aluminum hydride (0.91 g, 23.88 mmol) 
was added. At 2 h the solution was placed in a 0 °C ice bath. After 10 min, an additional 
1000 mL of ether was added. Water (2.75 mL) was added dropwise with vigorous 
stirring. After 5 min, 3 M aqueous NaOH (2.75 mL) was added. After an additional 5 
min, water (8.25 mL) was added and the mixture was allowed to stir at 23 °C for 2 h. The 
white precipitate was filtered off, washed with dichloromethane, concentrated, and the 
residue was purified by column chromatography (silica, 30% ethyl acetate – hexanes) to 
give S24  (6.26 g, 7.24 mmol, 91%).  1H NMR (600 MHz, CDCl3); δ (ppm): 7.47 (dd, J = 
7.4, 2.3 Hz, 2H), 7.41 – 7.35 (m, 3H), 7.32 (tdd, J = 11.2, 10.5, 5.7, 2.0 Hz, 6H), 6.07 
(ddd, J = 17.1, 10.5, 6.6 Hz, 1H), 5.71 (d, J = 2.6 Hz, 1H), 5.53 (s, 1H), 5.49 (ddd, J = 
18.0, 3.3, 1.9 Hz, 1H), 5.33 – 5.30 (m, 1H), 4.74 (s, 2H), 4.70 (d, J = 6.0 Hz, 2H), 4.63 – 
4.56 (m, 2H), 4.46 (q, J = 12.1 Hz, 2H), 4.14 – 4.06 (m, 1H), 3.94 (s, 2H), 3.84 (dd, J = 
9.1, 4.9 Hz, 1H), 3.67 (dd, J = 11.3, 6.4 Hz, 1H), 3.65 – 3.57 (m, 2H), 3.47 (dd, J = 11.3, 
6.7 Hz, 1H), 3.37 – 3.30 (m, 3H), 3.24 (dd, J = 9.3, 6.6 Hz, 1H), 2.83 (s, 1H), 2.22 (t, J = 
6.5 Hz, 1H), 1.98 (s, 2H), 1.85 – 1.79 (m, 1H), 1.79 – 1.67 (m, 3H), 1.61 (t, J = 6.0 Hz, 
1H), 1.47 (dd, J = 14.3, 7.3 Hz, 1H), 0.98 – 0.85 (m, 2H), 0.85 – 0.75 (m, 6H). 
 
Aldehyde (101). Dimethylsulfoxide (1.23 mL, 17.24 mmol) was added to a solution 



















min, a solution of S24 (5.11 g, 7.18 mmol) in dichloromethane (41 ml total with rinses) 
was added dropwise, and the mixture was stirred for 25 min. Triethylamine (3.61 ml, 
25.87 mmol) was added at -78 °C and, after 10 min the mixture was brought to 0 °C and 
stirred for 20 min. The reaction was quenched with 1 M aqueous HCl (100 mL). The 
aqueous layer was extracted with ethyl acetate (3x100 mL). The combined organic layers 
were washed with water and saturated aqueous sodium bicarbonate, dried with sodium 
sulfate, concentrated, and the residue was purified by column chromatography (silica, 
20% ethyl acetate – hexanes) to give aldehyde 101 (5.2 g, 6.68 mmol, 93%). 1H NMR 
(600 MHz, CDCl3); δ (ppm): 9.56 (s, 1H), 7.50 – 7.40 (m, 1H), 7.38 – 7.27 (m, 4H), 6.01 
(ddd, J = 17.2, 10.5, 6.8 Hz, 1H), 5.91 (s, 1H), 5.51 – 5.42 (m, 1H), 5.30 (ddd, J = 10.4, 
1.7, 0.9 Hz, 1H), 5.30 (ddd, J = 10.4, 1.7, 0.9 Hz, 1H), 4.66 (d, J = 6.4 Hz, 1H), 4.63 – 
4.55 (m, 1H), 4.53 – 4.40 (m, 2H), 4.12 – 4.02 (m, 1H), 3.93 (s, 1H), 3.68 – 3.55 (m, 2H), 
3.43 (t, J = 8.8 Hz, 1H), 3.35 (s, 2H), 3.26 (dd, J = 9.3, 6.4 Hz, 1H), 2.96 (d, J = 8.7 Hz, 
1H), 2.13 – 1.98 (m, 2H), 1.98 – 1.89 (m, 1H), 1.84 (d, J = 22.0 Hz, 1H), 1.80 – 1.70 (m, 
2H), 1.01 – 0.85 (m, 2H), 0.84 (d, J = 6.9 Hz, 2H), 0.65 (d, J = 6.5 Hz, 2H),  0.01 (s, 6H).  
 
Alcohol (133). A solution of iodide 100 (3.28 g, 4.28 mmol) in ether (16 mL) was 
added dropwise to freshly titrated t-BuLi (1.66 M in pentane, 5.20 mL, 8.58 mmol) in 
ether (30 mL) at -78 °C and stirred for 1 h 10 min. A solution of aldehyde 101 (3.04 g, 
















tBuLi, Et2O, -78 oC, 
1h 10 min















78 °C. After 1 h, the reaction mixture was placed in a 0 °C bath and continued to stir for 
and additional 6 min. The reaction was quenched with saturated aqueous ammonium 
chloride and diluted with dichloromethane. The aqueous layer was extracted with 
dichloromethane (4x150 mL). The combined organic layers were washed with a saturated 
aqueous solution of sodium bicarbonate, dried with sodium sulfate, concentrated, and the 
residue was purified by column chromatography (silica, 15% ethyl acetate – hexanes) to 
afford 133 (4.18 g, 3.12 mmol, 73%). 1H NMR (600 MHz, CDCl3); δ (ppm): 7.51 – 7.44 
(m, 1H), 7.38 – 7.28 (m, 4H), 6.11 (ddt, J = 17.1, 10.6, 6.5 Hz, 1H), 5.79 – 5.67 (m, 1H), 
5.54 – 5.44 (m, 1H), 5.32 – 5.25 (m, 1H), 4.85 (d, J = 12.1 Hz, 1H), 4.79 – 4.69 (m, 1H), 
4.67 (dd, J = 6.5, 2.9 Hz, 1H), 4.64 – 4.58 (m, 1H), 4.51 – 4.41 (m, 1H), 4.01 (dq, J = 
30.1, 7.1, 6.6 Hz, 1H), 3.87 – 3.78 (m, 1H), 3.67 – 3.57 (m, 1H), 3.57 – 3.47 (m, 1H), 
3.41 – 3.33 (m, 2H), 3.32 (s, 1H), 3.27 – 3.19 (m, 1H), 2.88 (s, 1H), 2.75 (d, J = 9.8 Hz, 
1H), 2.27 – 2.13 (m, 2H), 2.13 – 1.94 (m, 4H), 1.83 – 1.70 (m, 3H), 1.64 (dt, J = 14.0, 8.0 
Hz, 2H), 1.49 – 1.31 (m, 3H), 1.31 – 1.20 (m, 2H), 1.11 – 1.00 (m, 9H), 1.00 – 0.88 (m, 
6H), 0.80 (ddd, J = 18.2, 9.5, 6.9 Hz, 3H), 0.56 (q, J = 7.9 Hz, 3H), 0.01 (d, J = 6.1 Hz, 
6H).  
 
Diol (S25). Tetra-n-butylammonium fluoride (1.0 M in THF, 8.41 mL, 8.41 mmol) 
was added to a solution of 133 (5.4 g, 4.00 mmol) in THF (57 mL) at 23 °C. After 1 h 30 





























was extracted with ethyl acetate (4x200 mL). The combined organic layers were washed 
with brine, dried with sodium sulfate, concentrated, and the residue was purified by 
column chromatography (silica, 30% ethyl acetate – hexanes) to give the desired product 
S25 (4.03 g, 3.80 mmol, 95%). 1H NMR (600 MHz, CDCl3); δ (ppm): 7.50 – 7.43 (m, 
1H), 7.38 – 7.28 (m, 4H), 6.10 (dddd, J = 17.0, 10.6, 6.4, 4.7 Hz, 1H), 5.81 – 5.67 (m, 
1H), 5.58 – 5.42 (m, 1H), 5.36 – 5.25 (m, 1H), 4.82 – 4.70 (m, 2H), 4.66 (dd, J = 9.6, 6.5 
Hz, 1H), 4.63 – 4.56 (m, 1H), 4.50 – 4.41 (m, 1H), 4.10 – 3.99 (m, 2H), 3.93 (s, 2H), 3.71 
– 3.59 (m, 2H), 3.59 – 3.47 (m, 2H), 3.35 (d, J = 3.0 Hz, 2H), 3.29 (dd, J = 9.2, 7.4 Hz, 
1H), 3.23 (td, J = 8.9, 6.9 Hz, 1H), 2.89 (s, 1H), 2.36 (ddd, J = 28.2, 14.1, 4.9 Hz, 1H), 
2.28 – 2.11 (m, 2H), 2.07 (dd, J = 14.1, 7.6 Hz, 2H), 2.01 – 1.92 (m, 3H), 1.92 – 1.85 (m, 
2H), 1.84 – 1.71 (m, 4H), 1.71 – 1.55 (m, 5H), 1.54 – 1.41 (m, 2H), 1.38 – 1.25 (m, 4H), 
1.00 – 0.88 (m, 7H), 0.85 – 0.70 (m, 4H), 0.56 (q, J = 7.9 Hz, 4H), 0.00 (d, J = 1.0 Hz, 
6H). 
 
Keto Aldehyde (S26). Dess-Martin periodinane (7.76 g, 18.29 mmol) was added to a 
solution of S25 (4.85 g, 4.57 mmol) and pyridine (4.44 mL, 54.87 mmol) in 
dichloromethane (46 mL) at 23 °C. At 1 h, Dess-Martin periodinane (2.42 g, 2.28 mmol) 
was added to the reaction mixture and the reaction continued to stir for an additional 1 h. 
The reaction was quenched with a 1:1 mixture of saturated aqueous sodium bicarbonate – 






























was extracted with dichloromethane (3x200 mL). The combined organic layers was 
washed with water, 1M HCl (100 mL), water, a saturated aqueous solution of sodium 
bicarbonate, dried with sodium sulfate, concentrated, and the residue was purified by 
column chromatography (silica, 20% ethyl acetate – hexanes) to give S26 (4.39 g, 4.15 
mmol, 91%). 1H NMR (600 MHz, CDCl3); δ (ppm): 9.71 (t, J = 2.4 Hz, 1H), 7.50 – 7.41 
(m, 1H), 7.31 (td, J = 7.9, 6.0 Hz, 4H), 6.15 (ddd, J = 17.0, 10.5, 6.2 Hz, 1H), 5.77 (d, J = 
4.6 Hz, 1H), 5.48 (s, 1H), 5.34 – 5.23 (m, 2H), 4.78 (d, J = 1.8 Hz, 1H), 4.72 – 4.62 (m, 
2H), 4.55 (d, J = 2.5 Hz, 1H), 4.43 (s, 1H), 4.38 (ddt, J = 13.2, 7.6, 4.2 Hz, 1H), 4.11 – 
4.03 (m, 1H), 3.88 (s, 1H), 3.80 (dd, J = 9.3, 3.9 Hz, 1H), 3.65 (td, J = 9.6, 7.2 Hz, 1H), 
3.53 (td, J = 9.6, 7.3 Hz, 1H), 3.44 (t, J = 9.0 Hz, 1H), 3.32 (s, 2H), 3.20 (dd, J = 9.3, 6.7 
Hz, 1H), 3.06 (s, 1H), 2.59 – 2.30 (m, 3H), 2.23 – 2.04 (m, 3H), 2.03 – 1.84 (m, 4H), 1.83 
– 1.69 (m, 4H), 1.64 (d, J = 10.1 Hz, 2H), 1.62 – 1.40 (m, 6H), 1.28 (s, 4H), 0.93 (q, J = 
7.5, 7.0 Hz, 7H), 0.80 (d, J = 6.8 Hz, 2H), 0.65 (d, J = 5.7 Hz, 2H), 0.56 (q, J = 7.9 Hz, 
4H), 0.02 (s, 6H). 
 
Allylic Alcohol (134). Vinylmagnesium bromide (0.77 M in THF, 27.0 mL, 20.77 
mmol) was added to a solution of S26 (4.39 g, 4.15 mmol) in THF (32 mL) at -78 °C. 
After 5 min, the solution was placed in a -30 °C dry ice - acetone bath and was warmed 
to - 20 °C over 1 h 25 min. The reaction mixture was quenched with a saturated aqueous 































extracted with dichloromethane (4x100 mL). The combined organic layers were washed 
with a saturated aqueous solution of sodium bicarbonate, dried with sodium sulfate, 
concentrated, and the residue was purified by column chromatography (silica, 20% ethyl 
acetate – hexanes) to give the desired product 134 (4.20 g, 3.86 mmol, 93%). 1H NMR 
(600 MHz, CDCl3); δ (ppm): 7.47 – 7.42 (m, 1H), 7.31 (td, J = 8.0, 6.0 Hz, 4H), 6.15 
(dddd, J = 17.0, 10.6, 6.2, 1.5 Hz, 1H), 5.92 – 5.79 (m, 1H), 5.77 (d, J = 4.4 Hz, 1H), 
5.53 – 5.45 (m, 1H), 5.34 – 5.26 (m, 1H), 5.20 (ddt, J = 17.2, 5.2, 1.7 Hz, 1H), 4.99 (ddt, 
J = 10.5, 6.0, 1.6 Hz, 1H), 4.75 – 4.70 (m, 1H), 4.70 – 4.62 (m, 1H), 4.55 (dd, J = 2.3, 1.1 
Hz, 1H), 4.43 (s, 1H), 4.15 (d, J = 10.4 Hz, 1H), 4.12 – 3.99 (m, 2H), 3.88 (d, J = 8.1 Hz, 
1H), 3.79 – 3.71 (m, 5H), 3.65 (td, J = 9.6, 7.2 Hz, 1H), 3.53 (td, J = 9.5, 7.0 Hz, 1H), 
3.44 (td, J = 9.0, 1.9 Hz, 1H), 3.39 – 3.27 (m, 3H), 3.20 (dd, J = 9.3, 6.8 Hz, 1H), 3.10 – 
3.00 (m, 1H), 2.56 – 2.28 (m, 1H), 2.27 – 2.06 (m, 1H), 2.27 – 2.03 (m, 3H), 2.02 – 1.89 
(m, 3H), 1.89 – 1.68 (m, 10H), 1.56 (m, 7H), 1.37 – 1.22 (m, 3H), 1.02 – 0.87 (m, 6H), 




Macrocycle (135). Hoveyda-Grubbs catalyst, 2nd generation (0.166 g, 0.264 mmol) 
was added to a solution of 134 (3.21 g, 0.2.64 mmol) in degassed dichloromethane (528 
mL). The reaction was then refluxed at 44 °C for 21 h. After cooling to 23 °C, the 






























column chromatography (silica, 10% ethyl acetate – dichloromethane) to give desired 
macrocycle 135 (2.00 g, 1.66 mmol, 63%). 1H NMR (600 MHz, CDCl3); δ (ppm): 7.54 – 
7.49 (m, 1H), 7.39 – 7.28 (m, 5H), 6.08 – 5.87 (m, 2H), 5.72 (d, J = 4.7 Hz, 1H), 4.91 (s, 
1H), 4.82 – 4.76 (m, 1H), 4.76 – 4.66 (m, 2H), 4.61 – 4.54 (m, 2H), 4.49 (d, J = 6.7 Hz, 
1H), 4.40 (d, J = 9.2 Hz, 2H), 4.24 – 4.14 (m, 1H), 4.02 – 3.94 (m, 1H), 3.92 – 3.85 (m, 
2H), 3.92 – 3.85 (m, 2H), 3.33 (d, J = 1.2 Hz, 2H), 3.27 (dd, J = 9.0, 6.5 Hz, 1H), 3.12 
(ddd, J = 13.4, 9.2, 7.0 Hz, 1H), 3.08 – 2.98 (m, 1H), 2.42 (s, 1H), 2.27 – 2.07 (m, 4H), 
2.07 – 1.87 (m, 4H), 1.87 – 1.74 (m, 3H), 1.74 – 1.56 (m, 7H), 1.47 (qd, J = 13.4, 12.7, 
4.6 Hz, 2H), 1.40 – 1.30 (m, 2H), 1.27 (d, J = 4.2 Hz, 3H), 0.94 (td, J = 7.9, 2.6 Hz, 8H), 
0.70 (dd, J = 10.0, 6.7 Hz, 2H), 0.64 (dd, J = 17.7, 6.1 Hz, 2H), 0.56 (qd, J = 7.9, 3.8 Hz, 




Enone (S27). Dess-Martin periodinane (2.14 g, 5.05 mmol) was added to a solution 
of 135 (2.0 g, 1.68 mmol) and pyridine (1.3 mL, 15.15 mmol) in dichloromethane (84 
mL) at 23 °C. After 2 h 30 min, the mixture was diluted with dichloromethane and a 1:1 
mixture of saturated aqueous sodium bicarbonate – saturated aqueous sodium thiosulfate 
was added to the reaction flask. The aqueous layer was extracted with dichloromethane 
(3x100 mL). The combined organic layers were washed with water, 1M HCl (100 mL), 
water, a saturated aqueous solution of sodium bicarbonate, dried with sodium sulfate, 






























acetate – hexanes) to give the desired product S27 (1.67 g, 1.41 mmol, 84%). 1H NMR 
(600 MHz, CDCl3); δ (ppm): 7.51 – 7.41 (m, 2H), 7.40 – 7.27 (m, 6H), 6.97 (dd, J = 
16.0, 4.4 Hz, 1H), 6.48 (dd, J = 16.1, 1.8 Hz, 1H), 5.85 (s, 1H), 4.99 – 4.91 (m, 1H), 4.74 
(dd, J = 29.8, 7.1 Hz, 4H), 4.59 (d, J = 1.4 Hz, 2H), 4.41 (s, 3H), 3.90 (s, 2H), 3.84 (s, 
1H), 3.73 – 3.60 (m, 2H), 3.35 (s, 3H), 3.28 (dd, J = 9.3, 6.7 Hz, 1H), 3.13 (dd, J = 9.3, 
7.0 Hz, 1H), 2.96 (s, 1H), 2.86 (dd, J = 15.6, 4.0 Hz, 1H), 2.70 (dd, J = 15.7, 9.1 Hz, 1H), 
2.41 (s, 1H), 2.29 (ddd, J = 16.7, 9.5, 6.0 Hz, 1H), 2.21 – 2.08 (m, 4H), 2.05 (td, J = 12.0, 
8.3 Hz, 2H), 2.00 – 1.86 (m, 5H), 1.86 – 1.77 (m, 2H), 1.77 – 1.68 (m, 4H), 1.54 – 1.46 
(m, 2H), 1.41 (td, J = 13.0, 4.2 Hz, 1H), 1.24 (s, 3H), 1.22 – 1.13 (m, 1H), 0.94 (t, J = 7.9 
Hz, 10H), 0.70 (dd, J = 12.8, 6.4 Hz, 5H), 0.56 (q, J = 7.9 Hz, 6H), 0.03 (s, 6H). 
 
 
Diketone (S28). Methyl lithium (1.55 M in ether, 6.18 mL, 9.57 mmol) was added to 
copper cyanide (0.883 g, 9.85 mmol) in THF (12 mL) at -20 °C. The solution was then 
placed in a 0 °C ice bath and stirred for 10 min. The clear solution was cooled to -78 °C 
and freshly distilled boron trifluoride diethyl etherate (1.15 mL, 9.29 mmol) was added 
dropwise to the reaction mixture. After 5 min, a solution of S27 (1.67 g, 1.41 mmol) in 
THF (15 mL total with rinses) was added dropwise to the yellow solution and the mixture 
was stirred at -78 °C. After 1 h 45 min, a 9:1 mixture of saturated aqueous ammonium 
chloride: ammonia was added to the solution at -78 °C. The ice bath was removed and the 































acetate. The aqueous layer was extracted with ethyl acetate (3x100 mL). The combined 
organic layers were washed with a 9:1 mixture of saturated aqueous ammonium chloride: 
ammonia (100 mL), brine, dried with sodium sulfate, concentrated, and the residue was 
purified by column chromatography (silica, 25% ethyl acetate - hexanes) to give S28  
(1.40 g, 1.17 mmol, 83%). 1H NMR (600 MHz, CDCl3); δ (ppm): 7.42 – 7.36 (m, 2H), 
7.36 – 7.27 (m, 6H), 5.81 (s, 1H), 5.44 (s, 1H), 4.98 (s, 1H), 4.77 – 4.65 (m, 3H), 4.63 – 
4.53 (m, 2H), 4.42 (s, 2H), 4.27 (s, 1H), 4.02 (s, 1H), 3.93 (s, 2H), 3.71 – 3.52 (m, 4H), 
3.48 (d, J = 7.5 Hz, 1H), 3.41 – 3.25 (m, 5H), 3.25 – 3.14 (m, 2H), 2.70 (dd, J = 18.1, 3.5 
Hz, 1H), 2.64 – 2.52 (m, 3H), 2.51 – 2.39 (m, 2H), 2.27 (ddt, J = 17.3, 12.7, 6.0 Hz, 1H), 
2.19 – 2.09 (m, 4H), 2.08 – 1.69 (m, 15H), 1.54 (d, J = 0.6 Hz, 7H), 1.42 – 1.25 (m, 7H), 
1.12 (d, J = 6.8 Hz, 3H), 1.00 – 0.89 (m, 11H), 0.81 (dd, J = 10.9, 6.5 Hz, 3H), 0.73 (d, J 
= 6.9 Hz, 2H), 0.56 (q, J = 7.9 Hz, 6H), 0.02 (d, J = 9.5 Hz, 6H). 
 
 
Alcohol (S29). 2,3-dichloro-5,6-dicyano-p-benzoquinone (1.97 g, 8.73 mmol), was 
added to a solution of diketone S28 (2.1 g, 1.74 mmol) in dichloromethane (87 mL) and 
water (9 mL) at 23 °C and stirred vigorously for 1.5 h. The reaction mixture was diluted 
with dichloromethane and quenched with a 1:1 mixture of saturated aqueous sodium 
bicarbonate and saturated aqueous sodium thiosulfate. The aqueous layer was extracted 
with dichloromethane (3x100 mL). The combined organic layers were dried with sodium 































40% ethyl acetate – hexanes) to deliver S29 (0.640 g, 0.574 mmol, 33%) and recovered 
starting material (S28) (1.36 g, 1.11 mmol, 64%). The recovered starting material (S28) 
was re-submitted to the reaction conditions described above (the reaction time for 
additional reactions was increased to 2 h). Four recycles of the recovered starting material 
(S28) were performed. The total amount of product isolated from the 5 reactions was 1.55 
g, 1.39 mmol, 80%. 1H NMR (600 MHz, CDCl3); δ (ppm): 7.42 – 7.27 (m, 3H), 5.82 (s, 
1H), 5.45 (s, 1H), 4.99 (s, 1H), 4.77 – 4.66 (m, 2H), 4.60 (q, J = 6.5 Hz, 2H), 3.94 (s, 
1H), 3.69 – 3.53 (m, 3H), 3.36 (s, 3H), 3.23 (d, J = 8.7 Hz, 1H), 2.70 (dd, J = 18.0, 3.6 
Hz, 1H), 2.58 (ddd, J = 19.7, 11.9, 5.0 Hz, 2H), 2.52 – 2.37 (m, 2H), 2.22 – 2.07 (m, 3H), 
2.01 – 1.90 (m, 2H), 1.87 (td, J = 15.8, 15.3, 4.2 Hz, 1H), 1.85 – 1.66 (m, 5H), 1.45 – 
1.28 (m, 4H), 1.12 (d, J = 6.8 Hz, 2H), 0.97 – 0.86 (m, 8H), 0.82 (d, J = 6.2 Hz, 2H), 0.71 
(d, J = 6.9 Hz, 2H), 0.56 (q, J = 7.9 Hz, 4H), 0.03 (s, 6H). 
 
 
Tosylate (S30). p-Toluenesulfonic anhydride (1.1 g, 3.31 mmol) was added to a 
solution of pyridine (2.90 mL, 33.37 mmol) and alcohol S29 (1.50 g, 1.34 mmol) in 
dichloromethane (80 mL) at 23 °C for 20 min. The reaction mixture was diluted with 
dichloromethane and water. The aqueous layer was extracted with dichloromethane 
(4x100 mL). The combined organic layers were washed with 1 M HCl (100 mL), water, 
and a saturated aqueous solution of sodium bicarbonate, dried with sodium sulfate, 































acetate – hexanes) to deliver S30 (1.49, 1.18 mmol, 88%). 1H NMR (500 MHz, CDCl3); δ 
(ppm): 7.80 – 7.69 (m, 3H), 7.40 – 7.30 (m, 9H), 5.80 (s, 1H), 5.41 (s, 1H), 4.98 (s, 1H), 
4.71 (d, J = 16.1 Hz, 4H), 4.64 – 4.55 (m, 2H), 4.27 (s, 1H), 3.93 (s, 2H), 3.77 (ddd, J = 
29.7, 9.5, 7.0 Hz, 2H), 3.71 – 3.51 (m, 5H), 3.36 (s, 4H), 3.20 (d, J = 9.0 Hz, 1H), 2.70 
(dd, J = 18.1, 3.5 Hz, 1H), 2.65 – 2.51 (m, 3H), 2.51 – 2.39 (m, 7H), 2.22 – 2.09 (m, 3H), 
2.09 – 1.95 (m, 5H), 1.96 – 1.84 (m, 2H), 1.84 – 1.65 (m, 5H), 1.55 (s, 9H), 1.35 – 1.22 
(m, 8H), 1.12 (d, J = 6.8 Hz, 3H), 0.94 (t, J = 7.9 Hz, 17H), 0.75 (dd, J = 22.5, 6.5 Hz, 
3H), 0.68 (d, J = 6.8 Hz, 3H), 0.57 (q, J = 7.9 Hz, 9H), 0.11 (s, 6H). 
 
 
Azide (137). Sodium azide (4.71 g, 72.39 mmol) was added to a solution of S30 (1.49 
g, 1.17 mmol) in DMF (90 mL) and the reaction mixture was heated at 80 °C. After 1 h, 
the solution was cooled to 23 °C and diluted with water. The aqueous layer was extracted 
with ethyl acetate (5x75 mL). The combined organic phases were dried with sodium 
sulfate, concentrated, and dried under vacuum. The residue was purified by column 
chromatography (15% ethyl acetate - hexanes) to give the desired product 137 (1.21 g, 
1.09 mmol, 93%). 1H NMR (500 MHz, CDCl3); δ (ppm): 7.42 – 7.28 (m, 3H), 5.81 (s, 
1H), 5.45 (s, 1H), 4.98 (s, 1H), 4.79 – 4.66 (m, 2H), 4.60 (q, J = 6.4 Hz, 2H), 4.27 (q, J = 
5.1 Hz, 1H), 4.02 (ddt, J = 11.6, 8.3, 4.3 Hz, 1H), 3.70 – 3.54 (m, 3H), 3.36 (s, 2H), 3.23 
(d, J = 9.0 Hz, 1H), 3.09 (dd, J = 12.1, 7.1 Hz, 1H), 3.01 – 2.90 (m, 1H), 2.76 – 2.67 (m, 






























1.56 (s, 16H), 1.44 – 1.28 (m, 3H), 1.28 – 1.23 (m, 3H), 1.12 (d, J = 6.8 Hz, 2H), 0.94 (t, 
J = 7.9 Hz, 7H), 0.82 (d, J = 6.5 Hz, 2H), 0.74 (d, J = 6.8 Hz, 2H), 0.56 (q, J = 7.9 Hz, 
4H), 0.03 (s, 6H). 
 
 
Azido Triol (98). A 0.328 M solution of lithium tetrafluoroborate in 4% aq. 
isopropanol is prepared by dissolving lithium tetrafluoroborate (13.0 g, 139.0 mmol), in 
isopropanol (406 mL) and water (17.7 mL). Azide 137 (1.37 g, 1.21 mmol) is dissolved 
in a 4% aq. isopropanol – lithium tetrafluoroborate solution (0.328 M, 370 mL, 121 
mmol) under argon and the mixture is heated at 90 °C in a sealed vessel. After 3 h, the 
solution was cooled to 23 °C, and carefully quenched with a saturated aqueous solution 
of sodium bicarbonate. The reaction mixture is diluted with ethyl acetate and additional 
water. The aqueous layer is extracted with ethyl acetate (5x250 mL). The combined 
organic layers were dried with sodium sulfate, concentrated, and the residue was purified 
by column chromatography (silica, 60% then 100% ethyl acetate - hexanes) to give the 
desired product 98 (0.359 g, 0.484 mmol, 40%) and partially ketalized and partially 
deprotected intermediates. These intermediates were re-submitted to the reaction 
conditions listed above (3 recycles of the intermediates were performed). A total of 0.571 
g, 0.770 mmol, 64% of azido triol 98 was isolated from the 4 reactions. 1H NMR (600 
MHz, CDCl3); δ (ppm): 5.26 – 5.15 (m, 1H), 4.79 (d, J = 27.0 Hz, 2H), 4.35 (dd, J = 4.4, 





























J = 7.2, 5.4 Hz, 2H), 2.90 (d, J = 11.7 Hz, 1H), 2.58 – 2.31 (m, 3H), 2.28 (dd, J = 12.6, 
4.0 Hz, 1H), 2.22 – 1.47 (m, 28H), 1.42 – 1.17 (m, 8H), 0.97 (d, J = 6.8 Hz, 3H), 0.89 (d, 
J = 6.9 Hz, 3H), 0.79 (d, J = 6.9 Hz, 3H) 
 
PnTX-OH (141). Triphenylphosphine (9.0 mg, 33.7 µmol) was added to a solution of 
azido triol 98 (10.0 mg, 13.5 µmol) in THF−H2O (3:1, 4.5 mL). The reaction vessel was 
capped and heated at 55 °C for 36 h. After cooling, the reaction mixture was concentrated 
under reduced pressure. The crude material was dissolved in 5 mL of distilled toluene 
and concentrated and this was repeated three times. The crude residue was used 
immediately to the next step without further purification.  
The crude residue was dissolved in 14 mL of a mixture prepared by dissolving 2,4,6-
trimethylbenzoic acid (91.0 mg, 0.553 mmol) and triethylamine (77.0 µL, 0.553 mmol) in 
19 mL of freshly distilled toluene. The solution was heated at 85 °C for 60 h. After 
cooling, the solution was directly applied on a silica column (silica, 70% ethyl acetate – 
hexanes, 1% triethylamine) to afford PnTX-OH 141 (8.0 mg, 11.5 µmol, 85%).  1H NMR 
(600 MHz, CDCl3) δ (ppm): 5.14 (s, 1H), 4.76 (d, J = 6.2 Hz, 2H), 4.46 (dd, J = 5.0, 2.0 
Hz, 1H), 4.13 – 3.95 (m, 6H), 3.85 (dd, J = 11.6, 4.9 Hz, 2H), 3.78 (dd, J = 11.1, 4.8 Hz, 
1H), 3.72 (dd, J = 4.2, 2.1 Hz, 1H), 3.61 (dd, J = 11.3, 1.4 Hz, 1H), 3.29 – 3.25 (m, 2H), 



























6.7 Hz, 3H), 1.02 (d, J = 6.7 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H). MS-ESI (m/z): [M+H]+ 
calcd for C41H64NO8, 698.46; found, 698.51.  
 
PnTX-Fluorine (144). p-Toluenesulfonic anhydride (19.0 mg, 57.4 µmol) was added 
to a solution of PnTX-OH 141 (4.0 mg, 5.74 µmol) in CH2Cl2 (600 µL) at 23 °C . The 
reaction mixture was stirred at 23 °C for 12 h. The resulting mixture was concentrated 
under reduced pressure and used immediately to the next step without further 
purification.  
Tetrabutylammonium fluoride (1M in THF, 58.0 µL, 57.4 µmol) was added to a 
solution of crude tosylate dissolved in freshly distilled acetonitrile (600 µL) in a 
microwave vial and capped. The reaction mixture was heated by microwave irradiation at 
120 °C for 30 min. The mixture was diluted with ethyl acetate (4 mL) and water (4 mL). 
The aqueous later was extracted with ethyl acetate (3x5 mL). The combined organic 
layers were washed with brine, dried over sodium sulfate, concentrated and the residue 
was purified by column chromatography (silica, 50% ethyl acetate – hexanes) to give 
fluoride 144 (2.27 mg, 3.85 µmol, 67%). 1H NMR (600 MHz, CDCl3) δ (ppm): 5.22 (s, 
1H), 4.79 – 4.72 (m, 3H), 4.67 (s, 1H), 4.45 (d, J = 5.1 Hz, 2H), 4.15 – 4.01 (m, 3H), 3.87 
(dd, J = 11.5, 5.0 Hz, 2H), 3.78 (d, J = 11.3 Hz, 2H), 3.69 (d, J = 11.0 Hz, 1H), 3.67 – 
3.58 (m, 3H), 3.34 – 3.25 (m, 2H), 2.96 (t, J = 14.4 Hz, 2H), 2.54 – 1.82 (m, 26H), 1.80 – 
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6.7 Hz, 3H), 0.93 (d, J = 6.6 Hz, 3H). 19F NMR (564 MHz, CDCl3) δ (ppm): -214.69 (s, 
1F)  MS-ESI (m/z): [M+H]+ calcd for C41H63FNO7, 700.45; found, 700.42.  
 
Azido aldehyde (148). To a solution of azido triol 98 (33.0 mg, 44.5 µmol) in 
dichloromethane (4.5 mL) was added a solution of 2,2,6,6-tetramethylpiperidine-1-oxyl 
(1.0 mg, 6.4 µmol) and iodobenzene diacetate (0.112 g, 0.347 mmol) in dichloromethane 
(3.0 mL). The solution was allowed to stir at 23 °C for 2 h and 15 min. The solution was 
directly applied on a silica column (silica, 60% ethyl acetate – hexanes) to afford 
aldehyde 148 (23.0 mg, 31.4 µmol, 70%). 1H NMR (600 MHz, CDCl3) δ (ppm): 9.43 (s, 
1H), 6.26 (d, J = 2.0 Hz, 1H), 4.80 (d, J = 29.5 Hz, 2H), 4.12 – 3.99 (m, 4H), 3.58 (s, 
1H), 3.16 (d, J = 7.3 Hz, 2H), 3.10 (d, J = 11.4 Hz, 1H), 2.60 – 2.42 (m, 4H), 2.27 (dd, J 
= 13.0, 4.0 Hz, 2H), 2.23 – 2.06 (m, 6H), 2.00 – 1.47 (m, 22H), 1.40 (dd, J = 14.2, 11.7 
Hz, 2H), 1.28 – 1.23 (m, 6H), 1.00 (d, J = 6.8 Hz, 4H), 0.85 (d, J = 6.9 Hz, 3H), 0.79 (d, 
J = 7.0 Hz, 3H). MS-ESI (m/z): [M+Na]+ calcd for C41H61N3NaO9, 762.43; found, 
762.35.  
 
Azido alkyne (156). Potassium carbonate (21.5 mg, 0.155 mmol) was added to a solution 























































µmol) in dry methanol (6.9 mL) at room temperature and the reaction mixture was stirred 
for 18 h. The resulting solution was diluted with dichloromethane and quenched with 
saturated aqueous ammonium chloride. The layers were separated and the aqueous layer 
was extracted with dichloromethane (3x10 mL), dried over sodium sulfate and 
concentrated. The residue was purified by column chromatography (silica, 60% ethyl 
acetate – hexanes) to give alkyne 156 (13 mg, 18.4 µmol, 58%). 1H NMR (600 MHz, 
CDCl3) δ (ppm): 5.68 (d, J = 2.1 Hz, 1H), 4.89 – 4.72 (m, 2H), 4.33 (dd, J = 4.3, 2.0 Hz, 
1H), 4.12 – 4.00 (m, 2H), 3.91 (dd, J = 11.5, 4.4 Hz, 1H), 3.62 – 3.50 (m, 1H), 3.19 (d, J 
= 7.1 Hz, 2H), 2.91 (s, 1H), 2.58 – 2.41 (m, 2H), 2.34 – 2.06 (m, 7H), 2.01 – 1.64 (m, 
18H), 1.41 – 1.30 (m, 3H), 1.28 – 1.22 (m, 5H), 0.98 (d, J = 6.8 Hz, 3H), 0.91 (d, J = 6.8 
Hz, 2H), 0.79 (d, J = 6.8 Hz, 3H). MS-ESI (m/z): [M+Na]+ calcd for C42H61N3NaO8, 
758.44; found, 758.41.  
 
PnTX-yne (143). Triphenylphosphine (11.8 mg, 45.2 µmol) was added to a solution 
of azido alkyne 156 (13.3 mg, 18.1 µmol) in THF−H2O (3:1, 6.0 mL). The reaction 
vessel was capped and heated at 55 °C for 36 h. After cooling, the reaction mixture was 
concentrated under reduced pressure. The crude material was dissolved in 5 mL of 
distilled toluene and concentrated and this was repeated three times. The crude residue 












    55 oC, 36 h
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The crude residue was dissolved in 13.5 mL of a mixture prepared by dissolving 
2,4,6-trimethylbenzoic acid (0.132 g, 0.804 mmol) and triethylamine (112 µL, 0.804 
mmol) in 20 mL of freshly distilled toluene. The solution was heated at 85 °C for 60 h. 
After cooling, the solution was directly applied on a silica column (silica, 70% ethyl 
acetate – hexanes, 1% triethylamine) to afford PnTX-yne 143 (6.0 mg, 8.70 µmol, 48%).  
1H NMR (600 MHz, CD3OD) δ (ppm): 5.64 (s, 1H), 4.75 (d, J = 15.6 Hz, 2H), 4.44 (dd, 
J = 4.9, 1.9 Hz, 1H), 4.17 – 4.09 (m, 2H), 3.86 (ddd, J = 14.5, 11.3, 4.8 Hz, 2H), 3.69 
(dd, J = 4.4, 1.9 Hz, 1H), 3.52 (dd, J = 11.5, 1.4 Hz, 1H), 3.39 (d, J = 11.7 Hz, 1H), 3.08 
(dd, J = 11.9, 3.5 Hz, 1H), 2.64 (q, J = 7.2 Hz, 3H), 2.45 – 1.70 (m, 18H), 1.66 – 1.33 (m, 
12H), 1.21 (d, J = 6.7 Hz, 4H), 1.08 (t, J = 7.2 Hz, 5H), 1.01 (d, J = 6.7 Hz, 3H), 0.97 
(dd, J = 6.6, 3.4 Hz, 3H). MS-ESI (m/z): [M+H]+ calcd for C42H62NO7, 692.44; found, 
692.41.  
 
PnTX-2-fluoropyridine (145). Azide 157 was prepared according to a described 
synthetic procedure. Alkyne 143 (3.0 mg, 4.34 µmol) was dissolved in 300 µL of a 
mixture prepared by dissolving azide 157 (90 mg, 0.318 mmol), sodium ascorbate (23.0 
mg, 0.116 mmol) and copper (II) sulfate (9.0 mg, 58.0 µmol) in tert-butanol−water (4:1, 
30 mL) at 23 °C. The reaction mixture was stirred at 23 °C for 12 h. The resulting 
solution was diluted with ethyl acetate and water. The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3x10 mL), dried over sodium sulfate and 
143
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concentrated. The residue was purified by column chromatography (silica, 1% methanol 
– ethyl acetate, 2% triethylamine) to give triazole 145 (3.46 mg, 3.60 µmol, 84%). 1H 
NMR (600 MHz, CDCl3) δ (ppm): 7.76 (dq, J = 2.8, 1.4 Hz, 1H), 7.61 – 7.59 (s, 1H), 
7.31 (d, J = 9.2 Hz, 1H), 7.10 (dd, J = 7.9, 4.9 Hz, 1H), 5.96 (s, 1H), 4.77 (d, J = 6.1 Hz, 
2H), 4.59 (dd, J = 5.1, 1.9 Hz, 1H), 4.52 (t, J = 5.1 Hz, 2H), 4.19 (s, 2H), 4.11 (d, J = 7.1 
Hz, 2H), 3.93 (dd, J = 11.6, 4.9 Hz, 1H), 3.88 (t, J = 5.1 Hz, 2H), 3.81 (d, J = 13.0 Hz, 
2H), 3.70 (dd, J = 5.9, 3.1 Hz, 2H), 3.63 (dd, J = 8.5, 3.9 Hz, 3H), 3.42 (d, J = 11.6 Hz, 
1H), 3.08 – 2.97 (m, 1H), 2.46 – 2.25 (m, 6H), 2.26 – 2.10 (m, 7H), 2.11 – 1.94 (m, 6H), 
1.88 (ddt, J = 19.6, 14.0, 6.7 Hz, 5H), 1.79 – 1.58 (m, 26H), 1.56 – 1.46 (m, 6H), 1.23 (s, 
3H), 1.18 (d, J = 6.7 Hz, 3H), 1.15 – 1.12 (m, 1H), 1.03 (d, J = 6.7 Hz, 3H), 0.91 (d, J = 
6.6 Hz, 3H). MS-ESI (m/z): [M+H]+ calcd for C53H77FN5O10, 962.57; found, 962.68.  
 
Azido methyl ester (159). Sodium chlorite (12.0 mg, 0.135 mmol) was added to a 
solution of aldehyde 148 (10.0 mg, 13.5 µmol), sodium phosphate dibasic (18.0 mg, 
0.150 mmol) and 2-methoxypropene (0.54 mL, 5.66 mmol) in tert-butanol−water (4:1, 
2.2 mL) at 0 °C. This solution was stirred at 0 °C for 10 min and warmed to 23 °C for 50 
min. The reaction mixture was diluted with ethyl acetate and water. The layers were 
separated and the aqueous layer was extracted with ethyl acetate (4x10 mL), dried over 
sodium sulfate and concentrated. The crude residue was used immediately to the next 
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Trimethylsilyldiazomethane (1.13 M in hexane, 0.170 mL, 0.195 mmol) was added 
dropwise to a solution of the crude residue in a mixture of dichloromethane (2.3 mL) and 
methanol (0.6 mL) at 23 °C and stirred for 10 min. The mixture was concentrated under 
reduced pressure and the residue was purified by column chromatography (silica, 50% 
ethyl acetate – hexanes) to afford methyl ester 159 (8.5 mg, 11.6 µmol, 86%). 1H NMR 
(600 MHz, CDCl3) δ (ppm): 6.44 (q, J = 1.9 Hz, 1H), 4.86 – 4.74 (m, 2H), 4.43 (dd, J = 
4.4, 2.0 Hz, 1H), 4.10 (s, 1H), 3.96 (dd, J = 11.7, 4.4 Hz, 1H), 3.75 (s, 3H), 3.58 (s, 1H), 
3.18 (d, J = 7.3 Hz, 2H), 2.97 (d, J = 11.6 Hz, 1H), 2.51 (dq, J = 14.2, 7.1 Hz, 3H), 2.32 – 
2.16 (m, 4H), 2.15 – 1.96 (m, 8H), 1.95 – 1.81 (m, 8H), 1.75 – 1.65 (m, 7H), 1.46 – 1.35 
(m, 3H), 1.26 (s, 4H), 0.99 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 6.9 Hz, 3H), 0.80 (d, J = 6.9 
Hz, 3H). MS-ESI (m/z): [M+Na]+ calcd for C42H63N3NaO10, 792.44; found, 792.49.  
 
 
PnTX methyl ester (142). Tris(4-(trifluoromethyl)phenyl)phosphine (25.0 mg, 52.9 
µmol) was added to a solution of azido methyl ester 159 (16.0 mg, 21.1 µmol) in 
THF−H2O (3:1, 7.0 mL). The reaction vessel was capped and heated at 55 °C for 36 h. 
After cooling, the reaction mixture was concentrated under reduced pressure. The crude 
material was dissolved in 5 mL of distilled toluene and concentrated and this was 
repeated three times. The crude residue was used immediately to the next step without 
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2.




The crude residue was dissolved in 17 mL of a mixture prepared by dissolving 2,4,6-
trimethylbenzoic acid (0.142 g, 0.868 mmol) and triethylamine (121 µL, 0.868 mmol) in 
22 mL of freshly distilled toluene. The solution was heated at 85 °C for 60 h. After 
cooling, the solution was directly applied on a silica column (silica, 70% ethyl acetate – 
hexanes, 1% triethylamine) to afford PnTX methyl ester 142 (13.2 mg, 18.1 µmol, 86%).  
1H NMR (600 MHz, CDCl3) δ (ppm): 6.39 (s, 1H), 4.77 (d, J = 10.2 Hz, 2H), 4.54 (dd, J 
= 5.1, 2.0 Hz, 1H), 4.13 – 4.07 (m, 1H), 3.91 (dd, J = 11.4, 4.9 Hz, 1H), 3.75 (s, 4H), 
3.63 (d, J = 11.0 Hz, 1H), 3.33 (d, J = 15.3 Hz, 1H), 2.44 – 2.30 (m, 4H), 2.10 – 2.19  (m, 
7H), 2.08 – 1.91 (m, 5H), 1.91 – 1.84 (m, 4H), 1.77 – 1.60 (m, 12H), 1.51 (q, J = 14.9, 
13.8 Hz, 3H), 1.24 (d, J = 11.0 Hz, 4H), 1.18 (d, J = 6.7 Hz, 3H), 1.04 (d, J = 6.7 Hz, 
3H), 0.92 (d, J = 6.6 Hz, 3H). MS-ESI (m/z): [M+H]+ calcd for C42H64NO9, 726.46; 
found, 726.46.  
 
Alcohol (S33). t-BuLi (1.7 M solution in pentane, 2.85 mL, 4.85 mmol) was added 
dropwise to a solution of 3,5-diphenyl-1-bromobenzene (1.01 g, 4.85 mmol) in THF (40 
mL) at -20 °C. After 20 minutes a solution of S31 (0.165 g, 0.808 mmol), prepared from 
(2R,5S)-diethyl 2,5-dibromohexanedioate,83 in THF (10 mL) was added dropwise. The 
resulting solution was maintained at -20 °C for 1 h and then allowed to warm up to 23 °C 
and stirred for 16 h. The solution was quenched with saturated aqueous ammonium 
chloride and extracted with Et2O (4x50 mL). The combined organic extracts were dried 
















column chromatography (silica, 50% CH2Cl2 − hexane) affording alcohol S33 (0.691 g, 
0.654 mmol, 81%). 1H NMR (600 MHz, CDCl3) δ (ppm): 7.83 (d, J = 24.1 Hz, 2H), 7.82 
(d, J = 1.7 Hz, 2H), 7.74 (d, J = 1.7 Hz, 3H), 7.76 (d, J = 30.0 Hz, 2H), 7.65 – 7.57 (m, 
13H), 7.42 (ddd, J = 7.8, 6.9, 3.5 Hz, 11H), 7.37 – 7.31 (m, 6H), 4.98 (s, 2H), 3.74 (s, 
2H), 2.17 – 2.07 (m, 2H), 1.81 (dd, J = 7.9, 5.0 Hz, 2H). 
 
 
Ether (S34). NaH (60% in mineral oil, 0.100 g, 3.50 mmol) was added to a solution 
of S33 (0.420 g, 0.584 mmol) in THF (5.8 mL) and DMF (1.5 mL) at 0 °C. After 10 min 
iodoethane (0.60 mL, 11.68 mmol) was added dropwise and the resulting solution was 
allowed to warm to 23 °C and stirred for 12 h. The reaction mixture was diluted with 
CH2Cl2 (50 mL) and water (100 mL). The organic phase was separated and the aqueous 
layer was extracted with CH2Cl2 (3x50 mL). The combined organic extracts were dried 
over sodium sulfate and then evaporated under reduced pressure. The crude material was 
purified by column chromatography (silica, 30% CH2Cl2 − hexane) affording S34 (0.405 
g, 0.362 mmol, 62%). 1H NMR (600 MHz, CDCl3) δ (ppm): 7.74 (s, 6H), 7.71 (t, J = 1.6 
Hz, 2H), 7.65 (d, J = 1.6 Hz, 4H), 7.61 – 7.56 (m, 17H), 7.38 (td, J = 7.2, 6.4, 1.2 Hz, 
9H), 7.36 – 7.28 (m, 17H), 4.35 (s, 2H), 3.36 (p, J = 7.2 Hz, 2H), 3.13 (p, J = 7.1 Hz, 




















































Ylide (180). Methyl triflate (27.0 µL, 0.242 mmol) was added to a solution S34 (90.0 
mg, 80.9 µmol) and proton sponge (35.0 mg, 80.9 µmol) in CH2Cl2 (1.0 mL) at 23 °C. 
The resulting solution was stirred at 23 °C for 12 h. The resulting reaction mixture was 
concentrated and directly purified by column chromatography (30% ethyl acetate – 
hexanes) to afford 180 (89.0 mg, 69.6 µmol, 86%). 1H NMR (600 MHz, CDCl3) δ (ppm): 
7.82 (s, 1H), 7.77 (t, J = 1.5 Hz, 1H), 7.71 (s, 2H), 7.66 – 7.55 (m, 7H), 7.55 – 7.48 (m, 
5H), 7.47 – 7.31 (m, 24H), 7.31 – 7.21 (m, 30H), 6.92 (dd, J = 7.4, 1.2 Hz, 1H), 5.94 (t, J 
= 8.6 Hz, 1H), 3.64 (s, 1H), 3.25 (dd, J = 10.3, 6.0 Hz, 2H), 3.11 (t, J = 8.1 Hz, 2H), 3.02 
(s, 3H), 2.79 (s, 3H), 2.62 (d, J = 13.9 Hz, 1H), 2.26 (s, 2H), 1.17 (q, J = 7.2 Hz, 6H). 
 
 
Epoxide (188). Phosphazene base P2-tBu (2M in THF, 34.0 µL, 68.4 µmol) was 
added to a solution of aldehyde 187 (10.0 mg, 68.4 µmol) and ylide 180 (88.0 mg, 68.4 
µmol) in THF (3.4 mL) at -78 °C. After stirring for 1 h at -78 °C, the reaction mixture 
was allowed to warm to 23 °C. The resulting solution was diluted with CH2Cl2 (5 mL) 
and water (5 mL). The two phases were separated and the aqueous layer was extracted 
with CH2Cl2 (3x10 mL). The combined organic layers were dried with sodium sulfate, 
evaporated and purified by column chromatography (silica, 100% hexane, 3% triethyl 
amine) to afford 188 (9.8 mg, 60.9 µmol, 89%, 85% ee). 1H NMR (500 MHz, CDCl3) δ 
(ppm): 7.37 – 7.31 (m, 2H), 7.31 – 7.26 (m, 2H), 7.27 – 7.21 (m, 2H), 6.70 – 6.62 (m, 
1H), 3.50 (ddd, J = 4.2, 2.7, 0.7 Hz, 1H), 2.95 (dd, J = 5.2, 4.2 Hz, 1H), 2.82 (dd, J = 5.2, 






















Alkene (194). n-BuLi (2.13 M in hexane, 434 µL, 0.924 mmol) was added to a mixture 
of methyltriphenylphosphonium bromide (0.417 g, 1.17 mmol) in THF (18 mL) at -78 
°C. After 45 min, a solution of aldehyde 148 (36.0 mg, 48.7 µmol) dissolved in THF (6.4 
mL total with rinses) was added dropwise. After 30 min the solution was allowed to 
warm to -10 °C and stirred for 20 min. Quench with a saturated aqueous solution of 
ammonium chloride. The aqueous layer was extracted with ethyl acetate (3x20 mL). The 
combined organic layers were washed with brine, dried with sodium sulfate, 
concentrated, and the residue was purified by column chromatography (silica, 60% ethyl 
acetate – hexanes) to give 194 (17.0 mg, 24.4 µmol, 50%). 1H NMR (600 MHz, CDCl3); 
δ (ppm): 6.28 (dd, J = 17.5, 10.6 Hz, 1H), 5.25 – 5.09 (m, 2H), 5.04 (d, J = 10.8 Hz, 1H), 
4.80 (d, J = 25.3 Hz, 2H), 4.35 (t, J = 2.9 Hz, 1H), 4.20 – 4.01 (m, 2H), 3.93 (dd, J = 
11.5, 4.4 Hz, 1H), 3.58 (d, J = 9.2 Hz, 1H), 3.17 (d, J = 7.4 Hz, 2H), 2.99 (d, J = 11.5 Hz, 
1H), 2.54 (dt, J = 15.9, 7.6 Hz, 1H), 2.44 (ddd, J = 17.6, 7.8, 4.4 Hz, 1H), 2.39 – 2.26 (m, 
3H), 2.25 – 1.61 (m, 33H), 1.43 – 1.28 (m, 6H), 1.24 – 1.14 (m, 4H), 0.98 (d, J = 6.8 Hz, 



























PnTX G (193). Triphenylphosphine (16.0 mg, 59.3 µmol) was added to a solution of 
194 (17.5 mg, 23.7 µmol), triethylamine (33 µL, 0.237 mmol) in THF−H2O (3:1, 8.0 
mL). The reaction vessel was capped and heated at 55 °C for 36 h. After cooling, the 
reaction mixture was concentrated under reduced pressure. The crude material was 
dissolved in 5 mL of distilled toluene and concentrated and this was repeated three times. 
The crude residue was used immediately to the next step without further purification.  
The crude residue was dissolved in 19 mL of a mixture prepared by dissolving 2,4,6-
trimethylbenzoic acid (0.160 g, 0.972 mmol) and triethylamine (136.0 µL, 0.972 mmol) 
in 25 mL of freshly distilled toluene. The solution was heated at 85 °C for 60 h. After 
cooling, the solution was directly applied on a silica column (silica, 60% ethyl acetate – 
hexanes) to afford PnTX G 193 (15.9 mg, 21.8 µmol, 92%).  1H NMR (600 MHz, CDCl3) 
δ (ppm): 6.28 (dd, J = 17.5, 10.7 Hz, 1H), 5.21 – 5.11 (m, 2H), 5.04 (d, J = 10.7 Hz, 1H), 
4.80 – 4.67 (m, 2H), 4.47 (dd, J = 5.0, 2.0 Hz, 1H), 4.15 – 4.00 (m, 2H), 3.87 (dd, J = 
11.5, 4.9 Hz, 1H), 3.83 – 3.76 (m, 1H), 3.72 (s, 1H), 3.62 (dd, J = 11.2, 1.5 Hz, 1H), 3.37 
(d, J = 11.5 Hz, 1H), 3.05 – 2.90 (m, 1H), 2.41 – 2.11 (m, 8H), 2.11 – 1.99 (m, 2H), 1.98 
– 1.82 (m, 4H), 1.82 – 1.56 (m, 10H), 1.56 – 1.33 (m, 4H), 1.23 (s, 3H), 1.17 (d, J = 6.7 





















    Et3N (10 equiv)
    55 oC, 36 h
2.






Tetraol (192). AD-mix-α (32.0 mg, 2 mol%) was added to a solution of 193 (8.0 mg, 
11.5 µmol) in tert-butanol (0.6 mL) and water (0.6 mL) at 0 °C. The reaction mixture was 
stirred at 0 °C for 5 h. The reaction mixture was quenched with aqueous solution of 
sodium sulfite (5 mL) and stirred at 23 °C for 30 min. The resulting solution was diluted 
with ethyl acetate and the two layers were separated. The aqueous layer was extracted 
with ethyl acetate (3x5 mL) and the combined organic layers were dried with sodium 
sulfate and concentrated. The crude residue was purified by column chromatrography 
(silica, 60% ethyl acetate – hexanes) to afford tetraol 192 (15.9 mg, 21.8 µmol, 92%).  1H 
NMR (600 MHz, CDCl3) δ (ppm): 5.24 (d, J = 7.8 Hz, 1H), 5.11 (s, 1H), 4.76 (d, J = 8.2 
Hz, 2H), 4.47 (d, J = 5.1 Hz, 1H), 4.29 (hept, J = 6.9 Hz, 2H), 4.16 – 4.00 (m, 3H), 3.90 – 
3.83 (m, 2H), 3.76 (s, 1H), 3.68 (d, J = 17.0 Hz, 1H), 3.61 (d, J = 11.1 Hz, 1H), 3.53 
(ddd, J = 18.0, 11.0, 7.7 Hz, 1H), 3.45 – 3.38 (m, 1H), 3.35 (s, 1H), 3.29 (d, J = 10.6 Hz, 
1H), 2.96 (t, J = 14.2 Hz, 1H), 2.32 (d, J = 14.4 Hz, 2H), 2.28 – 2.09 (m, 2H), 2.03 (dd, J 
= 15.1, 4.8 Hz, 1H), 1.96 – 1.90 (m, 1H), 1.89 – 1.81 (m, 3H), 1.76 – 1.55 (m, 20H), 1.47 
(dd, J = 13.9, 12.0 Hz, 1H), 1.23 (s, 3H), 1.17 (d, J = 6.7 Hz, 3H), 1.03 (dd, J = 6.8, 2.1 



































































































































































































































































































































































































































































































                                                
1 Dalisay, D. S.; Morinaka, B. I.; Skepper, C. K.; Molinski, T.F. J. Am. Chem. Soc. 2009, 
131, 7552-7553. 
2 (a) Searle, P. A.; Molinski, T. F. J. Am. Chem. Soc. 1995, 117, 8126. (b) Searle, P. A.; 
Molinski, T. F.; Brzezinski, L. J.; Leahy, J. W. J. Am. Chem. Soc. 1996, 118, 9422. (c) 
Molinski, T. F. Tetrahedron Lett. 1996, 37, 7879. (d) MacMillan, J. B.; Xiong-Zhou, G.; 
Skepper, C. K.; Molinski, T. F. J. Org. Chem. 2008, 73, 3699. (e) Skepper, C. K.; 
MacMillan, J. B.; Zhou, G. X.; Masuno, M. N.; Molinski, T. F. J. Am. Chem. Soc. 2007, 
129, 4150. 
3 (a) MacMillan, J. B.; Xiong-Zhou, G.; Skepper, C. K.; Molinski, T. F. J. Org. Chem. 
2008, 73, 3699. (b) Skepper, C. K.; MacMillan, J. B.; Zhou, G. X.; Masuno, M. N.; 
Molinski, T. F. J. Am. Chem. Soc. 2007, 129, 4150. 
4 (a) Zampella, A.; D’Auria, M. V.; Minale, L.; Debitus, C.; Roussakis, C. J. Am. Chem. 
Soc. 1996, 118, 11085. (b) Zampella, A.; D’Auria, M. V.; Minale, L.; Debitus, C. 
Tetrahedron Lett. 1997, 53, 3243. (c) Burch, J. D.; Evans, D. A. Org. Lett. 2001, 3, 503-
505. (d) (a) Trost, B. M.; Dirat, O.; Gunzner, J. L. Angew. Chem., Int. Ed. 2002, 41, 841–
843. (b) Evans, D. A.; Hu, J.; Burch, J. D.; Jaeschke, G. J. Am. Chem. Soc. 2002, 124, 
5654–5655. (c) Trost, B. M.; Gunzner, J. L.; Dirat, O.; Rhee, Y. H. J. Am. Chem. Soc. 
2002, 124, 10396– 10415. (d) Paterson, I.; Davies, R. D. M.; Heimann, A. C.; Marquez, 
R.; Meyer, A. Org. Lett. 2003, 5, 4477–4480. (e) Huang, H.; Panek, J. S. Org. Lett. 2004, 
6, 4383–4385. (f) Evans, D. A.; Burch, J. D.; Hu, E.; Jaeschke, G. Tetrahedron. 2008, 64, 
4671–4699. (g) Carpenter, J.; Northrup, A. B.; Chung, D.; Wiener, J. J. M.; Kim, S.-G.; 
MacMillan, D. W. C. Angew. Chem., Int. Ed. 2008, 47, 3568–3572.  
 349 
                                                                                                                                            
5 Chlorocyclopropyl alcohol was reported in the synthetic study towards callipeltoside A. 
Valazquez, F.; Henrique, T. C.; Olivo, H. F.  Org. Lett. 2000, 2, 4055-4058.  
6 Flores, B.; Molinski, T. F. Org. Lett. 2011, 13, 3932-3935. 
7 (a) Shaner, C. E.; Ferrence, G. M.; Mitchell, A. T. Synlett 2013, 24, 1861-1864. (b) 
Olson, C. A.; Shaner, C. E.; Roche, S. C.; Ferrence, G. M.; Mitchell, A. T. Synthesis 
2015, 47, 2756-2766. 
8 Xiao, Q.; Young, K.; Zakarian, A. Org. Lett. 2013, 15, 3314-3317. 
9 (a) Duboudin, J. G.; Jousseaume, B.; Saux, A. J. Organomet. Chem. 1979, 168, 1–11. 
(b) Liu, F.; Negishi, E. J. Org. Chem. 1997, 62, 8591–8594.  
10 Boeckman, R. K., Jr.; Thomas, A. J. J. Org. Chem. 1982, 47, 2823–2824. 
11 (a) Reber, K. P.; Tilley, S. D.; Sorensen, E. J. Chem. Soc. Rev. 2009, 38, 3022–
3034. (b) Clemens, R. J.; Witzeman, J. S. J. Am. Chem. Soc. 1989, 111, 2186–2193. 
12 Reber, K. P.; Tilley, S. D.; Sorensen, E. J. Chem. Soc. Rev. 2009, 38, 3022–3034. (b) 
Clemens, R. J.; Witzeman, J. S. J. Am. Chem. Soc. 1989, 111, 2186–2193.  
13 (a) Scheerer, J. R.; Lawrence, J. F.; Wang, G. C.; Evans, D. A. J. Am. Chem. Soc. 
2007, 129, 8968–8969 (b) Yang, Z.; Shannon, D.; Truong, V.-L.; Deslongchamps, P. 
Org. Lett. 2002, 4, 4693–4696. (c) Petrovic, D.; Bruckner, R. Org. Lett. 2011, 13, 6524– 
6527. (d) Xue, H.; Yang, J.; Gopal, P. Org. Lett. 2011, 13, 5696–5699. 
14 (a) Stivala, C. E.; Zakarian, A. J. Am. Chem. Soc. 2008, 130, 3774–3776. (b) Stivala, 
C. E.; Zakarian, A. Org. Lett. 2009, 11, 839–842. (c) Araoz, R.; Servent, D.; Molgo, J.; 
 350 
                                                                                                                                            
Iorga, B. I.; Fruchart-Gaillard, C.; Benoit, E.; Gu, Z.; Stivala, C.; Zakarian, A. J. Am. 
Chem. Soc. 2011, 133, 10499–10511. (d) Stivala, C. E.; Zakarian, A. Tetrahedron Lett. 
2007, 48, 6845–6848.  
15 (a) Duboudin, J. G.; Jousseaume, B.; Saux, A. J. Organomet. Chem. 1979, 168, 1–11. 
(b) Liu, F.; Negishi, E. J. Org. Chem. 1997, 62, 8591–8594. (c) Liu, P.; Jacobsen, E. N. J. 
Am. Chem. Soc. 2001, 123, 10772– 10773. (d) Clausen, D. J.; Wan, S.; Floreancig, P. E. 
Angew. Chem., Int. Ed. 2011, 50, 5178–5181.  
16 (a) Chatterjee, A. K.; Morgan, J. P.; Scholl, M.; Grubbs, R. H. J. Am. Chem. Soc. 2000, 
122, 3783–3784. (b) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. 
Chem. Soc. 2000, 122, 8168– 8179. (c) Dewi, P.; Randl, S.; Blechert, S. Tetrahedron 
Lett. 2005, 46, 577–580. 
17 (a) N. Yoshikawa, M. Shibasaki, Chem. Rev. 2002, 102, 2187–2209; (b) G. A. 
Molander, J. B. Etter, Tetrahedron Lett. 1984, 25, 3281–3284; (c) G. A. Molander, G. 
Hahn, J. Org. Chem. 1986, 51, 1135–1138; (d) H. B. Kagan, J. L. Namy, Tetrahedron 
1986, 42, 6573–6614; (e) Z. Hou, Y. Fujiwara, H. Taniguchi, J. Org. Chem. 1988, 53, 
3118–3120; (f) M. F. Lappert, J. Organomet. Chem. 1995, 489, C92–C93.  
18 (a) M. Terada, H. Matsuzawa, K. Mikami, Angew. Chem. Int. Ed. 2002, 41, 3554–
3571; Angew. Chem. 2002, 114, 3704; (b) F. Bonadies, A. O. Lattanzi, R. Liliana, S. 
Pesci, A. Scettri, Tetrahedron Lett. 1993, 34, 7649–7650; (c) U. Groth, M. Jeske, Angew. 
Chem. Int. Ed. 2000, 39, 574–576; Angew. Chem. 2000, 112, 586; (d) J. Kratsch, P. W. 
Roesky, Angew. Chem. Int. Ed. 2014, 53, 376–383; (e) A. Krasovskiy, F. Kopp, P. 
Knochel, Angew. Chem. Int. Ed. 2006, 45, 497–500; Angew. Chem. 2006, 118, 511; (f) S. 
 351 
                                                                                                                                            
Kobayashi, Synlett 1994, 9, 689–701; (g) F. Bonadies, A. Lattanzi, L. R. Orelli, S. Pesci, 
A. Scettri, Tetrahedron Lett. 1993, 34, 7649–7650; (h) O. Ujikawa, J. Inanaga, M. 
Yamaguchi, Tetrahedron Lett. 1989, 30, 2837–2840; (i) F. B. Etter, G. A. Molander, J. 
Am. Chem. Soc. 1987, 109, 6556–6558; (j) H. C. Aspinall, Chem. Rev. 2002, 102, 1807–
1850. 
19 a) A. Nakao, K. Hayashi, Y. Fukuda, J. Chem. Soc., Dalton Trans. 2002, 4, 527–533; 
b) D. Li, J. Wang, L. Kang, T. Wu, Y. Li, X. You, C. Li, Eur. J. Inorg. Chem. 2009, 32, 
4844–4849; c) Q. Mei, B. Tong, Acta Crystallogr. Sect. E 2010, 66, m18; d) K. Hayashi, 
N. Nagao, K. Harada, M. Haga, Y. Fukuda, Chem. Lett. 1998, 27, 1173–1174. 
20 We found only one example for the use of a chiral terpyridine ligand in asymmetric 
catalysis: W. Wong, W. Lee, L. Cheng, W. Wong, H. Kwong, Tetrahedron: Asymmetry 
2001, 12, 2683–2694. 
21 (a) Largy, E.; Hamon, F.; Rosu, F.; Gabelica, V.; De Pauw, E.; Guédin, A.; Mergny, J.; 
Teulade-Fichou, M., Chem. Eur. J., 2011, 17, 13274-13283. (b) Wong, W.; Lee, W.; 
Cheng, L.; Wong, W.; Kwong, H., Tetrahedron: Asymmetry, 2001, 12, 2683-2694. 
22 (a) B. Zhao, T.-P. Loh, Org. Lett. 2013, 15, 2914. (b) R. L. Melby, J. N. Rose, E. 
Abramson, J. C. Caris, J. Am. Chem. Soc. 1964, 86, 5117–5125; (c) C. Freund, W. 
Porzio, U. Giovanella, F. Vignali, M. Pasini, S. Destri, Inorg. Chem. 2011, 50, 5417–
5429; (d) C. J. Kuehl, R. E. Da Re, B. L. Scott, D. E. Morris, K. D. John, Chem. 
Commun. 2003, 18, 2336–2337; (e) D. Li, C. Li, J. Wang, L. Kang, T. Wu, Y. Li, X. 
You, Eur. J. Inorg. Chem. 2009, 32, 4844–4849. 
23 Young, K.; Xiao, Q.; Zakarian, A. J. Am. Chem. Soc. 2015, 137, 5907-5910. 
 352 
                                                                                                                                            
24 Commercially available (+)-β-citronellene from Sigma-Aldrich comes as 70% ee. 
Instead, (+)-β-citronellene can be made in four steps from geraniol that starts with Noyori 
asymmetric hydrogenation to the corresponding citronellol in upwards of 95% ee. See 
following references: Takaya, H., Ohta, T., Sayo, N., Kumobayashi, H., Akutagawa, S., 
Inoue, S., Kasahara, I. & Noyori, R. (1987) J. Am. Chem. Soc. 109, 1596–1597, and 
correction (1987) 109, 4129. 
25 Kister, J.; Mioskowski, C. J. Org. Chem. 2007, 72, 3925. 
26 Perryman, M. S.; Harris, M. E.; Foster, J. L.; Joshi, A.; Clarkson, G. J.; Fox, D. J. 
Chem. Commun. 2013, 49, 10022. 
27 Xiao, Q.; Young, K.; Zakarian, A. Org. Lett. 2013, 15, 3314. 
28 (a) Tan, C.-H.; Holmes, A. B. Chem. Eur. J. 2001, 7, 1845. (b) Araoz, R.; Servent, D.; 
Molgó, J.; Iorga, B. I.; Fruchart-Gaillard, C.; Benoit, E.; Gu, Z.; Stivala, C.; Zakarian, A. 
J. Am. Chem. Soc. 2011, 133, 10499. (c) Lu, C.-D.; Zakarian, A. Org. Lett. 2007, 9, 3161.  
29 (d) Beaulieu, L.-P. B.; Zimmer, L. E.; Gagnon, A.; Charette, A. B. Chem. Eur. J. 2012, 
18, 14784. 
30 Liu, Y.; Wang, Q.; Zhang, Q.; Huang, J.; Nie, L.; Chen, J.; Cao, W.; Wu, X. J. Org. 
Chem. 2013, 78, 12009. 
31 Parenty, A.; Moreau, X.; Niel, G.; Campagne, J. M. Chem. Rev. 2013, 113, PR1−PR40. 
32 Palmer, C. F.; Parry, P. K.; Roberts, S. M.; Sik, V. J. Chem. Soc., Perkin Trans. 1 
1992, 8, 1021. 
 353 
                                                                                                                                            
33 Stivala, C. E.; Benoit, E.; Araoz, R.; Servent, D.; Novikov, A.; Molgo, J.; Zakarian, A. 
Nat. Prod. Rep. 2015, 32, 411-435. 
34 (a) Rhodes, L.; Smith, K.; Selwood, A. I.; McNabb, P.; van Ginkel, R.; Holland, P. T.; 
Munday, R. Harmful Algae 2010, 9, 384–389.  
35 Selwood, A. I.; Miles, C. O.; Wilkins, A. L.; van, G. R.; Munday, R.; Rise, F.; 
McNabb, P. J. Agric. Food Chem. 2010, 58, 6532–6542. 
36 (a) Otofuji, T.; Ogo, A,; Koishi, J.; Matsuo, K.; Tokiwa, H.; Yasumoto, T.; Nishihara, 
K.; Yamamoto, E.; Saisho, M.; Kurihara, Y.; Hayashida, K. Food Sunit. Res. 1981, 31, 
76-83. (b) Department of Public Health, Fukuoka Prefecture. Food Sanit. Res. 1976, 26, 
11-20. Zheng, S. Z.; Huang, F. L.; Chen, S.C.; Tan, X. F.; Zuo, J. B.; Peng, J.; Xie, R. W. 
Zhongguo Haiyang Yaowu (Chin. J. Mar. Drugs) 1990, 33, 33-35.  
37 Uemura, D.; Chou, T.; Haino, T.; Nagatsu, A.; Fukuzawa, S.; Chen, Z. H. J. Am. 
Chem. Soc., 1995, 117, 1155-1156. 
38 Chou, T.; Haino, T.; Nagatsu, A.; Fukuzawa, S.; Zheng, S.; Chen, H.; Uemura, D. J. 
Am. Chem. Soc. 1995, 117, 1155-1156. 
39 (a) Takada N, Umemura N, Suenaga K, Chou T, Nagatsu A, Haino T, Yamada K, 
Uemura D. Tetrahedron Lett. 2001, 42, 3491. (b) Takada N, Umemura N, Suenaga K, 
Uemura D. Tetrahedron Lett. 2001, 42, 3495. 
40 Chou, T.; Haino, T.; Kuramoto, M.; Uemura, D., Tetrahedron Letters, 1996, 37, 4027-
4030.  
 354 
                                                                                                                                            
41 Takada, J.; Umemura, N.; Suenaga, K.; Chou, T.; Nagatsu, A.; Haino, T.; Yamada, K.; 
Uemura, D., Tetrahedron Letters, 2001, 42, 3491-3494. (b) Takada, N.; Umemura, N.; 
Suenaga, K.; Uemura, D., Tetrahedron Letters, 2001, 42, 3495- 3497.  
42 Alexander, J.; Benford, D.; Boobis, A.; Ceccetallie, S.; Cravedi, J-F.; Domenico, A. D.; 
Doerge, D.; Dogliotti, E.; Elder, L.; Farmer, P.; Filipic, M.; Fink-Gremmels, J.; Furts, P.; 
Guerin, T.; Knutsen, H. K.; Machala, M.; Mutti, A.; Schlatter, J.; van Leeuwen, R., 
European Food Safety Authority (EFSA) Journal, 2010, 8, 1628-1639. 
43 Alexander, J.; Benford, D.; Boobis, A.; Ceccetallie, S.; Cravedi, J-F.; Domenico, A. D.; 
Doerge, D.; Dogliotti, E.; Elder, L.; Farmer, P.; Filipic, M.; Fink-Gremmels, J.; Furts, P.; 
Guerin, T.; Knutsen, H. K.; Machala, M.; Mutti, A.; Schlatter, J.; van Leeuwen, R., 
European Food Safety Authority (EFSA) Journal, 2010, 8, 1628-1639. 
44 Stivala, C. E.; Benoit, E.; Araoz, R.; Servent, D.; Novikov, A.; Molgo, J.; Zakarian, A. 
Nat. Prod. Rep. 2015, 32, 411-435. 
45 MacKinnon, S. L.; Cembella, A. D.; Burton, I. W.; Lewis, N.; LeBlanc, P.; Walter, J. 
A., J. Org. Chem. 2006, 71, 8724–8731. 
46 Matsuura, F.; Peters, R.; Anada, M.; Harried, S. S.; Junliang, H.; Kishi, Y., J. Am. 
Chem. Soc. 2006, 128, 7463-7465. (b) Hao, J.; Matsuura, F.; Masaki, K.; Kishi, Y.; 
Uemura, D.; Asai, N.; Iwashita, T., J. Am. Chem. Soc. 2006, 128, 7742-7743. (c) 
McCauley, J. A.; Nagasawa, K.; Lander, P. A.; Mischke, S. G.; Semones, M. A.; Kishi, 
Y., J. Am. Chem. Soc. 1998, 120, 7647-7648. 
 355 
                                                                                                                                            
47 (a) Ishihara, J.; Sugimoto, T.; Murai, A., Synlett. 1998, 603–606. (b) Sugimoto, T.; 
Ishihara, J.; Murai, A., Tetrahedron Lett. 1997, 38, 7379–7382. (c) Sugimoto, T.; 
Ishihara, J.; Murai, A., Synlett. 1999, 541–544. 
48 Sakamoto, S.; Sakazaki, H.; Hagiwara, K.; Kamada, K.; Ishii, K.; Noda, T.; Inoue, M.; 
Hirama, M., Angew. Chem., Int. Ed. 2004, 43, 6505–6510. 
49 Nakamura, S.; Kikuchi, F.; Hashimoto, S., Angew. Chem., Int. Ed. 2008, 47, 7091-
7094. 
50 (a) Stivala, C. E.; Zakarian, A., J. Am. Chem. Soc. 2008, 130, 3774-3776. (b) Araoz, 
R.; Servent, D.; Molgo, J.; Iorga, B. I.; Fruchart-Gaillard, C.; Benoit, E.; Gu, Z.; Stivala, 
C.; Zakarian, A., J. Am. Chem. Soc. 2011, 133, 10499-10511. 
51 Matsuura, F.; Peters, R.; Anada, M.; Harried, S. S.; Junliang, H.; Kishi, Y., J. Am. 
Chem. Soc. 2006, 128, 7463-7465. (b) Hao, J.; Matsuura, F.; Masaki, K.; Kishi, Y.; 
Uemura, D.; Asai, N.; Iwashita, T., J. Am. Chem. Soc. 2006, 128, 7742-7743. (c) 
McCauley, J. A.; Nagasawa, K.; Lander, P. A.; Mischke, S. G.; Semones, M. A.; Kishi, 
Y., J. Am. Chem. Soc. 1998, 120, 7647-7648. 
52 (a) Ishihara, J.; Horie, T.; Murai, A. Synlett 1998, 603-606. (b) Sugimoto, T.; Ishihara, 
J.; Murai, A. Tetrahedron Lett. 1997, 38, 7379-7382. (c) Sugimoto, T.; Ishihara, J.; 
Murai, A. Synlett 1999, 541-544.  
53 (a) Stivala, C. E.; Zakarian, A., J. Am. Chem. Soc. 2008, 130, 3774-3776. (b) Araoz, 
R.; Servent, D.; Molgo, J.; Iorga, B. I.; Fruchart-Gaillard, C.; Benoit, E.; Gu, Z.; Stivala, 
C.; Zakarian, A., J. Am. Chem. Soc. 2011, 133, 10499-10511. 
54 Changeux, J. P., J. Biol. Chem. 2012, 287, 40207-40215. 
 356 
                                                                                                                                            
55 Kalamida, D.; Poulas, K.; Avramopoulou, V.; Fostieri, E.; Lagoumintzis, G.; Lazaridis, 
K.; Sideri, A.; Zouridakis, M.; Txartos, S. J., FEBS J. 2007, 274, 3799-3845. 
56 Alexander, S. P.; Peters, J. A.; Kelly, E.; Marrion, N.; Benson, H. E.; Faccenda, E.; 
Pawson, A. J.; Sharman, J. L.; Southan, C.; Davies, J. A., Br. J. Pharmacol. 2015, 172, 
5870-5903. 
57 (a) Wong, D. F.; Kuwabara, H.; Kim, J.; Brasic, J. R.; Chamroonrat, W.; Gao, Y.; 
Valentine, H.; Willis, W.; Mathur, A.; McCaul, M. E.; Wand, G.; Gean, E. G.; Dannals, 
R. F.; Horti, A. G. Journal of Nuclear Medicine, 2013, 54, 1-7. (b) Chokkathukalam, A.; 
Kim, D. H.; Barrett, M. P.; Breitling, R.; Creek, D. J. Bioanalysis 2014, 6, 511–524. (d) 
Alauddin, M. M. Am. J. Nucl. Med. Mol. Imaging. 2012; 2, 55–76. (e) Klein, S.; Heinzle, 
E. WIREs Syst. Biol. Med. 2012, 4, 261–272. 
58 Posada, I.; Lopez-Hernandez, B.; Cena, V., Curr. Neuropharmacol. 2013, 11, 298-314. 
59  (a) Schoenheimer, R.; Rittenberg, D. J. Biol. Chem. 1935, 111, 163–168. (b) 
Schoenheimer, R.; Rittenberg, D. J. Biol. Chem. 1937, 121, 235–253. 
60  Chokkathakalam, A.; Kim, D-H.; Barrett, M. P.; Breitling, R.; Creek, D. J., 
Bioanalysis, 2014, 6, 511-514. Iglesias, J.; Sleno, L.; Volmer, D. A., Curr. Drug Metab. 
2012, 13, 1213-1225. 
61 Elmore, C. S.; Bragg, R. A. Bioorganic & Medicinal Chemistry Letters 2015, 25, 167–
171. 
62 Solon, E. G.; Kraus, L. J Pharmacol Toxicol Methods 2001, 46, 73-81.  
 357 
                                                                                                                                            
63 Ma, Y.; Kiesewetter, D. O.; Lang, L.; Gu, D.; Chen, X. Curr Drug Metab. 2010, 11, 
483–493.  
64  Pichikaa, R.; Easwaramoorthya, B.; Collinsa, D.; Christianb, B. T.; Shib, B.; 
Narayananb, T. K.; Potkina, S. G.; Mukherjeea, J. Nuclear Medicine and Biology  2006, 
33, 295–304.  
65 (a) Robertson, D.W.; Bloomquist, W.; Cohen, M. L.; Reid, L. R.; Schenck, K.; Wong, 
D. T. J . Med. Chem. 1990, 33, 3176-3181, (b) Martín, A.; Szczupak, B.; Gomez-Vallejo, 
V.; Domerc, M.; Cano, A.; Padro, D.; Munoz, C.; Higuchi, M.; Matute, C.; Llop, J. The 
Journal of Neuroscience, 2015, 5, 5998–6009.  
66 Ostlund, R. E.; Seemayer, R.; Gupta, S.; Kimmel, R.; Ostlund, E. L.; Sherman, W. R., 
J. Biol. Chem. 1996, 271, 10073-10078. 
67 Kim, D-Y.; Kim, H-J.; Yu, K-H, Min, J-J., Biorg. Med. Chem. Lett. 2012, 22, 319-322. 
68 Kuboyama, T.; Nakahara, M.; Yoshino, M.; Cui, Y.; Sako, T.; Wada, Y.; Imanishi, T.; 
Obika, S.; Watanabe, Y.; Suzuki, M.; Doi, H., Bioorg. and Med. Chem. 2011, 19, 249-
255. 
69 Muller, S. B.; Liepold, G.; Roth, J.; Bestmann, J., Synlett. 1996, 6, 521-522. 
70 Schrigten, D.; Breyholz, H-J.; Wagner, S.; Hermann, S.; Schober, O.; Schaefers, M.; 
Haufre, G.; Kopka, K., J. Med. Chem. 2012, 55, 223-232. 
71 Himo, F.; Lovell, T.; Hilgraf, R.; Rostovtsev, V. V.; Noodleman, L.; Sharpless, K. B., 
J. Am. Chem. Soc. 2005, 127, 210-216. 
 358 
                                                                                                                                            
72 Wu, H.; Liu, B.; Kou, F.; Jia, F.; Yuan, J.; Bai, Y. J. Chin. Chem. Soc. 2012, 59, 836-
842. (b) Chuanopparat, N.; Kongkathip, N.; Kongkathip, B. Tet. Lett. 2012, 53, 6209-
6211.  
73 Matsuura, F.; Peters, R.; Anada, M.; Harried, S. S.; Hao, J.; Kishi, Y. J. Am. Chem. 
Soc. 2006, 128, 7463-7465. 
74 Hao, J.; Matsuura, F.; Kishi, Y.; Kita, M.; Uemura, D.; Asai, N.; Iwashita, T. J. Am. 
Chem. Soc. 2006, 128, 7742-7743. 
75 (a) Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K. S.; Kwong, H. 
L.; Morikawa, K.; Wang, Z. M.; Xu, D.; Zhang, X. L. Sharpless, B. K. J. Org. Chem. 
1992, 57, 2771-2773. (b) Lee, H. M.; Nieto-Oberhuber, C.; Shair, M. D. J. Am. Chem. 
Soc. 2008, 130, 16864–16866. 
76 Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, B. K. Chemical Reviews, 1994, 94, 
2483-2547. 
77 Van, T. N.; De Kimpe, N. Tetrahedron 2000, 56, 7969-7973. 
78 (a) Duboudin, J. G.; Jousseaume, B., Saux, A. J. Organomet. Chem. 1979, 168, 1-11. 
(b) Liu, F.; Negishi, E. J. Org. Chem. 1997, 62, 8591–8594. 
79 Takaya, H.; Ohta, T.; Inoue, S.; Tokunaga, M.; Kitamura, M.; Noyori, R. Org. Synth. 
1995, 72, 74. 
80 (a) Tan, C-H.; Holmes, A. B. Chem. Eur. J. 2001, 7, 1845-1854. (b) Araoz, R.; 
Servent, D.; Molgó, J.; Iorga, B. I.; Fruchart-Gaillard, C.; Benoit, E.; Gu, Z.; Stivala, C.; 
Zakarian, A. J. Am. Chem. Soc. 2011, 133, 10499-10511. 
 359 
                                                                                                                                            
81 Beaulieu, L-P, B.; Zimmer, L. E.; Gagnon, A.; Charette, A. B. Chem. Eur. J. 2012, 18, 
14784-14791. 
 
 
